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ABSTRACT 
 
Human color perception is mediated by cone photoreceptor cells which mainly locate on the fovea 
of the eye. Bright light activates the photosensitive opsin pigments which are embedded in the 
outer segment membrane discs of cone retinal cells thereby initiating the complex process of 
photopic vision with a fast response. The cone visual pigments are G-protein coupled receptors 
which share analogous structure and functional features with rhodopsin, the most thoroughly 
studied G-protein coupled receptor from rod photoreceptor cells mediating scotopic vision and 
distributed throughout the retina. These visual pigments are believed to play an unique role in 
modulating spectral tuning of visible light depending on the molecular variance around the protein 
bound chromophore, 11-cis-retinal, which is a vitamin A derivative acting as an inverse agonist. 
Various mutations have been clinically identified in the cone opsin genes and associated with 
visual dysfunction ranging from mild color blindness to severe cone dystrophies. As the crystal 
structure of the cone pigments is yet to be resolved, identifying key molecular mechanisms that 
play major roles in optimal functioning of these photoreceptor proteins, should be helpful in 
providing a deeper understanding of their function and in designing novel therapeutic strategies 
for congenital retinal cone dysfunction.   
In order to study such light sensitive, delicate membrane proteins, the human cone opsin genes 
have been transiently expressed in mammalian cells, regenerated with their natural chromophore 
and immunopurified in dark conditions. The purified recombinant chromophore-regenerated cone 
opsins in solution have been characterized in detail by means of biophysical approaches, including 
spectroscopic, biochemical, and functional analysis, in order to uncover novel properties that help 
in optimizing the function of these receptors. The studied molecular properties of cone opsins, 
include stability in solution, the mechanism of chromophore regeneration and their functional 
analysis have been compared to those of rhodopsin. Site-directed mutagenesis was employed to 
obtain the clinically identified mutations in cone opsins related to visual disorders and to compare 
the structure and function of these mutated opsins with the molecular properties of the wild-type 
cone opsins expressed in the same way.   
The results of the present study indicate that the cone opsins are less stable in solution and their 
retinal binding site is more open than rhodopsin. The ligand binding studies using retinal analogs, 
show that the photoactivated rhodopsin loses its ability to regenerate with its natural chromophore 
with time but not with an analog, 9-cis-retinal and cone opsins show regeneration with both retinal 
analogs under the same experimental conditions.  
The highly identical red and green cone opsins exhibit different ligand binding modes during 
regeneration with their natural chromophore, 11-cis-retinal. A secondary retinal uptake, with a 
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slower kinetics, has been also observed with the red and green cone pigments during regeneration 
with 11-cis-retinal which is altered in the case of blue cone opsin. The role of specific amino acids 
involved in the regeneration mechanism has also been clarified.  
Most of the cone opsin mutants studied, associated with visual disorders, fail to regenerate with 
the ligand due to protein misfolding resulting in aggregation in solution. R330Q green cone opsin 
mutant show a regeneration ability similar to that of the native pigment but a compromised 
transducin binding efficiency. Though the N94K deuteranopic mutant apparently aggregates 
when expressed in mammalian, chromophore binding to opsin would be through an unprotonated 
Schiff base linkage.  
Overall, in the present study the molecular properties of cone opsins have been compared among 
them and with the well-studied rhodopsin. This has led to the proposal of novel molecular 
mechanisms for cone opsins. The determined structural differences between visual pigments may 
be linked to their molecular evolution, and the proposal of secondary retinoid binding to visual 
pigments may function as a regulatory mechanism of dark adaptation in the phototransduction 
process. As the crystal structure of these pigments is yet to be resolved, the identified key 
structural determinants, in the regeneration process, should be helpful in designing novel 
therapeutic strategies for congenital retinal cone dysfunction.   
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ABBREVIATIONS, ACRONYMS AND SYMBOLS 
 
11CR 11-cis-retinal 
7TM seven transmembrane 
9CR  9-cis-retinal 
a.u. arbitrary unit 
ABCA4 ATP-binding cassette subfamily A member 4 
Abs absorbance 
Amax absorption maximum 
ATP adenosine-5’-Triphosphate  
ATR  all-trans-retinal 
BN-PAGE blue native PAGE 
bp basepair  
BSA bovine serum albumin 
BTP bis-tris propane 
c concentration 
cDNA complementray DNA 
cGMP cyclic Guanosine 5’-monophosphate 
CI / CIII cytoplasmic loop I/III 
cpm counts per minute 
CRALBP cellular retinaldehyde binding protein 
DAPI 4', 6-diamidino-2-phenylindole 
DDHAPC 1, 2-didocosahexaenoyl-sn-glycero-3-phosphocholine 
DHPC L--1, 2-dihexanoyl-sn-glycero-3-phosphocholine 
DM n-dodecyl β-D-maltoside 
DMEM Dulbecco's modified eagle's medium  
DMPC 1, 2-dimyristoyl-sn-glycero-3-phosphocholine 
DNA deoxy riboneuclic acid 
dpm disintegrations per minute 
DTNB 5, 5’-dithio-bis-(2-nitrobenzoic acid) 
E I / E III extracellular loop I/III 
FBS fetal bovine serum 
FITC fluorescein isothiocyanate 
GC guanylate cyclase 
GDP guanosine-5’-diphosphate 
GMP guanosine 5’-monophosphate 
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GPCR G-protein coupled receptor 
GTP guanosine 5’-triphosphate 
GTPS35 guanosine 5’-O- (3-thio) triphosphate 
hν quantum of light 
ICL I / ICL III  intracellullar loop I / III 
IPBR interphotoreceptor binding protein  
IPM interphotoreceptor matrix 
L-cone  long wavelength cone opsin / red cone opsin 
l length  
LCA Leber congenital amaurosis 
LCR locus control region 
LN long N-terminus 
LRAT lecithin: retinol acyl transferase 
LWL longer wavelength 
M-cone  middle wavelength cone opsin / green cone opsin 
MES 2-(N-morpholino) ethanesulfonic acid  
MWL middle wavelength 
NADPH nicotinamide adenine dineucleotide phosphate 
NaPi sodium phosphate buffer 
NRPE N-retinylidene phosphotidyl ethanolamine 
P promotor 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDE phosphodiesterase 
PE phosphotidyl ethanolamine 
PEI polyethylenimine 
PSB protonated Schiff base 
PSB11 11-cis-retinal-prononated Schiff base 
PSB13 13-cis-retinal-prononated Schiff base 
PSB7 7-cis-retinal-prononated Schiff base 
PSB9 9-cis-retinal-prononated Schiff base 
PSBT all-trans-retinal-prononated Schiff base 
RDH retinol dehydrogenase 
REH retinyl esterhydrolase 
Rho rhodopsin 
ROS rod outer segment 
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RP  retinitis pigmentosa 
RPE retinal pigment epithelium  
RT room temperature 
RU resonance unit 
S-cone short wavelength cone opsin / blue cone opsin 
SB  Schiff base 
SDS sodium dodecyl sulfate  
SPR surface plasmon resonance 
SWL short wavelength 
t1/2 half-time 
T2R taste2 receptors 
TBS tris buffered saline 
TM1 / TM7  transmembrane1/7 
UV-vis ultra violet – visble 
WT wildtype 
max wavelength maximum 
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Amino acids 
 
A alanine (Ala) 
C cysteine (Cys) 
D aspartate (Asp) 
E glutamate (Glu) 
F phenylalanine (Phe) 
G glycine (Gly) 
H histidine (His) 
I isoleucine (Ile) 
K lysine (Lys) 
L leucine (Leu) 
M methionine (Met) 
N asparagine (Asn) 
P proline (Pro) 
Q glutamine (Gln) 
R arginine (Arg) 
S serine (ser) 
T threonine (Thr) 
V valine (Val) 
W trptophan (Trp) 
Y tyrosine (Tyr) 
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1.1. Cellular  Communication 
A cell is an open system, capable of receiving and transforming mass and energy through the 
plasma membrane. Structurally, cells are defined at their periphery by hydrophobic plasma 
membrane which is majorly composed of lipid and protein molecules that separate the contents 
of the cell from its surroundings (1). In multicellular organisms, the homeostasis is maintained by 
a coordinated communication with the exogenous/environmental mediators or through the 
mediators released by other cells within the living system into the extracellular milieu (2). The 
mediators, otherwise known as external stimuli with most of them being ligands, include light, 
gases, small molecules, amino acids, peptides, proteins, among others. These stimuli exert their 
functions by targeted interactions with specific, complementary, propagative molecules of the 
cells known as receptors.  Based on the nature of these signaling molecules, the receptors are 
classified into two types including intracellular and cell surface receptors. The signaling 
molecules can be transported through the plasma membrane into the cell and exert their function 
by a complementary interaction with intracellular receptors. There are external ligands which can 
elicit a physiological response by interacting with cell surface receptors embedded within the 
plasma membrane (3).  
A cell surface receptor is structurally composed of three domains namely, the extracellular 
domain, the transmembrane domain and the intracellular domain. The extracellular domain 
mainly consists of turns, a typical secondary structure of proteins, and the N-terminus of the 
receptor. This domain is important for the folding of the receptor and may participate in the 
interaction with ligands that may result in a conformational change of the receptor. The 
transmembrane domain is the membrane spanning structure of the receptor which is mainly made 
of hydrophobic residues and consists of -helical segments, or -sheet structure in the -barrel 
structure. The intracellular domain is composed of loops and turns and the C-terminus of the 
protein. This is the functional part of the receptor which initiates the downstream process of signal 
transduction after receptor activation (4). 
A typical mammalian cell can present cell surface receptors to more than 100 different types of 
extracellular signaling molecules. The ligand-imposed conformational changes on these cell 
surface receptors can stimulate various signaling mechanisms depending on the nature of the 
receptor. Based on the functional similarity between the signaling mechanism, the cell surface 
receptors are classified (5) as,  
-  G-protein-coupled receptors: these are receptors with seven transmembrane (TM) -
helices and an intracellular domain interacting with a heterotrimeric G protein. These 
receptors are activated by a wide range of signaling stimuli, such as light, ions, odorant 
molecules, neurotransmitters, hormones, etc. 
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- Receptors associated with enzymatic activity: these are receptors containing mainly a 
single transmembrane -helix with an intracellular domain possessing either intrinsic 
enzymatic activity or associated with enzymes. Receptors associated with immunological 
functions belong to this category.  
- Ligand-gated ion channels: these are receptors in which the transmembrane domain acts 
as an ion pore. Binding of ligand at the extracellular domain either opens or closes the 
ion pore thereby regulate the diffusion of ions into the cell. 
 
 
 
Figure 1.1. Cell surface receptors.  (I) G-protein-coupled receptors, the binding of ligand activates 
the G-protein which in turn engages in further downstream signaling (II) Receptors associated with 
enzymatic activity, binding of the ligand induces receptor dimerization which unleashes the intrinsic 
enzymatic activity of the receptor, (III) Ligand-gated ion channels, binding of a specific ligand opens 
the transmembrane ion channel. 
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1.2. G-protein-coupled receptors 
The G-protein-coupled receptors (GPCRs) superfamily is one of the largest families of proteins 
in the mammalian genome (6). GPCRs are characterized by two main features. The first one 
relates to the presence of seven hydrophobic transmembrane -helices embedded into the cell 
membrane lipid bilayer with each helical stretch of about 25 to 35 amino acids. This 
transmembrane core enables the binding of an extracellular ligand -or a chromophore- in order to 
exert a specific activity towards cellular function. The second principal feature is the ability of 
these seven transmembrane receptors to interact, upon activation, with G-proteins (7).  
The total number of members for the GPCR superfamily is unknown, but it is estimated around 
800 different human genes, of which approximately 350 are known for exhibiting their function 
by detecting hormones, pheromones, growth factors, neurotransmitters and other endogenous 
ligands (8,9).  In human, all these GPCRs are classified in 5 major groups based on their sequence 
and functional similarity known as A-F classification (10,11) which include, 
Class A. The rhodopsin family 
Class B. The secretin family 
Class C. The glutamate family 
Class D . The Adhesion family  
Class F.  Frizzled/Taste2 family 
The typical mechanism of action of GPCRs involves activation by a ligand (or light in the specific 
case of rhodopsin) which causes a conformational change in the inactive receptor, allowing the 
activated conformation to bind and activate a heterotrimeric G-protein. This process encompasses 
GDP for GTP exchange and dissociation of the α-subunit of the G-protein for further signaling 
(12). 
Class A. The Rhodopsin-like GPCRs: class A or rhodopsin family, is the largest group of GPCRs 
containing around 701 receptors and the family is further divided into four subgroups – 
and from which the  subgroup contains visual opsins. These family of GPCRs is highly 
heterogeneous in terms of primary structure and the preference of ligand. Most of the rhodopsin-
like receptors are primarily activated by interactions between the ligand and the transmembrane 
regions and extracellular loops owing to their short N-terminal stretch of amino acids (7,13). 
Class B. The Secretin family GPCRs: the secretin family is a small family of GPCRs, containing 
an extracellular binding domain, possessing hormones and peptide hormones as ligands. All the 
receptors from this family contain conserved cysteine residues in the first and second extracellular  
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Figure 1.2. Classification of GPCR.  The 5 major groups of GPCRS with the number of receptors in 
each group are stated in brackets and the resolved structures are shown in circles. (adapted from GPCR 
network-The Scripps Research Institute) 
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loops of the transmembrane regions. Calcitonin like receptors, glucagon-like peptide receptors 
are some of the members of this family. This class of receptors are the major targets for 
hypercalcaemia, hypoglycaemia and osteoporosis (14,15).  
Class C. The glutamate family GPCRs: calcium sensing receptors, the taste and umami taste 
receptors and several orphan receptors belong to the glutamate family GPCRs. Most members of 
this family of receptors bind their endogenous ligand within the N-terminal region. The ligand-
binding mechanism of receptors of this family has been compared to a Venus flytrap mechanism, 
in which the two lobes of the ligand binding region form a cavity where glutamate binds and 
thereby activates the receptor (16,17). 
Class D. The adhesion family GPCRs: the adhesion family receptors contain a proteolytic domain 
which gets activated on binding of the ligand. This family is also referred as LNB7TM receptors, 
where LN refers to Long N-terminal and the rest denotes the sequence similarity between 
transmembrane regions of class B receptors. The diverse N terminal regions of the adhesion 
family GPCRs may contain several domains that can also be found in other proteins, such as 
adhesion molecules include cadherin, lectin, laminin, olfactomedin, immunoglobulin and 
thrombospondin domains (18,19). 
Class F. Frizzled/Taste2 family GPCRs: this family includes two distinct clusters of receptors, 
the frizzled receptors and the taste2 receptors. The frizzled receptors control cell fate, 
proliferation, and polarity during metazoan development upon activation by secretary 
glycoproteins called Wnt.  These receptors have a 200-amino acid N terminus with conserved 
cysteines that are enabling the binding of Wnt. Human genome contains 25 functional taste2 
receptors (T2R) which are clustered on chromosomes 7q31 and 12p13. The structural diversity 
noted within T2Rs helps to sense the thousands of bitter compounds which can interact with the 
extracellular loops (7,20).  
1.2.1. GPCR numbering system 
Based on the sequence and structural homologies, Ballesteros and Weinstein proposed a 
numbering scheme for GPCRs in order to relate the site-defined properties of amino acids at a 
particular helix of this seven transmembrane superfamily (BW numbering system) (21). Such 
conservation analysis was developed based on the quantitation of the global degree of sequence 
conservation among amino acids at each helix.  Among the various numbering schemes that were 
also proposed for GPCRs, in the BW system there are three numbers assigned to each amino acid 
of the GPCR which is known as identifier. The identifier is noted as X.YY notation, where X is 
the helix identifier and YY, a number that defines the residue based on the most conserved residue 
in the helix. The highly conservative reference residue of each helix is assigned as 50 for YY. For 
example, the most conserved amino acid in TM6 is proline of which the identifier would be P6.50 
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and written as P6.50. A tryptophan residue which is two amino acids above this proline is 
represented as W6.48 and a threonine which is two amino acids below that proline would be written 
as T6.52. The table shows the general numbering scheme for the GPCR sequences which are used 
in this thesis. 
 
 
 
 
 
 
 
 
 
 
Table 1.1. Ballesteros and Weinstein numbering model for GPCR. The conservative residue from 
each transmembrane helices has denoted as integer of the helix, followed by a decimal point as 50 and 
the corresponding amino acid and its positions in rhodopsin are presented. 
 
1.3. Visual Pigments 
Vision provides an animal with an instantaneous ability to detect, perceive, and act around its 
environment and it is believed that vision of vertebrates evolved about 500 million year ago (22).  
The retina is a thin tissue layer of the eye that converts visual signals into electrical impulses 
which are transmitted to the brain. The vertebrates retina contains two kinds of photoreceptor 
cells, rods and cones which were distinguished from each other on the basis of the morphological 
shape of their outer segments. Rods are abundant and distributed throughout the retina, whereas 
cone cells are much scarcer and concentrated mainly on the fovea of the eye (23). It was soon 
established that rod and cone cells are responsible for scotopic and photopic vision mediated by 
rhodopsin and cone opsins, respectively. These photoreceptor cells have membrane invaginations, 
on which the visual pigments are embedded (24). 
The visual pigments found in retinal photoreceptor cells belong to the GPCR superfamily, and 
consist of a heptahelical transmembrane apoprotein, opsin, covalently linked to its natural 
TM helix amino acid BW number 
amino acid number 
in rhodopsin 
TM1 Asn (N) 1.50 55 
TM2 Asp (D) 2.50 83 
TM3 Arg (R) 3.50 135 
TM4 Trp (W) 4.50 161 
TM5 Pro (P) 5.50 215 
TM6 Pro (P) 6.50 267 
TM7 Pro (P) 7.50 303 
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chromophore, the vitamin A derivative, 11-cis-retinal (11CR), acting as an inverse agonist. The 
opsin pigments get activated by a specific wavelength of photons and intiate the phototransduction 
cascade (25).  Photoactivation-induced conformational changes allow the active intermediate 
opsin to bind transducin, the specific heterotrimeric G-protein. Binding of the pigment to 
transducin causes dissociation of its α-subunit which, in turn, activates a cGMP phosphodiesterase 
(23). The physiological response of both rhodopsin and cone opsins is different, with cone opsins 
showing lower sensitivity to light than rhodopsin, which allows rhodopsin to mediate sensitive 
dim light vision whereas cone opsins mediate bright daylight vision (26). This is evident from the 
fact that the rate of transducin activation -by cone opsins- was found to be 5 fold lower than that 
of rhodopsin (27). 
 
 
Figure 1.3. Process of vision. The hierarchy of vision: from eye to visual pigments. The bright light 
focused on the fovea of retina where the cone photoreceptor cells are populated. The membrane 
invaginations of photoreceptor cells, on which the visual pigments are embedded, can be observed. 
(adapted from (28)) 
 
1.3.1. Rhodopsin 
Rhodopsin mediates dim light vision by converting photons into chemical signals that can trigger 
the biological processes which enable the brain to sense the light stimulus (29).  The visual 
pigment rhodopsin is found in the rod outer segments (ROS) of the rod photoreceptor cells from 
the retinal layer. ROS is a specialized compartment that consists of a stack of 1000 – 2000 distinct 
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discs of membrane invaginations enclosed in a plasma membrane. The major protein component 
of these bilayer discs is rhodopsin, which absorbs light and initiates photo-transduction cascade, 
followed by phospholipids and cholesterol. It has been estimated that there are around 8 x 104 
rhodopsin molecules per disc (30,31). The length or ROS increases and the concentration of 
rhodopsin rises, when the light is reduced for an extended time. Such phenomenon is known as 
photostasis, “where the photoreceptor outer segment length and its rhodopsin content vary 
depending on environmental lighting” (32).  
In human, rhodopsin is expressed from the gene RHO/OPN2 that contains five exons spanning 5 
kb which are interrupted by four introns, located cytogenetically at 3q22 chromosome (33).  
Rhodopsin gets activated by the conformational change elicited by the isomerization of 11CR, 
the inverse agonist caused by photons of a wavelength maximum of 500 nm. The rod 
phototransduction system is extremely sensitive so that even a single photon can be detected (34). 
Retinal photoisomerization caused by absorption of a single photon of light is accompanied by a 
shift in the absorption maximum (λmax) from 500 nm to 380 nm. A number of studies address this 
shift in wavelength that results from the opsin conformational change ensuing illumination. This 
shift is a very sensitive parameter, and a number of short-lived photointermediate conformations 
can be detected until all-trans-retinal (ATR) release. The photoactivated intermediates of 
rhodopsin have been shown to be affected by several parameters such as ionic strength, pH, 
glycerol, and temperature affects. As a result, these intermediates can be trapped at low 
temperature and their lifetime can be determined (35). 
The photosensitivity of rhodopsin is associated with its molar extinction coefficient which was 
calculated to be 40,600 M-1cm-1 (36) with a quantum yield of 0.65 (37) which is a refined value 
from the long-time accepted number of 0.67 (38).  The measured sensitivity of rhodopsin is twice 
higher than its free chromophore and also the rate of isomerization is much faster when the retinal 
is bound to the protein than when the chromophore is free in solution. The opsin apoprotein  
enhances the speed of retinal isomerization and suppresses the competitive relaxations (39). 
1.3.2. Cone opsins 
Human color perception is mediated by cone photoreceptor cells which mainly locate on the fovea 
of the retina (40,41).  Bright light activates the photosensitive opsin pigments which are embedded 
in the outer segment membrane discs of cone retinal cells thereby initiating the complex process 
of photopic vision with a fast response (42). The cone visual pigments correspond to blue opsin 
(SWL, short wavelength), green opsin (MWL, medium wavelength) and red opsin (LWL, long 
wavelength). Red and green cone opsins present a 96% of sequence identity differing merely in 
15 amino acids. This very high sequence identity has prompted the assumption that both green 
and red pigments share the same structural and functional features. The blue pigment, however, 
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shows a lower degree of homology to the red and green opsins. Thus, aside from their specific 
role in spectral-tuning into different absorption wavelengths, the differences in structure-function 
relationships caused by this minor sequence variance have not been previously elucidated. 
Furthermore, most of the mechanistisc insights into cone phototransduction are extrapolated from 
the rod photoreceptor cell system, responsible for dim-light scotopic vision, and its visual pigment 
rhodopsin which has been much more extensively studied (25). 
It was first  observed that cones are less sensitive than rod by studying the difference in dark 
adaptation between rods and cones (43) by means of  biophysical, biochemical and functional 
approaches 
 
Figure 1.4. Gene array of human red and green cone opsins. multiple green cone opsin genes are 
found in retinal cone cells, at chromosome X, followed by a single red cone opsin gene copy,. The LCR 
determines the expression of the particular gene by coupling to its P. Numbers in boxes denote the 6 
exons of the opsin gene. (adapted from (44)) 
 
Similar to rhodopsin, blue cone opsin (OPN1SW) is located at an autosome, 7q32.1, whereas the 
red cone opsin gene (OPN1LW) is arranged proximal to a green cone opsin gene (OPN1MW) in 
an array at Xq28 with 98% identical nucleotide sequences (44,45). The gene array of red and 
green cone opsin is composed of a single red cone opsin gene followed by one or more green cone 
opsin genes with 6 exons on each gene. However, the green cone opsin proximal to the red cone 
will be expressed and the other genes are inactivated. A locus control region (LCR) is located 
between 3.1 and 3.7 kb 50 of the gene array which is known as a “master switch”. The LCR is 
essential for the expression of both the red and green cone opsin genes. Individuals with mutations 
at LCR have nonfunctional red and green cones (blue cone monochromats) (46). 
In a single cone cell, the expression is exclusive to either one of the cone opsin genes. There is a 
permanent coupling between the LCR and the promoter (P) of either red or green cone opsin 
which is to be expressed (Fig. 1.4). This binding of LCR and P is mediated by certain DNA 
binding proteins. The LCR is inaccessible, at least from the third and more distal green pigment 
genes which are too distant from the LCR to be activated. Therefore, the LCR has a very low 
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probability to couple to the distal green promoters (44). Due to higher sequence similarity between 
red and green cone opsin genes and availability of multiple copies of the green cone opsin gene, 
intragenic crossing over may happen between L and M cone genes. Such crossing over may occur 
most likely within introns leading to a greater size of introns and resulting in hybrid M and L cone 
genes. If the hybrid gene begins with a red cone exon, sequences are known as 5’L-3’M (5’red-
3’green) hybrid gene which express proteins that are similarly functional to green opsin genes 
with 6 exons on each gene, and would express a red cone functional protein (28).     
 
Figure 1.5. Sequence alignment of rhodopsin and cone opsins. Rhodopsin and cone opsins protein 
sequences were aligned, using ClustalW2 and the difference residues between red and green cone 
opsins are shown highlighted in red.  
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1.4.  Structure of cone opsins using rhodopsin as template 
All opsins are GPCRs that respond to photons and initiate intracellular signal transduction 
pathways that eventually result in visual perception (24,47). Various biophysical and biochemical 
investigations, at the molecular level, have carried out since the 1950s in order to refine our 
understanding of the molecular mechanisms involved in the sophisticated physiological process 
of vision.  During the course of such continued research efforts, a milestone was achieved when 
the crystal structure of rhodopsin bound with 11CR was released in 2000 (48). This was the first 
resolved structure among GPCRs and later the ligand free opsin crystal structure was also 
elucidated (49). These structures of rhodopsin has been used as templates for various GPCRs in 
order to understand their molecular mechanisms, including those of cone opsins whose crystal 
structures have not been yet reported.  The theoretical models for cone opsins were deposited as 
PDB files and their identifiers are 1KPN, 1KPW, 1KPX (50). The sequence comparison of 
rhodopsin and cone opsins was made using ClustalW2 (Fig. 1.5). In this approach, amino acids 
were aligned as sharing similar positions in the protein secondary structures. The overall 
secondary structure of cone opsins would apparently be very similar to that of rhodopsin (Fig. 
1.6) which is composed of three domains, including an extracellular domain consisting of 3 loops 
E-I, E-II and E-III, a transmembrane domain with 7 TM helices and an intracellular domain made 
up by three cytoplasmic loops, C-I, C-II and C-III.  
Extracellular domain: rhodopsin contains a compact extracellular domain, known as ‘retinal 
plug’, including two antiparallel -sheets (1 and 2) in the N terminus and loop E-II. The 1 
strand, comprising G3 to P12, form a typical -sheet fold running almost parallel to the expected 
plane of the membrane. Compared to the rhodopsin structure, at the similar positions where only 
G12 and Y19 are conserved in red/green cone opsins but other amino acids are different 
suggesting a potentially different interactions at the N-terminus of cone opsins.  Loop E-II folds 
back into the protein to contribute residues SRYI from 186 to 189 for a -strand (2) which shares 
the similarity with red/green cone opsins containing SRYW. This whole retinal plug structure, 
with the antiparallel β-sheets is maintained in opsin which can be also observed from the 
theoretical model developed for cone opsins. 
In the case of rhodopsin, the N-terminus is located just near the loop E-III, with the side chain of 
D282 close to that of N2, and this arrangement may also be possible with blue cone opsin by the 
residues R2 and G279 at the homologous positions. The N-terminus of red and green cone opsins 
contain 51 amino acids which are longer than rhodopsin. Two oligosaccharides at N2 and N15 
are present in rhodopsin whereas N34 from red/green cone opsin suggest the presence of only one 
oligosaccharide chain which is similar in blue cone opsin containing N14. Cys from E-II forms a 
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disulfide bond with C3.25 at the extracellular end of TM3. This disulfide is conserved in all opsins 
and also in most GPCRs. All other residues forming the loops are shown in Fig. 1.6. 
Transmembrane domain: from the structure of frog rhodopsin, helices are found closely packed 
towards the intracellular side, and there is a cavity at the extracellular region for retinal binding 
formed by helices 3, 4, 5, 6 and 7. TM2 and TM3 keep TM6 and TM7 separated from TM4 (51) 
which has been also identified in the crystal structure of bovine rhodopsin (48). A relocation of 
conserved residues W6.48 and F6.44 towards L5.51 and P5.50, and of L/G3.40 away from P5.50. This 
transmission switch links ligand binding to the movement of TM5 and TM6 through the 
rearrangement of the TM3–TM5–TM6 interface, and possibly constitutes a common theme of 
GPCR activation(52). This region is believed to exhibit an irregular helicity, mainly around K7.43 
to which chromophore is covalently bound. The cytoplasmic ends of TM2 and TM4 are near to 
each other, but they diverge in the region of W161, one of the residues that are highly conserved 
among GPCRs. A salt bridge occurs between R3.50 which is part of the conserved E(D)RY motif 
in GPCRs, and E6.30. Together with E3.49 and T6.34, they form a more extended hydrogen-bonded 
network, called the ‘ionic lock’ (53,54). Residue 6.34 is conserved as Thr in rhodopsin, red and 
green cone opsins, but in the case of blue cone opsin, it is S6.34 which also contains an OH 
functional group. The presence of the ionic interaction stabilizes TM6 within the helical bundle. 
TM7 has the NPxxY(x)5,6 F motif  which is linking TM7 with helix 8 (H8) and is conserved in all 
class A GPCRs including cone opsins. Though the major role of this motif is yet unclear, 
mutations at this motif are reported to affect ligand binding (55-57).   
Intracellular domain: the intracellular domain of opsins consists of three loops with the C-I 
shorter than the other two and connected to TM2 by N2.40. Specific amino acids contributing to 
the loops can be identified and compared (Fig. 1.6). C-III of rhodopsin is rigid at the site of a 
tetrapeptide from Q236 to E239, containing 3 Gln residues, but the polar side chains S240 to T242 
pull the C-III towards the C-terminus. The C-III of red/green cone opsins, occupied by Q252-Q-
K-E, has the presence of Lys instead of Gln compared to the rhodopsin sequence. However, this 
does not alter the rigidity of this structure and followed by polar amino acids also support that the 
C-III is closer to C-terminus of cone opsins similar to rhodopsin. It is known that the rhodopsin 
C-terminal amino acid sequence QVS(A)PA, functions as a structural  motif which directs the 
sorting of visual pigments to the outer segment membrane. 
 C322 and C323 of rhodopsin project outside the protein and both the residues are palmitoylated 
(58). In contrast, only one Cys at position 320 can be found in blue cone opsin which is 
palmitoylated and no such Cys residues are present in red/green cone opsins. 
Retinal binding site:  the retinal binding of rhodopsin has been well elucidated from its crystal 
structure (48) and structural details on the rearrangement of specific residues upon illumination  
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Figure 1.6. Secondary structure models of visual pigments. The secondary structure of rhodopsin 
(A) with the conservative residues marked in dark circles, (adapted from (48)). Red and green cone 
opsins (B), with the amino acids differences between red (dark) and green (white) that are half circled, 
(adapted from (59)). The blue cone opsin (C) where the conserved residues are marked in a similar 
fashion to rhodopsin. (adapted from (50)) 
 
has been determined (Fig. 1.7) (49). The amino acids that constitute the retinal binding site are 
mainly hydrophobic, which favors the accommodation and interactions with the polyene chain of 
the chromophore. F2125.47 at TM5 and F2616.44 at TM6 are near the ionone ring of the retinal. 
These residues are C2285.47 in red and green cone opsin, and interestingly the other one is F2776.44 
in green cone opsin and the polar amino acid Y2776.44 in red cone opsin. 
The retinal bends towards the side chain of W265 at the ground state conformation of rhodopsin, 
which is W281 in red and green cone opsins but Y262 in blue cone opsin. The conformational 
changes ensuing illumination of the protein results in fluorescence changes in this Trp which is 
used in order to understand the dynamics of the retinal binding site (60). The Schiff base linkage 
between the retinal and Lys7.43 is located near Glu3.28 that serves as the counterion to the 
protonated Schiff base (PSB) in visual pigments. Another notable position is F293 of rhodopsin 
located near the PSB which undergoes a 120º rotation upon illumination moving away from the 
C 
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binding pocket, and Y309 only in red cone opsin which is one of the major differences between 
red and green cone opsin at the retinal binding site.  
 
 
Figure 1.7. Retinal binding site of rhodopsin. Residues of the retinal-binding pocket in rhodopsin in 
the inactive state (green) and active state (orange) are rendered as sticks. The yellow double arrows 
indicate differences in side-chain positions. Retinal in rhodopsin is shown as a ball-and-stick model for 
reference. (adapted from (49)) 
 
1.5. Chromophore 
The visual pigments are composed of a light-absorbing 11CR chromophore, a vitamin A 
derivative, covalently bound to the ε-amino group of a Lys residue of the opsin apoprotein via a 
PSB linkage thereby maintaining the inactive conformation (23,48). The 11CR chromophore has 
been conserved throughout evolution, because of its highly specialized role in vision, which 
includes a high quantum yield and a very fast response for photon-triggered isomerization. Retinal 
analogs, other than the natural 11-cis chromophore, such as 7-cis, 9-cis, 13-cis, and all-trans, have 
been investigated for their binding properties to the visual pigments in order to unravel the 
structural features of the retinal binding site and the details of the opsin-ligand recognition process 
(Fig. 1.8) (61-63). 9-cis-retinal (9CR) is often used as an exogenous analog to study the structure 
and function of visual pigments (64,65). 
 Schiff-base linkage with K7.43 of visual pigments, thereby maintaining the inactive conformation 
(23,48). The fluorescence emission of W6.48 (in red and green cones opsins) /Y6.48 (only in blue 
cone opsin), which is located very close to the -ionone ring of the retinal, and W3.41 (66) are 
quenched by the bound retinal of these dark-adapted visual pigments. Hydrolysis of the retinyl-
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idene linkage by photoisomerization causes the release of retinal and the parallel increase in 
fluorescence due to the fact that these aromatic residues, particularly that at position 6.48 (60), 
are no longer quenched. 
 
 
Figure 1.8. PSBs with retinal analogs. Schematic representation of 7-cis- (PSB7, green), 9-cis- (PSB9, 
blue), 11-cis- (PSB11, black), 13-cis- (PSB13, purple), and all-trans-retinal (PSBT, red). R refers to 
Lys7.46 from opsin. (adapted from (67)) 
 
1.5.1. The retinoid cycle 
The active photointermediate (MetaII) of visual pigment activates the α-subunit of a 
heterotrimeric G protein, transducing, which is the first event leading to closure of cGMP-gated 
cation channels in the ROS and resulting in photoreceptor cell membrane hyperpolarization. A 
surge of neurotransmitters from the photoreceptor cell neutralizes the polarization and the MetaII 
intermediate of the visual pigments decays subsequently by yielding free opsin and ATR. The 
isomerized retinal is replenished by the retinoid cycle, an enzymatic pathway by which ATR is 
converted back to 11CR. Various proteins are involved in this process thus ensuring the required 
11CR supply to the photoreceptor cells. The proteins involved in the retinoid cycle can be 
categorized into transporter proteins which are retinoid binding proteins and the isomerizing 
enzymes (68). Mutations in these proteins, some of them with recessive inheritance, can lead to 
vision impairment associated with several retinal diseases, like  Leber congenital amaurosis 
(LCA), Stargardt macular degeneration, congenital cone-rod dystrophy, and retinitis pigmentosa 
(RP) (69). 
Upon decay of the MetaII intermediate, ATR readily condenses with phosphotidyl ethanolamine 
(PE) to form N-retinylidene-PE (NRPE). By binding to ABCR (a retina specific ATP binding 
cassette transporter), NRPE is transported across the membrane discs to the cytoplasmic side of 
the photoreceptor cells where it is reduced to all-trans-retinol by dehydrogenases with the  
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Figure 1.9. The retinoid cycle in rod and cone photoreceptor cells. The isomerized ATR from rod and 
cone photoreceptor cells, is transported across RPE and Müller glia and with the help of various 
oxidizing enzymes (LRAT - lecithin/retinol acyl transferase, RDH - retinol dehydrogenase, REH - 
retinyl ester hydrolase, ARAT - acyl-CoA-retinol acyl transferase) is converted back to 11CR 
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expenditure of NADPH.   Photoreceptor cells release the all-trans-retinol into interphotoreceptor 
matrix (IPM) and the retinol is protected from oxidation and isomerization by binding to an 
interphotoreceptor binding protein (IPBR) and transported to the retinal epithelium (RPE) by 
endocytosis. 
Within the RPE, retinol is esterified by lecithin/retinol acyl transferase (LRAT) producing retinyl 
esters. Rpe65, a RPE specific 65kDa isomerase using Fe2+ as co-factor converts the all-trans-
retinoids to 11-cis-retinol.  11-cis-retinol is preserved by binding to cellular retinal binding protein 
(CRALBP) which can also bind to 11CR. 11-cis-retinol is either readily oxidized to 11CR and 
released to photoreceptor cells or it can be stored by being converted to 11-cis-retinyl esters by 
LRAT. These stored esters are again hydrolyzed by 11-cis-retinyl ester hydrolase (11-cis-REH) 
(68).  
An alternate pathway has also been identified for cone photoreceptor cells in which the all-trans-
retinol from cone photoreceptor cells are transported to müller cells and converted to 11-cis-
retinol which in turn is converted to 11CR inside the cone photoreceptor cells by retinol 
dehydrogenase (RDH).  
1.6. Trafficking, activation and signaling of visual pigments 
1.6.1. Trafficking 
Rod and cone photoreceptor cells have evolved into highly specialized cells consisting of three 
distinct areas that include the outer segment containing membrane discs where the visual pigments 
and other signaling proteins involved in phototransduction are located, the inner segment in which 
biosynthesis and other cellular processes occur, and the synaptic terminal that transmits the signal 
via neurotransmitter to downstream neurons. There is continuous renewal of the rod and cones in 
the outer segments in approximately, and every 10 days a complete renewal happens (70) through 
a narrow cilium connecting the outer segments to the cell body. A mouse rod outer segment is 
estimated to contain between 5x107 and 7x107 rhodopsins (71). Therefore, 80 rhodopsin 
molecules have to be synthesized and delivered each second which require an effective 
biosynthesis of the retinal proteins, with reliable transport and targeting pathways (72,73).  
The opsins are transported from the endoplasmic reticulum, the biosynthetic site to Golgi complex 
and a trans-golgi network where they are sorted into vesicles with the help of interactions with 
various proteins and destined to the outer segment via the cilium (42). The last four amino acids 
at the C-terminal of opsins are known as VXPX motif which serves as an intracellular targeting 
signal (74), and also the Phe-Arg doublet at H8, known as FR signal, is also characterized to play 
a major role in protein targeting (75). The opsin assembly into the outer segments depends on an 
intraflagellar transport which is a highly conserved process, characterized as a bi-directional 
trafficking pathway along a microtubule backbone known as the ciliary axoneme (76,77).   
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Figure 1.10. Axoneme and photoreceptor outer segment. Schematic drawings of the primary cilium 
depict tangential sections through the sub-ciliary compartments: basal body, transition zone, axoneme 
doublets, and axoneme singlets. (adapted from (42)) 
 
1.6.2. Oligomerization 
Oligomerization in GPCRs have been well established by various studies stating its importance 
for receptor activation. Homo or hetero oligomerization of GPCRs modulate the ligand binding 
selectivity and potency (78).  AFM studies visualized the densely packed rhodopsin oligomers in 
the native membrane which also argued for a potential role of dimerization on G-protein 
recognition, binding kinetics, and signal amplification (79). Though the molecular mechanism of 
cone opsins dimerization is yet unclear, rhodopsin dimers in the dark state could be formed in a 
“head to head” orientation interfacing the TM1 of each monomer and a close interaction with H8 
at the C-terminal (80). In the photoactivated rhodopsin a parallel dimer with the similar interface 
at TM1 and H8, and the involvement of TM2, has been proposed (81).  The photoactivated 
rhodopsin and transducin can freely diffuse through the membrane milieu and a single trimeric 
G-protein can bind to a dimer of rhodopsin (82) which may also be asymmetric where the 
rhodopsins are at unequal activated states (83,84). Structurally, the opsin dimers are the building 
blocks of a hierarchical supramolecular architecture in membranes. Such higher order architecture 
of the pigments exhibits an efficient and faster signaling. A higher order organization of 
oligomerized rhodopsin has been observed in a recent study stating a four level structural 
organization in which rhodopsin dimerizes, and at least ten dimers form a row in native 
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membrane. A pair of rows, known as tracks would be aligned parallel to form disk incisures. 
These parallel alignments would be necessary for the sensitivity of visual pigments, and the 
rhodopsin tracks may trap the preassembled G-protein molecules (85). 
 
 
Figure 1.11. Oligomerization and higher order organization of rhodopsin. Four levels of organization 
of rhodopsin (purple) in the intact disk membrane: The dimerization of rhodopsin monomers with a 
center-to-center distance of 4 nm (a); dimers form rows with a dimer-to-dimer distance of 5 nm (b); 
rows come in pairs separated by 5 nm (c); two pairs of rows (tracks) are separated by 15 nm. (adapted 
from (85)) 
 
1.6.3. Activation 
The main difference between the visual pigments and other GPCRs is the specific nature of the 
light-induced conformational isomerization with a faster photointermediate conformation that 
activates the G-protein. In the inactive dark-adapted state of cone opsins, the retinal chromophore 
is covalently bound to these visual pigments through its aldehyde group via a PSB linkage to the 
ε-amino group of K3217.43 for red/green cone opsins and K2937.43 for blue cone opsin at TM7, 
similar to rhodopsin. The PSB is stabilized by a salt bridge with the carboxylic group of the 
counterion, E3.28 at TM3 (86). A PSB is a structural feature of visual pigments and the 
corresponding visible spectrum of a free PSB would show an absorption maximum at 440nm. 
However, the characteristic differences in visual sensitivities are due to specific amino acid 
variations at the retinal binding pocket which result in different absorption maxima -as a result of 
the so-called opsin shift effect- corresponding to 560nm for the red cone pigment, 530nm for the 
green cone pigment, and 420nm for the blue cone pigment (87-89).  
The first step in the phototransduction process involves photon absorption by the visual pigments 
that causes 11CR isomerization to ATR (23). This activates the receptor by eliciting a 
conformational change, with formation of the active MetaII conformation resulting in binding and 
activation of the G-protein, transducin (90). There is a subsequent breakage of the PSB linkage 
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of the isomerized chromophore which no longer fits into the retinal binding cavity and leaves the 
binding pocket eventually exiting the protein. Visual pigment photoactivation changes the pKa of 
the PSB and induces deprotonation which is the primary molecular event of the visual 
transduction cascade after retinal isomerization (91). This is accompanied by  a small 
displacement of the PSB away from the counterion which would result in a red-shifted absorption 
maximum (92). Upon photoactivation, isomerization of 11CR results in a series of short-lived 
photointermediates (photo- , batho-, lumi-) that lead to the MetaI opsin intermediate conformation 
which still shows a PSB linkage. Subsequence deprotonation of the PSB results in the formation 
of the MetaII intermediate with typical absorbance at 380 nm. MetaII decay is accompanied by 
disruption of the salt bridge between the isomerized chromophore and the free opsin apoprotein.  
 
Figure 1.12. Photoactivated intermediates of rhodopsin. The intermediates of photoactivated 
rhodopsin with their absorption maximum and their conversion kinetics at the given temperature.  
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The MetaII active photointermediate of cone opsins is short lived compared to that of rhodopsin 
(93-96). Overall, the photoactivated cone opsins are prone to spontaneous fast dissociation into 
free opsin and ATR. 
 
Figure 1.13. Photoactivated intermediates of cone opsins. The intermediates of photoactivated cone 
opsins include batho-, lumi-, and, meta- intermediates.  
 
1.6.4. Signaling 
The G-proteins of the GPCRs superfamily comprise various isoforms including 16 Gα (four 
subfamilies: Gαs, Gαi, Gαq, and Gα12), 5 Gβ and 12 Gγ subunits (97). Both rods and cones mediate 
their function via Gi class of G proteins. The G-protein binding to rhodopsin is transducin, 
composed of Gαt1 (39 kDa) and the Gβγ dimer complex (Gβ1, 36 kDa, and Gγ1, 8 kDa). Cone opsins 
activate Gαt2β3γ8 trimer (98-100). The G-protein complexes activating both rod and cone opsins 
share a high degree of homology, i.e., Gαt1 is 78% identical to Gαt2, Gβ1 is 80% identical to Gβ3, 
and Gγ1 is 64% identical to Gγ8. The α-subunit of the G-protein possesses GTP-binding and GTP-
hydrolyzing properties. The type of the nucleotide bound to α-subunit controls the activation 
process with the GDP-bound state being inactive and the GTP-bound form the active state. The 
photoactivated active state conformation of rhodopsin, MetaII (R*), characterized by the 
unprotonated Schiff-base linkage, enables the binding of transducin and catalyzes the exchange 
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of the bound GDP with GTP (101). It is believed that a single molecule of R* can activate 20–
100 molecules of Gt (102). 
Immediately after formation of R*-Gtα-GTP complex, Gβγ dissociates and the dissociation of 
Gβγ is essential for production of free Gtα-GTP, which is capable of interacting with a 
phosphodiesterase (PDE). The lifetime of the active Gtα-GTP is controlled by the GTPase activity 
of Gtα. The basal GTPase activity is relatively slow and it is accelerated when the Gtα interacts 
with other regulatory protein by forming a complex with PDE/RGS9 (regulator of G-protein 
signaling 9).  The GTPase reaction is crucial for the kinetics of the photoresponse (103).  
 
 
Figure 1.14. Activated opsins and G-protein. The schematic representation of initial events of the 
phototransduction of visual pigments. (R* - activated visual pigments, Gtα- trimeric G-protein 
complex). 
 
Two Gt·GTP subunits bind to the two inhibitory  subunits of PDE, thereby activating the 
catalytic subunits and enhancing the hydrolysis of cGMP to GMP. The subsequent decrease in 
the concentration of cGMP leads to the closure of cyclic nucleotide gated ion channels, and 
blockage of the influx of Na+ and Ca2+ causing a hyperpolarization which is neutralized by the 
release of neurotransmitters from the synaptic endings of photoreceptor cells. The response of 
activated opsin is small and faster with cone opsin compared to that of rhodopsin as the MetaII 
intermediate is short-lived in cone opsins which also lowers the sensitivity of the pigments 
(25,104).  
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The rod and cone pigments are equivalent with respect to downstream signaling upon activation. 
Though the lifetime of the functionality of activated pigments is regulated by the decay of MetaII 
intermediate, phosphorylation and arrestin binding also play a major role in shutting off the signal.  
The rhodopsin kinases which phosphorylate the activated pigments and enables the binding of 
arrestin to opsin (105).   
 
 
Figure 1.15. Signal transduction of visual pigments. Photoactivated opsins (R*) exhibit 
conformational changes which activate transducin (G) by interacting with and replacing the bound GDP 
with GTP (R*G). GTP bound -subunit dissociates and activates PDE (G*-E*). PDE converts cGMP 
(cG) produced by guanylate cyclase (GC) to GMP which leads to the closure of cGMP gated ion 
channels. (adapted from (104)) 
 
1.7. Cone opsin mutants 
Adaptive evolution is the key to the switch from red cone pigments to green cone opsin pigments 
in which the specific positively selected point mutations give rise to green cone opsin. These 
positively selected green cone opsin pigments are found in animals with red-green color vision 
but some of these random mutations may also have adverse effects and lead to red/green color 
blindness in animals. Evolutionary genetic analysis have identified that both the constructive 
adaptive mutations responsible for color vision and the deleterious mutations causing retinal 
disorders have been strongly selected independently in different lineages (106,107).  
Trichromatic color vision requires the absorption of photons from different visible wavelengths. 
The loss of function of one of the cone pigments, caused by certain congenital disorders, limits  
vision to dichromacy and the loss of two cone pigments leads to monochromacy (108). Table 1.2 
shows some important clinically identified mutants of cone opsins which are known to cause 
visual alterations ranging from simple polymorphism, which only shift the absorption maximum 
wavelength by a few nm, to degenerative cone dystrophies.  
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1.7.1. Retinal disorders associated with blue cone opsin mutations 
Tritanopia: tritanopia is an autosomal dominant disorder linked to blue cone opsin gene at 7q32.1 
and associated to a selective deficiency of blue spectral sensitivity. The amount of functional loss 
varies from minor to complete depending on the position of the mutation. Six mutations have 
been identified to cause tritanopia that include L56P, G79R, T190I, S214P, P264S, and R283Q 
(109-113). Tritanopes are unable to differentiate light blues and greys, dark purples and black, 
mid-greens and blues, and oranges and reds. 
 
Blue Cone Pigments Green Cone Pigments Red Cone Pigments 
G79R N94K S180A 
T190I W177R C203R 
S214P C203R R247ter 
 R330Q G338E 
 
Table 1.2. Cone opsin mutants causing retinal disorders. Clinically identified point mutations of blue, 
green and red cone opsins causing retinal disorders.   
 
1.7.2. Retinal disorders associated with green cone opsin 
Deuteranopia: loss of functional green cone pigments, due to point mutations at the green cone 
opsin gene, can lead to a dichromatic condition known as deuteranopia. N94K, R330Q are 
mutations causing deuteranopia previously identified. It was suggested that N94K disrupts opsin 
folding and R330Q affects the functionality of the pigment but shows absorption maximum 
similar to native green cone pigment (114). 
C203R in green cone opsin is identified to cause the condition known as deuteranomaly where 
the defect implies a shift in the spectral sensitivity. Surprisingly, this mutation was found to be 
presented in 2% of the population -which is fairly common- but apparently it was not always 
expressed. In analogy with the lack of expression of some 5’ green-red hybrid genes in persons 
with normal color vision, it was suggested that failure to manifest occurs when the mutated gene 
is located at a distal (3’) position among several green opsin genes. This mutation might also 
predispose to certain X-linked retinal dystrophies (115). 
X-linked cone dystrophies: these are a heterogenous group of disorders showing dysfunction and 
degeneration of cone photoreceptor cells. W177R mutation on exon 3 of chromosome Xp21 is 
the most common cause for cone photoreceptor degeneration. The affected individuals tend to 
develop a variable degree of photophobia in childhood or early adult life, reduced central vision, 
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and color-vision disturbance. W177 is highly conserved in visual and non-visual opsins across 
species. This mutation W177R in green cone opsin is equivalent to W161R mutation in rhodopsin 
which results in protein misfolding and retention in the endoplasmic reticulum. In addition to 
W177R, mutations in 11 other genes, including GUCA1A, a guanylate cyclase activator, 
peripherin, and ABCA4, retinal transporter protein have been identified to cause degenerative 
cone dystrophies (59,116). 
 
Figure 1.16. Visual perception of congenital dichromats.  Comparison between the normal vision and 
visual perception of protanopes, deuteranopes and tritanopes. (adapted from 
http://www.colourblindawareness.org) 
 
1.7.3. Retinal disorders associated with red cone opsin 
Protanopia: purified G338E red cone mutant does not show any absorbance indicating the 
complete loss of functional red cone pigment, known as protanopia (114).  
S180A is a polymorphism that exists over the population (60% serine, 40% alanine) which is 
characterized by shifting the absorption spectrum by 7 nm. Hence, individuals with different 
residue at position 180 tend to visualize the color red with a slight difference (117,118). 
Blue cone monochromancy: C203R in green cone opsin and C203R in red cone opsin can be 
identified in certain individuals as well. In such condition, the affected individuals are 
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monochromats with only blue spectral sensitivity. This may be a consequence of LCR deletion 
adjacent to the red and green cone opsins gene array. In the R247ter mutant, the red cone pigment 
gene carries a point mutation (C to T) at the amino acid coding position 247 in exon 4 resulting 
in termination of protein synthesis beyond amino acid 246 (119). 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
2. OBJECTIVES 
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The main aim of this thesis are  to characterize the structure and function of human cone opsins 
in their purified form and to anaylze the retinal binding behavior in comparison with rhodopsin. 
To this aim the regeneration of red, green and blue cone opsins with retinal analogs and  the 
possible conformational differences -other than those known associated with spectral tuning- will 
be investigated. The present study is also aimed at characterizing specific mutations in cone opsins 
associated with retinal disorder and to investigate the alterations in their structure-function 
relationships when compared to the respective non-mutated recombinant pigments. These main 
objectives can be broken down in the following specific objectives: 
 
1. To characterize purified recombinant human red, green and blue cone pigments and to 
compare their biochemical and biophysical properties with those of rhodopsin. 
 
2.  To investigate the ligand binding specificity of a selected photoactivated cone pigment 
and to compare it with chromophore regeneration of photoactivated rhodopsin at a late 
photoactivation state.  
 
3. To compare the nature of chromophore regeneration with retinal analogs between red, 
green and blue cone opsins immediately after photoactivation. 
 
4. To construct the clinically identified mutants of human cone opsins and to characterize 
the biochemical and biochemical features in comparison with their respective wild type  
pigments and to identify the possible alterations in structure-function relationships. 
 
5. To stablize a cone opsin mutant, which cannot regenerate with its natural ligand in its 
purified form, by means of different stabilizing strategies, like introducing a new disulfide 
bond..  
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
3. EXPERIMENTAL PROCEDURES  
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3.1.   Materials 
Red, green and blue cone opsin genes, which were cloned into pMT4 plasmid vector, were kindly 
provided by Prof. Kevin D. Ridge.  
Dulbecco's modified eagle medium (DMEM) (Sigma, Spain) supplemented with fetal bovine 
serum (FBS) (Sigma, Spain), L-glutamine (Sigma, Spain), and penicillin-streptomycin (Sigma, 
Spain) was used to culture COS-1 cells (ATCC no. CRL-1650).  Opti-MEM (Fisher scientific, 
France), DMEM-F12 (lab clinics, Spain) supplemented with FBS and penicillin- streptomycin 
were used to culture HEK-293s-GnTi- cells. 
11-cis-retinal (11CR) was provided by the National Eye Institute, National Institutes of Health 
(USA). Purified mAb rho-1D4 was obtained from Cell Essentials (Boston, USA) and was coupled 
to CNBr-activated Sepharose beads (Sigma, Spain). n-dodecyl--D-maltoside (DM) was 
purchased from Affymetrix (Germany).  The nonamer-peptide H-TETSQVAPA-OH was 
obtained from Unitat de Tècniques Separatives i Síntesi de Pèptids, Universitat de Barcelona 
(Barcelona, Spain). The 9-cis-retinal (9CR), hydroxylamine, protease inhibitor cocktail, and 
phenylmethanesulfonyl fluoride (PMSF) were purchased from Sigma (Spain), and 
polyethyleneimine (PEI) was purchased from Polysciences Inc. (USA).  
Dark adapted bovine retinas were purchased from W L Lawson Company (NE, USA). The 
cellulose membrane and manifold used for G-protein activation assay were purchased from 
Millipore (France). GTPS35 (250 Ci) from Perkin Elmer, (Spain), and biodegradable 
scintillation fluid from GE healthcare life sciences (Spain). 
Acrylamide/Bisacrylamide mix, 1.5 mM Tris-HCl, (pH 8.8), 0.5 mM Tris-HCl (pH 6.8) and other 
electrophoretic materials and reagents were purchased from BioRad (USA).  
1, 2-didocosahexaenoyl-sn-glycero-3-phosphocholine (DDHA-PC), 1, 2-dihexanoyl-sn-glycero-
3-phospho choline (DMPC), and 1, 2-dimhexanoyl-sn-glycero-3-phospho choline (DHPC) were 
purchased from Avanti polar lipids (Alabama, USA) 
The oligonucleotides used to introduce the desired mutations, as well as those used for DNA 
sequencing, were purchased from Sigma (Spain). Pfu ultraII fushion hsDNA polymerase, and 
dpnI were purchased from Agilent technologies, (CA, USA) 
All other chemicals and reagents were purchased from Sigma, Spain 
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3.2. Methods 
3.2.1. Cell culture methods 
Cells maintenance:  COS-1 cells were routinely cultured in complete DMEM supplemented with 
10% FBS, 2 mM L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin. When the 
cells attained 95% confluence, the mono-layer of adherent cells was passaged by trypsinization. 
The media was removed using a suction pump under a pre-UV-sterilized laminar flow hood, 
washed using sterile 1x PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM 
KH2PO4) in order to remove the dead cells and residual media which may inhibit the action of 
trypsin. Cells were treated with 1% trypsin (0.05% trypsin in 1x PBS), incubated for 3-4 min and 
5 ml of complete DMEM was added in order to inactivate the trypsin, and the cells were spun 
down by centrifuging at 300g for 5 min. Cells were then suspended into fresh complete DMEM 
and dispensed in culture plates, and replenished with media to cover the cell monolayer. Plates 
were incubated in a 37ºC humid incubator with circulating CO2 (5%). 
HEK293S-GnTi- cells, in which the genes of glycosylating enzymes were silenced, were cultured 
using DMEM-F12 supplemented with 10% FBS, 2 mM L-glutamine, 100 units/ml penicillin, and 
100 g/ml streptomycin. These cells were passaged without trypsin, as the adherence is weak on 
the cell culture plates. After washing the plate gently using 1x PBS, 10 ml of complete DMEM-
F12 was added to the plate and the cells were flushed carefully by pipetting the media. The 
detached cells were suspended in fresh media and cultured on new plates. The cultured plates 
were incubated in a 37ºC / 5% CO2 incubator. 
Freezing and thawing of cells: cells that were not immediately needed were frozen for long term 
storage in order to avoid senescence and genetic drift. After trypsinization, the cells were spun 
down and resuspended in 1ml/plate of freezing media (DMEM supplemented with 20% FBS, 
10% DMSO). The cells were aliquoted in 1ml labeled cryotubes and kept at 4ºC for 2 h followed 
by treatment at -20ºC for 1 h and then the frozen cryotubes were transferred to -80ºC for overnight 
storage. Next day the frozen cells were transferred to a liquid nitrogen container.  
The cells were recovered by thawing the cryotubes at 37ºC in a water bath. After thawing, the 
cryotubes were cleaned using 70% ethanol and cells were added aseptically into a cell-culture 
plate containing complete DMEM. The thawed cells were incubated in a 37ºC / 5% CO2 incubator 
and the media was replaced after 24h. 
3.2.2. Expression of opsins 
The opsin genes were expressed in transiently transfected COS-1 cells by chemical transfection 
using polyethylenimine (PEI) reagent according to the manufacturer’s instructions. PEI powder 
was dissolved in distilled water and the pH was adjusted to 7.0 (the solution becomes clear as the 
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pH is adjusted). After PEI was completely dissolved, the final concentration was adjusted to 
1mg/ml and filtered through a 0.22 M filtering unit. The prepared PEI regent can be aliquoted 
and stored at -20ºC. Once a PEI aliquot is thawed, it should be maintained at 4ºC.  
500 l of PEI (1 mg/ml) was added in a 50 ml sterile tube containing 12.5 ml of Opti-MEM, and 
in another sterile tube, 150 g of plasmid was mixed with 12.5 ml of Opti-MEM. Both tubes were 
incubated separately for 5 min at room temperature (RT), and then the tubes were mixed and 
incubated for 20 min at RT. 5 ml of Opti-MEM/PEI/DNA was added to each plate of 80% 
confluent COS-1 cells, together with 5 ml of fresh complete DMEM. The transfected plates were 
incubated for 48 h in a 37ºC / 5% CO2 incubator. 
3.2.3. Purification of visual pigments  
The CNBr-activated Sepharose beads were coupled to the 1D4 antibody according to the 
manufacturer instructions (GE Healthcare). 
The transfected cells were harvested 48-60 h after transfection and regenerated with 10 µM 11CR 
in 1x PBS buffer by overnight incubation at 4°C. Regenerated cells were subsequently solubilized 
using 1% DM with PMSF and protease inhibitors, and the pigments were purified by 
immunoaffinity chromatography using Sepharose coupled to the rho-1D4 antibody. After 5 times 
washing the beads using 1x PBS containing 0.05% DM in order to remove the free retinal, the 
bound proteins were eluted in PBS containing the nonamer peptide and 0.05% DM (elution 
buffer). COS-1 cells were used for the expression of the recombinant proteins in all experiments 
except for samples used in the electrophoretic analysis. 
Rhodopsin can be purified using either PBS buffer or sodium phosphate (NaPi) buffer (2 mM 
sodium dihydrogen phosphate and disodium hydrogen phosphate mixed to pH 7.4). Cone opsins 
were purified only using PBS buffer as chloride plays a role in the stability of cone opsins. 
3.2.4. UV-visible spectroscopy  
Spectroscopy deals with the electromagnetic radiation of a particular frequency, or a range of 
frequencies, that is allowed to impinge on the sample under study. The radiation coming out of 
the sample is then analyzed in terms of the intensity at different frequencies which will indicate 
which particular frequencies are absorbed by the molecule, thus giving a picture of the molecular 
energy levels. These, in turn, can be interpreted in terms of the chemistry or stereochemistry of 
the molecule.  
If a beam of light of intensity I0 falls on the sample, the emergent radiation intensity I is less 
intense than the incident radiation, since a portion of it is absorbed by the sample. The absorption 
wavelengths depend on the characteristic of the sample. This characteristic quantity is called the 
absorbance and may be calculated from the Beer-Lambert principle. The Beer- Lambert law states 
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that in a sample, each successive portion along the path of the incident radiation, containing an 
equal number of absorbing molecules absorbs an equal fraction of the radiation that traverses it. 
If we consider an infinitely thin slice of the sample (dl), the light traversing it may be considered 
a constant. Then the fraction of the light absorbed is simply proportional to the number of 
absorbing molecules,  
−𝑑𝐼/𝐼 =  𝐶𝜀′𝑑𝑙 
where C is the concentration of the molecule in moles per litre, 𝜀′ is a proportionality constant 
called the molar extinction coefficient and the negative sign indicates a diminution of the intensity 
of the radiation as it traverses the sample. 𝜀′ is a constant for a given wavelength for a given 
molecule and is independent of the concentration. Integrating this equation over the entire sample 
thickness 1, then  
𝐴 = log (
𝐼0  
𝐼
) =  𝐶𝜀(𝜆)𝑙 
where 𝜀 = 𝜀′/2.303 i.e. molar extinction coefficient converted to log base 10 and expressed as a 
function of wavelength 𝜆. The term log (
𝐼0  
𝐼
) is called the absorbance A. The wavelength at the 
maximal extinction and the extinction coefficient at this wavelength are used to characterize the 
sample. A double beam spectrophotometer has a beam splitter that splits the beam into two 
equidistant paths. The sample is placed in the path of one half of the beam and the reference in 
the other (120). 
The assay is non-destructive as the protein in most cases is not consumed and can be recovered. 
Secondary, tertiary and quaternary structures all affect absorbance; therefore, factors such as pH, 
ionic strength, etc. can alter the absorbance spectrum. The aromatic rings in the protein (mainly 
tryptophan, but to a lesser extent also tyrosine) absorb UV light at an absorbance maximum of 
280 nm (121). The unique absorbance property of proteins could be used to estimate the level of 
proteins and their interactions and binding to the chromophore.  
Purified pigments were spectroscopically characterized using a Varian Cary 100 Bio 
spectrophotometer (Varian, Australia), equipped with a water-jacketed cuvette holder connected 
to a circulating water bath. Temperature was controlled by a peltier accessory connected to the 
spectrophotometer. All the spectra were recorded in the 250 nm-650 nm range for rhodopsin and 
green cone opsin, 250 nm-600 nm for blue cone opsin and 250 nm-700 nm for red cone opsin, 
with a bandwidth of 2 nm, a response time of 0.5 s, and a scan speed of 400 nm/min. 
The concentration of the visual pigments was calculated using the measured absorption maximum 
(Amax) at visible region max, using the formula, 
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𝑐 =  
𝐴
𝜀𝑙
 
c – concentration of the sample, 
A – Amax at the max at the visible region  
molar extinction coefficient  
The estimated molecular extinction coefficients of cone opsins  include those of chicken red cone 
opsin,   47,200 (122), green cone opsin, 40,800 (123),  and mouse blue cone opsin 41,760 (124) 
which have used during the course of the present study to calculate the concentration of the 
purified cone opsins.  
l – length of the cuvette. 
Photoactivation: the samples of rhodopsin, red and green cone opsins were illuminated with a 
495 nm cut-off filter for 30 s using a Dolan-Jenner MI-150 fiber optic illuminator, and the blue 
cone opsin was illuminated without the cut-off filter because the Amax of blue cone opsin is at 
420nm. 
Thermal decay: the thermal stability of visual pigments was monitored as previously described 
(125). The thermal stability rates of visual pigments were measured by monitoring the decrease 
of absorbance at λmax of the visible spectral band as a function of time at 37°C. Spectra were 
recorded every min and half-life times were determined by fitting the experimental data to single 
exponential curves using Sigma Plot version 10.0 (Systat Software, Chicago, IL,USA). 
Chemical decay: hydroxylamine can readily access the binding pockets of cone opsins and cleave 
the Schiff base linkage of 11CR which results in retinaloxime release in solution (126). A solution 
of 1M hydroxylamine, adjusted to pH 7, was added to dark-adapted samples in a spectroscopic 
cuvette (final concentration of 50 mM). The successive spectra were recorded every min to 
monitor the loss of pigment (Amax) and formation of retinaloxime (A365 nm). Reactions were 
carried out in the dark at 20°C (127). The half-time of the decay process was determined by fitting 
the experimental data to single-exponential curves using SigmaPlot version 10.0 (Systat 
Software). 
Regeneration experiments: for regeneration experiments, 2-2.5-fold molar concentration of 
retinal over pigment was added to the purified pigments in the spectroscopic cuvette and 
thoroughly mixed. Retinal was added either before or after photoactivation which will be 
indicated at the particular results section. The volume of the retinal stock added to the protein 
sample represented a maximum of 1% of the total sample volume so the effect of the carrier 
(ethanol in which the retinal stock was dissolved) on the observed results may be negligible. 
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Acidification: acidifying the visual pigments, using 3-4 l of 2N H2SO4, which yields a pH ~ 2.0, 
and reprotonates the Schiff base shifting Amax to 440 nm (128). This assay would help in 
identifying the presence of Schiff-base linked species during the course of the regeneration 
experiments. 
3.2.5. Fluorescence spectroscopy  
Fluorescence is a phenomenon by which light is absorbed by a system at one wavelength and 
emitted by it at a different, and longer, wavelength. The basic principle of fluorescence can be 
understood in terms of the electronic energy levels in one of which, according to quantum 
mechanics, the molecule is usually found (Fig. 3.1). Each of these electronic levels themselves 
has a so-called ‘fine structure’ due to the vibrational motion of the molecules, i.e. each electronic 
level is not a single energy value but consists of a band of closely spaced energies which arise 
due to the different vibrational modes. The molecule usually exists in the ground state. When a 
beam of light (visible or UV) falls on it, some of the energy is absorbed and electrons jump up to 
the excited state where they can go to any of the vibrational levels. So far the experiment is the 
same as UV-vis spectroscopy. However, now the electron in the upper electronic level can lose 
some of its energy in many ways. One of these is by going to a lower vibrational level within the 
same electronic level. When now the electron jumps back to the ground state, it does so by 
emitting radiation, but the radiation is of less energy and therefore longer wavelength than the 
incident light. The molecule is said to fluoresce. A study of the intensity of the fluorescent 
radiation as a function of the wavelength is known as fluorescence spectroscopy (120). 
 
 
 
 
 
 
 
 
 
Figure 3.1. Energy levels in a molecule. (a) Transition from ground state to excited state. (b) Non-
radiative loss of energy. (c) Radiative transitions to lower state.  
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A QuantaMaster 4 spectrofluorimeter (Proton Technology International, New Jersey, US) was 
employed to measure the Trp fluorescence emission from W6.48 which is located close to the -
ionone ring of the retinal. These fluorescence changes are a measure of the retinal release and 
retinal uptake processes in rhodopsin, and red and green cone opsins. The excitation wavelength 
was 295 nm, and the emission wavelength was 330 nm, measuring 1 point per second for 2 s 
followed by 28 s pause (with the help a beam shutter to prevent sample bleaching by the 
fluorimeter lamp), the excitation slit settings were 0.5 nm, and emission 10 nm. In blue cone 
opsin, amino acid at 6.48 is a Tyr, and in this case the fluorescent changes of Tyr were measured 
with the setup of excitation wavelength at 285 nm and the emission wavelength adjusted to 335 
nm. 
A purified pigment was added to the micro cuvette and Trp fluorescence was monitored over 
time, in the dark, until a steady baseline was obtained. Then, the sample was photobleached with 
or without a 495 nm cut-off filter for 30 s using a Dolan-Jenner MI-150 fiber optic illuminator 
and the change in fluorescence was recorded. 
Regeneration experiments and hydroxylamine treatment were also carried out by means of 
fluorescence spectroscopy under the same experimental conditions mentioned for UV-vis 
spectroscopy. 
3.2.6. Surface Plasmon Resonance (SPR) spectroscopy  
Surface plasmon resonance (SPR) spectroscopy is a biosensor technology that allows monitoring 
molecular interactions between two or more molecules in real time. SPR biosensors are sensitive 
to changes in mass of the molecule bound on the sensor surface and measures the changes in 
refractive index. Therefore, the interactions of visual pigments with transducin can be studied 
using this technique. In this technique, the visual pigments can be immobilized on a sensor chip 
surface whereas the G-protein, transducin, is injected in a mobile phase that is flushed into a 
miniature flow cell. The interactions between transducin and immobilized opsin on the surface 
lead to a change in refractive index. The time dependent changes in refractive index are recorded 
as sensograms which provides information about the binding kinetics and affinity of the 
interactions (129). 
All the steps involved in measuring the SPR signals, arising from the interaction between 
transducin and visual pigments, were performed with a Biocore 1000 using the BIAcore control 
software 1.2 as previously described (130). The surface of the sensor chip (XanTec CMD50d) 
contains carboxymethylated dextran on which the 1D4-antibody is immobilized via amine 
coupling. De-gased HBS buffer (0.01 M Hepes pH 7.5, 150 mM NaCl, 3 mM EDTA, and 0.005% 
Tween 20 (v/v)) was used as running buffer in a constant flow of 5 l/min. A mixture of 80 l of 
50 mM N-hydroxysuccinimide (NHS) and 80 l of 200 mM N-ethyl-N′-[(dimethylamino)propyl] 
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carbodiimide (EDC) was used for activating the surface which eases the covalent linkage of 1D4-
antibody to the surface. The antibody was diluted to 0.1 mg/ml in 10 mM sodium acetate pH 4.3, 
and it was injected producing an increase of 725 RU (Fig. 3.2). The surface was blocked with two 
injections of 35 l of 1 M ethanolamine, pH 8.5. The visual pigments were immobilized, in the 
dark, on the 1D4 surface of the sensor chip, and 35 l of 300 nM transducin was injected as 
mobile phase.  
 
 
Figure 3.2. SPR sensogram of 1D4 antibody coupling on an activated sensor chip surface. The 
dextran surface of the sensor chip was activated by NHS/EDC mix and coupled with 1D4 antibody via 
amine coupling. The unbound surface of the chip was blocked using ethanolamine. 
 
3.2.7. Blue Native-Polyacrylamide Gel Electrophoresis (BN-PAGE) 
BN-PAGE allows separation and identification of proteins in their native form. BN-PAGE was 
performed as previously described (131,132) with few modifications. For electrophoresis, a Bio-
Rad Mini-PROTEAN 2 gel running apparatus was used with the corresponding gel running buffer 
(50 mM Tricine, 15 mM Bis-Tris, 0.02% Coomassie blue G, pH 7.0). The gel was composed of 
13% separating gel and 4% stacking gel as per table 3.1. Here, the opsin genes were expressed in 
transiently transfected HEK293S-GnTi- cells -which lack glycosylation- in order to avoid the 
smeary appearance of protein bands due to differences in glycosylation patterns (133).  
Concentrations of the purified samples were normalized using A280nm in the UV-visible spectra. 
Equal amount of protein samples in sample buffer (5% glycerol and 0.01% Ponceau-Red) were 
loaded onto the gel. After 4hr of electrophoresis, the gel was destained (30% methanol and 10% 
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glacial acetic acid in distilled water) and visualized using a gel documentation system, Chemidoc 
XRS, BioRad. 
 
Table 3.1. Protocol for casting BN-PAGE gel 
 
3.2.8. SDS-PAGE  
Equal concentrations of purified visual pigments in DM were analyzed based on their 
electrophoretic mobility which depends on the molecular weight of the protein by SDS-PAGE as 
described earlier (134). Sodium dodecyl sulfate (SDS), an anionic detergent, is used to reduce 
proteins to their primary (linearized) structure and coat them with uniform negative charges so 
that the mobility of the proteins is solely based on molecular weight. The gel was casted with a 
composition of 12% separating gel and 4% stacking gel as indicated in table 3.2. The protein 
sample to be analyzed was diluted with a sample buffer (0.4 M dithiothreitol (DTT), 62.5 mM 
Tris, 2% SDS, 10% glycerol, 0.1% bromophenol blue). The prepared samples, and a 10 l-sample 
of the protein molecular weight marker, were loaded onto the gel and the electrophoresis was 
carried out using a gel running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) at 100 v for 2 
h. The run gel was stained overnight using a staining solution (0.025% Commassie R-250, 40% 
methanol, 10% glacial acetic acid diluted in distilled water). The stained gels were destained until 
visualizing the bands using destaining solution (40% methanol, 10% glacial acetic acid diluted in 
distilled water). 
3.2.9. Western blot analysis  
After separating the proteins using SDS-PAGE, the proteins from the gel were transferred onto a 
nitrocellulose membrane and detected using 1:10,000 dilution of the rho-1D4 anti-mouse 
antibody and 1:5,000 dilution of goat anti-mouse IgG conjugated to horseradish peroxidase (Santa 
Cruz biotechnology, California, US). The blots were developed using substrate SuperSignal West 
Pico Chemiluminescent Substrate (Luminol/H2O2) (Thermo Fisher scientific, France). 
Reagents Stock Separating gel (ml) Stacking gel (ml) 
Acrylamide/Bisacrylamide 37.5% / 0.8% 3.5 0.7 
Bis-Tris 1M, pH 7.0 0.4 0.25 
Distilled water - 4.0 4.0 
APS 10% 0.1 0.05 
TEMED 10% 0.05 0.05 
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Table 3.2. Protocol for casting SDS-PAGE gel 
 
3.2.10 Isolation of transducin from bovine retina 
Transducin was puriﬁed from bovine retinas as previously described (135).  Briefly, 100 dark 
adapted frozen bovine retinas were thawed overnight at 4ºC under room light. The retinas were 
diluted with 47% sucrose (with 2 mM DTT, 0.1 mM PMSF) and homogenized. After a 
centrifugation at 42,000xg for 20 min at 4ºC, ROS membrane stuck on the walls were carefully 
taken and washed using buffer A (20 mM Tris, pH 7.4, 1 mM CaCl2, 2 mM DTT, 0.1 mM PMSF). 
ROS membranes were resuspended in buffer A and layered on top of a sucrose density gradient 
(1.2 mM / 1.0 mM / 0. 8 mM). The orange layer was taken out carefully and washed using buffer 
C (10 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 2 mM DTT, 0.1 mM PMSF) followed by 
bufferD (10 mM Tris, pH 7.4, 0.1 mM EDTA 3 mM DTT, 0.1 mM PMSF) in order to remove the 
sucrose and the excess salts were chelated by buffer D. The final pellet was homogenized in 50 
ml of buffer D with 40 M GTP and rotated for 30 min at 4ºC. The supernatant was collected 
after centrifugation and filtered via 0.2 m filter to remove traces of membrane. The collected 
sample was concentrated and dialyzed using buffer E (10 mM Tris, pH 7.4, 2 mM MgCl2, 50% 
glycerol, 1mM DTT). The harvested transducin was stored at -20ºC. The concentration and 
quality of the purified transducin were analyzed using SDS-PAGE with bovine serum albumin 
(BSA) standards (Fig. 3.3). 
Reagents 
12% Separating gel 5% Stacking gel 
Stock Volume (ml) Stock Volume (ml) 
Distilled water - 1.25 - 2.9 
Tris-HCl 1.5M, pH 8.8 5.0 0.5M, pH 6.8 1.25 
Acrylamide/Bisacrylamide 37.5% / 0.8% 3.2 37.5% / 0.8% 0.67 
SDS 10% 0.1 10% 0.05 
APS 10% 0.1 10% 0.05 
TEMED 10% 0.05 10% 0.05 
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Figure 3.3. SDS-PAGE of transducin extracted from bovine retina. SDS-PAGE was carried out with 
extracted transducin and 0.5, 1.0, 1.5, 2.0, 3.0 g standards of BSA.   
 
3.2.11. Transducin activation assay  
For the transducin activation assay, 10 nM concentration of rhodopsin and red cone opsin or 300 
nM cone pigments were used, depending on the experiment. The samples were added to a mixture 
of 500 nM transducin in assay buffer (25 mM Tris, pH 7.5, 5 mM MgCl2, 100 mM NaCl, 2.5 mM 
DTT, and 0.013% DM) containing 5 µM GTPS35 (0.156 mCi/mmol). The reaction mixture was 
incubated at room temperature for 20min in the dark and transferred onto a 96-well cellulose 
membrane plate. The plate was fixed to a manifold filtering unit and the membrane was washed 
thoroughly with assay buffer. Bound GTPγS35 was measured by means of a Tri Carb 2100TR 
liquid scintillation counter (Perkin-Elmer, The Netherlands). 
The activity measured as cpm which is converted by pmol using the formula, 
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =  
𝑑𝑝𝑚
2.22 𝑥 1012 𝑥 𝑟𝑎𝑑𝑖𝑜𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑙𝑖𝑔𝑎𝑛𝑑
 
Where, 
𝑑𝑝𝑚 =  
𝑐𝑝𝑚
𝑐𝑜𝑢𝑛𝑡𝑒𝑟 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦
  ;  
counter efficiency = 55%  
1Ci = 2.22 x 1012 dpm 
radioactivity of the ligand = 1250 Ci/mMol 
 43 
 
3.2.12. Site directed Mutagenesis 
3.2.12.1. Plasmid details  
The working plasmid containing the opsin gene was the pMT4 vector which is 6.2 kbp. The vector 
has ampicillin resistance and EcoRI and NotI cloning sites are at the two ends of the opsin gene. 
A nine amino acid epitope for anti-rhodopsin monoclonal antibody rho-1D4 is inserted at the C-
terminus of all three cone opsins in order to facilitate immunopurification. The plasmid is resistant 
to ampicillin and hence the cells transformed with this plasmid will exhibit the colony selection 
on growth media supplemented with ampicillin. 
 
 
Figure 3.4. pMT4 plasmid containing the opsin gene. The opsin gene was inserted between the 
restriction sites EcoRI and NotI. -lactamase confer the antibiotic resistance to the bacteria carrying 
this plasmid which would aid for artificial selection of the transformed cells on an ampicillin 
supplemented media.  
 
3.2.12.2. Introducing the mutations into the opsin gene 
Quickchange mutagenesis protocol (Stratagene) was employed to introduce the mutations into 
the opsin gene. This protocol involves the following steps: 
Mutagenic primer designing: mutagenic primers are oligonucleotides containing the desired 
mutation which can anneal to the same sequence on opposite strands of the gene. The primers 
should be 25 to 45 bp with a melting temperature (Tm) of > 78ºC. The GC content of the primers 
should be more than 40% and the desired mutation should be located in the middle of the primer. 
By taking into account of all these parameters, the mutated primers for forward and backward 
strands were designed using a DNA codon table. 
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PCR amplification: the mutated opsin genes were synthesized using a thermal cycler by a 
polymerase chain reaction (PCR). The reaction mix for synthesizing and amplifying the mutated 
plasmid is shown in table 3.3. 
 
Reagents Volume (l) 
10x reaction buffer* 5.0 
pMT4 plasmid (100 ng/l) 1.0 
Forward primer (125 ng/l) 1.0 
Reverse primer (125 ng/l) 1.0 
dNTP mix (100 mM) 1.0 
Double-distilled water 41.0 
PfuTurbo DNA polymerase (2.5 U/l) 1.0 
 
Table 3.3. PCR mix for site directed mutagenesis. *10x reaction buffer (100 mM KCl, 100 mM 
(NH4)2SO4, 200 mM Tris-HCl (pH 8.8), 20 mM MgSO4, 1% Triton® X-100, 1mg/ml nuclease-free 
bovine serum albumin (BSA)). 
 
The reaction mix was prepared in a microfuge tube and was subjected to a thermocycler with a 
specific protocol (Table 3.4.). 
 
Step Temperature Time 
Initial denaturation 95ºC 30 s 
18 cycles 
95ºC 
60ºC 
68ºC 
30 s 
60 s 
6 min (1 min/bp of plasmid) 
Final extension 68ºC 5 min 
Hold 4ºC  
 
Table 3.4. Thermo-cycle conditions for a mutagenic PCR. 
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dpnI digestion: in order to digest the temple plasmid, l l of the Dpn I restriction enzyme (10 
U/l) was added and mixed well by pipetting the solution up and down several times. The contents 
were incubated at 37°C for 2 h.  
The resulting DNA was analyzed by 0.8% agarose gel electrophoresis. 
 3.2.12.3. Transformation, DNA miniprep and DNA sequencing 
Competent cells preparation: competent cells are treated cells which can easily uptake foreign 
DNA. E coli DH5 was used to transform pMT4 plasmid. In order to prepare competent cells, 
DH5cells were cultured until the absorbance at 600 nm reached 0.6. The cultured cells were 
incubated on ice for 30 min and the cell pellet was mixed with 100mM autoclaved CaCl2.  After 
incubating on ice for 30 min, the cell pellet was resuspended in 20% glycerol and 80% CaCl2. 
The prepared competent cells were stored at -80ºC until use. 
Transformation: 5 l of the PCR amplified plasmid was added a 50 l aliquot of competent cells, 
and incubated on ice for 30 min. The cells were subject to heat-shock treatment at 42ºC for 42 s 
and the tube was immediately transferred to ice for 5 min. 500 l of autoclaved 2YT media (16 
g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) was added to the transformed cells and incubated 
at 37ºC, shaking for 1 h. The cells were plated on an ampicillin (100 mg/ml) supplemented LB 
agar plate which was incubated at 37ºC overnight.  
Miniprep: a single colony from the transformed plate was inoculated into 10 ml of LB broth 
supplemented with 100 mg/ml ampicillin was and incubated at 37ºC by overnight shaking. The 
DNA was purified from the transformed cells using QIAprep spin Miniprep kit (Qiagen plasmid 
purification kits, La Jolla, CA). Concentration and quality of the sample of DNA were measured 
using UV-Vis Spectrophotometry at 260 nm. 
The concentration of purified DNA was calculated using the formula, 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐷𝑁𝐴 (𝜇𝑔/𝑚𝑙) = 𝐴260𝑛𝑚 𝑋 50 𝑋 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
As 50 g/ml of DNA contributes to the absorbance 1.0. 
DNA sequencing: the mutation introduced into the opsin gene was confirmed by DNA 
sequencing. The primers for DNA sequencing were designed from the sequence which is at least 
50bp upfront to the mutation site. The primers used for the cone opsins are: 
red and green cone opsin mutants: 
5’ GAATTACCACATCGCTC 3’ 
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blue cone opsin mutants: 
5’ GTCTTCCTTATAGGGTTC 3’ 
The purified cone opsin mutant DNA and their corresponding primers were outsourced to 
Servei de Genòmica, UAB, Barcelona or STAB-VIDA, Portugal for DNA sequencing. 
3.2.12.4. Maxiprep 
Large scale DNA purification for transient transfection was carried out using QIAGEN maxiprep 
kit (Qiagen plasmid purification kits, La Jolla, CA) which is based on alkaline lysis, followed by 
binding the DNA to a QIAGEN anion-exchange resin. The eluted DNA was resuspended in TE 
buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA).  The DNA yield was measured in a UV 
spectrophotometer at 260 nm. The purified plasmid was stored at -20ºC until use. 
3.2.13. Sub-cellular localization 
COS-1 cells were plated in 6-well plates containing sterile coverslips and incubated for 24 h to 
reach 90% confluence. After the old media was removed, the cells were washed with PBS and 
treated with 1.2 ml of complete media (DMEM supplemented with FBS). For each well, PEI mix 
contained: 400 l of Opti-MEM, 15 l PEI (1 mg/ml; pH 6.0); DNA mix: 400 l of Opti-MEM, 
1 to 3 g DNA, were prepared and incubated separately for 5 min. DNA mix was added gently 
into PEI mix and incubated for 20 min at room temperature. This transfection mix was added to 
the cells and incubated for 36-48 h, and immunofluorescence analysis was carried out. After 
removing the media, 1 ml of 37% formaldehyde was added and incubated at 37ºC for 20 min in 
order to fix the transfected cells onto the coverslips. Cells were 3X washed with TTBS and 
incubated with 1D4-mouse monoclonal antibody (dilution 1:2000) for one h. After 3X washing 
with TTBS, goat anti-mouse-1D4 tagged with FITC (dilution 1:200) was added. Again, after 3X 
washing with TTBS, cover glasses containing cells were taken and mounted on a glass slide with 
a help of mounting media supplemented with DAPI, which stains the nucleus. Images were 
collected using a fluorescence microscopy system, Nikon eclipse Ti equipped with the camera 
DS-QiMc. 
3.2.14. Bicelle Preparation 
Bicelles are bilayer-mimic structures which are composed of phospholipids such are DMPC and 
DHPC in a ratio of 1:1. As a stock, 2% (w/v) DMPC and 10% (w/v) DHPC were prepared in 
buffer A (pH 6.0, 10 mM Bis-Tris propane (BTP), 140 mM NaCl, 2 mM MgCl2, 2 mM CaCl2), 
vortexed well and stored at -20ºC. Prior to use, the DHPC stock was taken out and let warm up 
for 5 min. In contrast, DMPC was taken from ice and vortexed for 5 min and incubated at 42ºC 
for 15 min in order to dissolve completely. The clear DHPC sample should be maintained at 4ºC.  
1% DMPC and 1% DHPC were prepared by diluting with buffer A. The mixture was vortexed 
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briefly for 1 min and incubated at 42ºC for 15 min. The bicelles mixture was subject to shaking 
at room temperature for 1 h. The prepared bicelles should be used within 36 h or stored at 4ºC 
until use. 
3.2.15. Estimation of sulfhydryls  
Quantifying the free sulfhydrals groups, functional group of Cys from a protein, could be used as 
an indirect measure of the presence of disulfide bonds in a protein (136). 5,5’-dithio-bis-(2-
nitrobenzoic acid), or DTNB or Ellman’s reagent, reacts with free sulfhydrals at the periphery of 
the protein and produces a mixed disulfide with protein and a yellow colored TNB2- which can 
be measured at 412 nm (137). 
 
Figure 3.5. Reduction reaction with Ellman’s reagent. DTNB (or Ellman’s reagent) reacts with free 
sulfhydral groups of the protein producing mixed disulfides with the protein and a yellow colored 
TNB2- which is spectroscopically detectable.  
 
25 l of the protein sample was added to 0.25 ml reaction buffer (0.1 M sodium phosphate, pH 
8.0, 1 mM EDTA and 5l of Ellman’s reagent solution (DNTB 4 mg/ml (w/v) in reaction buffer) 
in a tube, and incubated at RT for 15 min. Using the reaction buffer as control, the absorbance at 
412 nm was measured by means of a UV-visible spectrophotometer. The concentration of free 
sulfhydryls in the protein sample was estimated by using the following formula: 
c = 
𝐴
𝑏𝐸
 
c - concentration of free sulfhydryls 
A - absorbance average at 412 nm  
b – path length of the cuvette (1 cm) 
E – molar extinction coefficient of DTNB (14,150 M-1cm-1) 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. RESULTS AND DISCUSSION 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1. Molecular characterization of human cone opsins 
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The biochemical and biophysical characterization of human cone opsin pigments is inevitable to 
unravel the structural subtleties of these pigments whose structural differences have been very 
little investigated. By studying these pigments we should obtain relevant information about the 
structure-function relationships of these photoreceptor proteins in comparison with the much 
better studied rhodopin from the rod photoreceptor cells. These characterization studies also help 
in identifying the similarities and variances in conformational aspects of functionally-relevant 
intra and intermolecular interactions among the three cone opsins. Such characterized parameters 
can be compared with those of cone opsin mutants which are responsible for inherited retinal 
disorders ranging from colorblindness to degenerative retinal dystrophies.   
4.1.1. Purified recombinant human cone opsins 
Plasmids containing human red, green and blue cone opsin genes were expressed in COS-1 cells. 
The expressed cells were harvested and regenerated with 11CR. Purification was carried out using 
1D4 antibody coupled to a Protein A-Sepharose matrix. The purified cone pigments, in DM 
solution, were analyzed at room temperature using a UV-Vis spectrophotometer in which the 
absorbance spectra were measured from 250 nm to 700 nm. The measured spectra (Fig. 4.1) 
showed two main characteristic bands for all opsins, one at 280 nm characteristic of the opsin 
apoprotein and another one in the visible region at 564 nm, 532 nm, and 418 nm for red, green 
and blue cone opsins respectively corresponding to opsin regenerated with the chromophore. The 
peak at the 280 nm of wavelength corresponds to the total protein and it can include the 
regenerated protein, misfolded protein which cannot regenerate with 11CR, and protein species 
which lose the bound retinal due to the purification process (138).  
 
 
 
 
 
 
 
 
 
Figure 4.1. Purified recombinant human cone opsins.  UV- Vis spectra of purified human red, green 
and blue cone pigments which were expressed by transfecting the pMT4 plasmid containing the cDNA 
of human cone opsins, (OPNSW, OPNMW, OPNLW) into COS-1 cells. The expressed cells were 
regenerated with 11CR and immunopurified using 1D4-Sepharose column.  
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In the case of rhodopsin, its UV-Vis spectrum shows its characteristic regenerated chromophoric 
band at 500 nm. Photoactivation of the rhodopsin shifts the absorbance to 380 nm (Fig. 4.2A) 
similarly, Illumination of the cone pigments lead to isomerization of the bound retinal to ATR 
which would no longer fit into the protein and leaves from the protein resulting a conformational 
change that shifts the absorption maximum of the pigments from their typical dark max to 380 
nm (Fig. 4.2B) which is faster in the case of cone opsin than rhodopsin correlating with the 
physiological faster response to the light stimuli. 
 
Figure 4.2. Photoactivation of recombinant visual pigments.  (A) The purified recombinant rhodopsin 
in DM was a spectrophotometer was illuminated (dotted line) after measuring a dark spectrum (solid 
line). (B) UV-Vis spectra of red, green and blue cone opsins in dark (solid line), was illuminated (dotted 
line) causing a shift in peak to 380 nm. 
 
4.1.2. MetaII decay of cone opsins 
The isomerized chromophore, after illumination, causes a conformational change in the dark 
inactive state of visual pigments resulting to a series of short-lived photointermediates which lead 
to the formation of the active MetaII species. This active conformation decays with time yielding 
the protein ready for another retinal uptake and restoring the dark-adapted state in adaptation 
(visual cycle). The kinetics of this process is linked with the stability of the apo-protein with time. 
The decay of MetaII intermediate can be studied by means of fluorescence spectroscopy. This 
technique has been standardized for rhodopsin by measuring the fluorescence from W2656.48 
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which is located in the ligand binding site. In the dark inactive state, the fluorescence of W2656.48 
is quenched by the -ionone ring of the retinal, and upon illumination, the release of the 
isomerized retinal from the photoactivated pigment increases the fluorescence which can be 
followed with time and it can be a measure of the conformational change in the binding pocket 
involving W2656.48 that can be used as a reporter amino acid. In order to measure the Trp 
fluorescence, the fluorimeter was set with an excitation wavelength of 295 nm and an emission 
wavelength of 330 nm and the fluorescence changes were monitored continuously with time 
(60,90). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. MetaII decay of rhodopsin, red, and green cone opsins.  (A) Purified recombinant 
rhodopsin in DM was illuminated (>495 nm) and Trp fluorescence change was measured after a stable 
dark baseline was attained. (B) The same was carried out in red/green cone opsins to detect the 
photoactivation-induced fluorescence changes of Trp at the binding pocket. 
 
The MetaII decay of the rod photoreceptor protein rhodopsin was studied in parallel to red and 
green cone opsins by means of fluorescence spectroscopy and fluorescence changes of Trp in the 
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retinal binding pocket are measured. In rhodopsin, the fluorescence increase upon illumination 
showed a slower rate with t1/2 of 10.2 min for the process (Fig 4.3A) indicating that the 
photoisomerized retinal gets released from the protein at a slower rate. 
This W6.48 residue is also located in the binding pocket at the position 281 in red and green cone 
opsin sequences, and hence the same approach can be followed to study red and green cone opsins. 
Purified human recombinant red, or green, cone opsin in a fluorimetric cuvette at 20ºC, was 
illuminated (λ> 495 nm) after a stable fluorescence baseline was obtained in the dark. This causes 
a sudden increase in the fluorescence signal that immediately reaches a plateau (Fig. 4.3B) 
indicating a very fast response of red and green cone opsins to the light stimulus. The 
corresponding UV-Vis spectra of red, green cone opsins in dark and the spectral shift to 380 nm 
upon illumination the illumination shifting the peak to 380 nm indicate an analogous 
photobleaching behavior for these three proteins.  (Fig. 4.2B). 
 
 
Figure 4.4. MetaII decay of blue cone opsin.  (A, B) Using fluorescence spectroscopy, excitation (A) 
and emission (B) scans were carried out with purified blue cone opsin in DM which were measured as 
285 nm and 335 nm as max of excitation and emission respectively in order to measure the 
fluorescence changes of Tyr in the retinal binding pocket of blue cone opsin. (C) Fluorescence change 
from Tyr was measured in the case of blue cone opsin metaII intermediate and resulting spectra 
represented as illuminated. 
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In blue cone opsin the bound chromophore quenching the fluorescence of Y2626.48 which is also 
an aromatic amino acid located at the same position. Therefore, the MetaII decay of blue cone 
opsin upon illumination can be studied by measuring the Tyr fluorescence change in an analogous 
manner than measuring Trp for red and green cone opsins. It is known that, along with W6.48, the 
fluorescence from W3.41 which is W126 in rhodopsin and W142 in red/green cone opsins is also 
quenched by the retinal chromophore (66). The same residue is also located in human blue cone 
opsin as W1233.41 which is believed to contribute to the fluorescence measurement of blue cone 
opsin MetaII decay. The optimal excitation and emission wavelengths were determined to be 285 
nm and 335 nm (Fig 3.4A) for measuring maximum fluorescence emission from Y2626.48 in blue 
cone opsin.  
Purified blue cone opsin in DM was added to the fluorimetric micro-cuvette and illuminated 
using white light after a stable dark state baseline was obtained and an immediate increase in the 
fluorescence caused by Y2626.4 was measured (Fig. 4.4B) This fluorescence increase may be 
contributed by W1233.41 as the excitation and emission wavelengths of this Trp also fall within 
the range of Tyr absorbance. After the photoactivation-induced fluorescence increase (as seen 
with red and green cone opsin), a peculiar decrease in the fluorescence at a slower rate can been 
observed. This decrease in fluorescence after illumination may reflect a conformational change 
that can modify the retinal binding site accessibility hiding the exposed Tyr into the protein 
hydrophobic core.  
4.1.3. Stability of cone opsins. 
Thermal Stability 
Visual pigments can be activated in dark by increasing the temperature that would promote opsin 
to a higher energy state and force chromophore isomerization. Such thermally-induced retinal 
isomerization is a two-step process, which includes Schiff base deprotonation followed by 
isomerization of 11CR to ATR and subsequent release of the retinal from the retinal binding 
pocket (139-141). Thermal stability of visual pigments is determined by measuring the 
absorbance decrease in the visible region over time, at a given temperature (142). Here, the 
thermal stability of cone opsins was determined at 37ºC. Purified red, green and blue cone opsins 
in DM were measured by means of UV-Vis spectrophotometry and the corresponding dark-state 
spectra were recorded at room temperature. Next, the temperature was increased to 37ºC and 
spectra were measured every min until complete loss of absorbance in the visible region was 
reached. The change of absorbance was plotted and fit with an exponential decay curve.  The half-
time for the thermal decay of each cone opsin was determined to be 10.25 ± 1.01 min for red cone 
opsin; 7.17 ± 0.98 min for green cone opsin; and 26.53 ± 2.24 for blue cone opsin (Fig. 4.1.5). 
Compared with the thermal stability of rhodopsin which was found to be 3100 ± 45 min (143), 
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red and green cone opsins are ~300 times less stable than rhodopsin at this temperature. It has 
been suggested that cone opsins undergo spontaneous dark activation as the activation energy 
required for isomerization of cone opsins is much lower than that for rhodopsin (144,145). The 
measured thermal decay half-time for blue cone is double than red and green cone opsin could be 
due to blue cone opsin sharing a more structural similarity with rhodopsin than others. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Thermal stability of cone opsins. Purified red, green, and blue cone opsins in DM were 
subject to thermal decay at 37ºC till the pigments had completely decayed. The thermal decay was 
measured by means of a UV-Vis spectrophotometer, the absorbance spectra were recorded every min 
and the Abs changes were plotted and fit to an exponential curve. 
 
Chemical stability 
The chemical reagent hydroxylamine can enter the retinal binding site of cone opsin in dark, break 
the Schiff base linkage and sequester the retinal molecule from the cone opsins resulting a 
retinaloxime and the opsin apo-protein. Hydroxylamine, added in dark, causes a decrease in the 
visible maximal absorbance, especially with cone opsins in which the binding pocket is quite open 
and accessible. In contrast, hydroxylamine does not react with rhodopsin even after 12 h of 
treatment in the dark (146). The retinal binding site accessibility –i.e. the chemical stability of 
cone opsins to hydroxylmine in the dark is a parameter that can be also compared with cone opsin 
mutants. Purified red, green and blue cone opsins in DM were treated with 50 M hydroxylamine 
in dark and the UV-Vis spectra were recorded every min at 20ºC till the complete decay of the 
opsin visible band was recorded. The Abs change at the max in the visible region was plotted 
and fit with an exponential decay curve.  The half-life times for the chemical stability of each 
cone opsin was determined to be 42.53 ± 2.68 min for red cone opsin; 38.65 ± 4.03 min for green 
cone opsin; and 4.71 ± 0.89 min for blue cone opsin (Fig. 4.6). It can be noted that blue cone 
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opsin is approximately 10 times more sensitive to hydroxylamine than red and green cone opsins. 
It is surprising that blue cone opsin, compare to red and green cone opsins, showed a slower 
thermal decay but a much faster hydroxylamine reactivity. These results may suggest that blue 
cone opsin has a very open retinal binding site with easy accessibility to the bound chromophore, 
but the activation energy required to thermo-isomerize the protein-bound retinal is higher than in 
the case of red and green cone opsins. The reason for these differences is not known but may be 
connected to the fact that red and green cone opsins are genetically more closely related than blue 
cone opsin which may have some features of rhodopsin. 
The half-life times for the thermal and chemical decay of cone opsins are listed in Table 4.1.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Hydroxylamine reactivity of cone opsins. Purified red, green, blue cone opsins in DM 
were added with 50mM hydroxylamine in a UV-Vis spectrophotometer. The absorbance spectra were 
recorded every min till the pigments were decayed completely and the max at each min were plotted 
and fitted in an exponential curve. 
 
 
T1/2  (min) Red cone opsin Green cone opsin Blue cone opsin 
Thermal Stabilitya  10.25 ± 1.01 7.17 ± 0.98 26.53 ± 2.24 
Chemical Stabilityb 42.53 ± 2.68 38.65 ± 4.03 4.71 ± 0.89 
 
Table 4.1. Stability of cone opsins. The estimated half-life times for the thermal and chemical stabilities 
of purified red, green, and blue cone opsins in DM measured in min, at 37ºCa and 50 M 
hydroxylamineb respectively. 
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4.1.4. Functionality of purified recombinant cone opsins 
The functionality of the purified cone pigments is tested by monitoring their ability to bind 
tranducin upon illumination. Activation of transducin by the cone pigments can be measured by 
means of a GTPS35 binding assay. In a mixture containing transducin and GTPS35, 300 nM 
visual pigments were added, incubated and the amount of GTPS35 bound to tranducin interacting 
with the photoactivated visual pigment could be determined by the  radioactive binding assay.  
After normalizing the activity data with regard to the basal activity of the pigments in the dark, 
the functionality of the photoactivated pigments is shown in fig. 4.7.  The bound GTPS35 was 
measured (see methods) in pmol as 0.73 ± 0.06 for red cone opsin, 0.8 ± 0.06 for green cone 
opsin, and 0.97 ± 0.41 for blue cone opsin, and the values are similar for the three cone opsins. In 
the case of rhodopsin, as the activity was 5.8 ± 0.16 pmol GTPS35 bound which is 5 times higher 
than the average value for cone opsins.  The activity of rhodopsin has been usually tested with a 
concentration of 10 nM (147). Here, 300 nM of rhodopsin has been used in order to compare the 
functionality of opsins at equal concentration, as the green and blue cone opsins do not show 
activity at this lower concentration although red cone opsin can show activity at 10 nM (148).  It 
is also interesting to note that the transducin used for the experiment was isolated from bovine 
retina (that means from rod photoreceptor cells) and in addition the recombinant rhodopsin used  
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Transducin activation of cone opsins. 300 nM purified red, green, blue cone opsins and 
rhodopsin in DM were added with 500 nM transducin (purified from bovine retina), and GTPS35 mix 
which was analyzed by a radioactive filter-binding assay. The basal dark activity was normalized to 
zero and the activity upon illumination was estimated by means of bound GTPS35. 
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in the assay was also from bovine origin. It has been known that rhodopsin shows greater 
transducin activation capacity than cone opsins due, in part, to the fact that the metaII 
intermediate, which is the active-state for transducin activation, of cone opsins is short-lived when 
compared to that of rhodopsin (27,149). 
4.1.5. Surface plasmon resonance (SPR) spectroscopy of visual pigments 
GPCR and G-protein interactions can be studied by immobilizing the receptor on a sensor chip 
and flowing the G-protein over the bound receptor. Binding of the G-protein onto the immobilized 
receptor would cause a change in refractive index that is measured as resonance units and reflects 
the specific protein-protein interaction which is the principle of SPR spectroscopy (150,151).   
Rhodopsin in MES buffer, at different pH values, was immobilized and passed through the 1D4-
coated SPR sensor chip, and the change of resonance units was compared (Fig 4.8A). This 
comparison shows that ΔRU was only around 100 at pH 6.0, whereas it was 1129 at pH 5.0. 
Therefore, the maximum binding of rhodopsin onto the 1D4-coated surface was obtained at pH 
5.0. 0.585 M transducin in MES pH 5.0 was passed through the rhodopsin immobilized surface 
which showed an increase in resonance units which denotes the dark binding of transducin to 
rhodopsin. Upon illumination there was no increase in the resonance observed and later washing 
with buffer removes the weak bound transducin showing the actual binding of around 5000 RU 
(Fig. 4.8B). Unlike the previous study which showed light induced binding of transducin with 
SPR immobilized rhodopsin (152), only the dark binding of transducin to rhodopsin was observed 
indicating that the experimental conditions destabilize the bound the rhodopsin which would 
activate the protein prior to illumination. Hence the buffer was changed to PBS for green cone 
opsin experiment in SPR 
The same experiment was carried out for the first time with purified green cone opsin which 
showed a stable immobilization of ΔRU 4472 in PBS buffer pH 5.0 (Fig 4.9A). An increase in 
the resonance response was observed after transducin treatment of the opsin sample suggesting 
dark binding of transducin but no light induced binding was noticed upon illumination. 
Surprisingly, a slow dissociation of the bound transducin could be detected with a rate of 1.82 x 
10-4 s-1 (Fig 4.9B) which is specific to the cone opsin and different from that of rhodopsin which 
was 4.7 x 10-4 s-1 (152). Such spontaneous dissociation without addition of GTP could be the 
reason behind the lower Gt activation ability observed with cone opsins (Fig. 4.7) when compared 
to rhodopsin. 
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Figure 4.8. SPR of rhodopsin. (A) Immobilization of 1.25 M purified rhodopsin in MES buffer 
containing 0.05% DM was carried out in pH 5.0 (dashed line) and pH 6.0 (solid line) on a 1D4 coated 
sensor chip of surface plasmon resonance spectroscopy and (B) Transducin, at a concentration of 1.25 
M, was passed through the rhodopsin bound surface and illuminated for 30 sec.  
 
 
Figure 4.9. SPR of green cone opsin. (A) Immobilization of purified green cone opsin in MES buffer 
pH 5.0 containing 0.05% DM was carried out on a 1D4 coated sensor chip of surface plasmon resonance 
spectroscopy and (B) 1.25 M Transducin was passed through the rhodopsin bound surface and 
illuminated for 30 sec.  
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4.2. Ligand binding specificity of photoactivated rhodopsin 
and red cone opsin 
 
 
 
 
 
 
 
(The contents of this chapter have been published as 
Srinivasan S, Ramon E, Cordomí A, Garriga P. Binding specificity of retinal analogs to 
photoactivated visual pigments suggest mechanism for fine-tuning GPCR-ligand 
interactions.Chemistry & Biology (2014) 21(3):369-378, PMID: 24560606, doi: 
10.1016/j.chembiol.2014.01.006.) 
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Active state decay of visual photoreceptors has been extensively studied mainly for rhodopsin, 
and less for cone pigments. However, the receptor conformational properties at the post-bleaching 
phase are still unclear, particularly for cone opsin pigments. These properties can be used, for 
instance, to analyze in detail the structural and functional features of mutants associated with 
visual diseases, such as those associated with retinitis pigmentosa (RP) and congenital stationary 
night blindness (60,153-156). The effect of other factors such as lipids and salts on this decay has 
also been previously investigated (125,157). In this section, it was aimed at carrying out a detailed 
comparison of the regeneration differences of purified rhodopsin and red cone opsin, after 
photoactivation, with two retinal analogs.  
 
4.2.1. Only 9CR can access the rhodopsin binding pocket at the post-Meta II phase  
Upon illumination of purified rhodopsin, an increase in Trp fluorescence is observed due to the 
retinal release from its binding pocket (Fig. 4.2.1A) that closely parallels the MetaII decay process 
under the current experimental conditions. The fluorescence curve can be fit to a single 
exponential function with t1/2 ~ 15 min in agreement with previously published data (125). 
Addition of 11CR, ~90 min after photobleaching (after complete decay of MetaII) did not 
decrease Trp fluorescence, indicating that 11CR is not able to enter opsin and reach the binding 
pocket (Fig. 4.10A). On the other hand, addition of 9CR resulted in a decrease of the fluorescence 
signal compatible with the presence of the exogenously added retinal in the binding pocket (Fig. 
4.10B).  
 
Figure 4.10. Regeneration of photoactivated rhodopsin with retinal analogs. Purified recombinant 
rhodopsin added to the micro-cuvette was illuminated for 30 s (>495 nm) after the dark state spectra 
had stabilized. 2.5 fold of 11CR/9CR to the concentration of rhodopsin sample was added and mixed 
well (A, B). Regeneration was also followed by UV-visible spectroscopy on the same fluorimetric 
samples (inset A, B; 1; dark, 2; illuminated, 3; regenerated).  
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Parallel experiments, carried out using UV-visible spectroscopy, with identical experimental 
conditions to those of the MetaII decay fluorescence assay, showed the presence of the 500 nm 
band indicating regeneration of photobleached opsin. These spectra indicated no regeneration 
with 11CR (Fig. 4.10A, inset), whereas ~25% regeneration could be detected with 9CR (Fig. 
4.10B, inset). These results are not only in agreement with the fluorescence measurements, but 
also prove that retinal binds covalently to opsin.  
 
Figure 4.11. Intrinsic fluorescence of retinal does not interfere with the observed opsin fluorescence 
changes. (A) PBS was initially measured and it was illuminated (hν), and 9-cis-retinal (9CR), 
hydroxylamine (NH2OH), and sulfuric acid (H2SO4) were subsequently added. Fluorescence was 
continuously measured with the excitation at 295 nm and emission at 330 nm. (B) Fluorescence 
emission scan between 310 nm and 360 nm was measured for a PBS sample (―) and after addition of 
9CR to the PBS buffer (•••). 
 
Two control assays were carried out in order to discard that this behavior was due to intrinsic 
fluorescence properties of 9CR or other compounds present in the assay sample. First, the 
fluorescence of a sample of PBS buffer with 0.05% DM (elution buffer) was continually measured 
under different conditions: in the dark, upon photoactivation, addition of 9CR, addition of 
hydroxylamine, and addition of sulfuric acid, mimicking rhodopsin assays (Fig. 4.11A). The 
results show that there is no significant contribution of the buffer to the observed spectroscopic 
results and confirmed that there was no significant fluorescence change upon addition of retinal. 
Second, an emission scan from 310 nm to 360 nm was also performed to determine whether or 
not 9CR caused any contribution to the fluorescence observed in the experiments measured at 330 
nm (Fig. 4.11B). The emission scan for 9CR in PBS buffer solution (excitation wavelength 295 
nm) did not result in any significant increase in fluorescence. Additional controls such as adding 
9CR or 11CR, immediately either after rhodopsin photobleaching or during the process of MetaII 
decay, are detailed below. In all cases this resulted in quenching of the fluorescence signal as 
expected and in agreement with previous reports (60), meaning that both retinals were able to 
bind the two visual receptors under these experimental conditions (Fig. 4.12).  
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Figure 4.12. Effect of the addition of 11CR, or 9CR, to visual pigment shortly after photobleaching. 
Purified recombinant rhodopsin (A) and red cone opsin (B) were illuminated (λ>495 nm) for 30 s (hν) 
after a stable fluorescence baseline was obtained in the dark.  Five minutes after illumination a 2.5 fold 
of 11CR, or 9CR, was added to the illuminated samples.   
 
When 11CR is added immediately after photoactivation, i.e. while MetaII intermediate of 
rhodopsin has not decayed yet, similar results were observed to those previously published for 
11CR (60) suggesting that rhodopsin is brought back to its native chromophore-regenerated state. 
In the case of red cone opsin, of which the t1/2 of MetaII decay is in the ms time range (156), 
addition of retinal immediately after photoactivation led to a considerable decrease in Trp 
fluorescence suggesting the regeneration of red cone opsin with both retinals (Fig. 4.12). It is well 
established that rhodopsin visual pigment shows maximum regeneration when retinal is added 
immediately after photobleaching, and that the regeneration ability is gradually lost with time due 
to the formation of opsin conformations which impair retinal acceptance into the binding pocket 
(158). 
An experiment was also performed in which 9CR was previously mixed with hydroxylamine 
before adding it to the photobleached rhodopsin sample. In this case, a fast decrease in 
fluorescence was observed, (Fig. 4.13A) suggesting that 9CR could enter the binding pocket 
without formation of a Schiff base linkage (which would not be possible with the retinaloxime 
formed with hydroxylamine). Different kinetics could be observed when only 9CR (and no 
hydroxylamine) was added to the sample (Fig. 4.13B).  
In order to track the loss of 11CR regeneration ability for rhodopsin after photoactivation, the 
regeneration experiment was carried out at different time points after photobleaching (0 min, 30 
min, and 60 min). The spectroscopic analysis showed a minimal regeneration at 30 min after 
photoactivation which was virtually abolished at 60 min. Hence the loss of 11CR regeneration 
was gradual, but in the case of 9CR, a significant regeneration level could be detected throughout 
this time period (Fig. 4.14). These data suggest that opsin stability plays a role -in addition to - 
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Figure 4.13. Binding kinetics of 9CR to photobleached rhodopsin. (A) 9CR (0.4M) was previously 
mixed with 50 mM hydroxylamine to form retinaloxime and added to photobleached rhodopsin similar 
to Fig4.10B and the measured fluorescence was fit with an exponential curve. Note the faster decay 
compared to (A) which may indicate fast entering of the retinal into the opsin binding pocket. (B) The 
fluorescence decrease observed in Fig 4.10B, after 9CR addition to the photobleached rhodopsin 
sample, was fit to a single exponential function.  
 
Figure 4.14. Timeline of rhodopsin regeneration. Purified recombinant rhodopsin added to the micro-
cuvette was illuminated for 30 s (>495 nm) after the dark state spectra had stabilized. In a series of 
experiements, 2.5 fold of 11CR (A) or 9CR (B) with regard to the concentration of rhodopsin was added 
and mixed well at 0 min, 30 min and 60 min. The regeneration process was also followed by UV-visible 
spectroscopy on the same fluorimetric samples (C, D).  
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retinal accessibility to the retinal binding pocket- in the observed pigment behavior. 
 
4.2.2. 11CR and 9CR can access red cone opsin binding pocket at the post-MetaII phase 
Upon illumination of the red cone opsin sample, a sudden fluorescence increase is detected (Fig. 
4.15), compatible with a faster retinal release in cone pigments when compared to rhodopsin 
(155). Once the complete retinal release was observed (Trp fluorescence reached a plateau), the 
addition of either 11CR or 9CR resulted in a decrease in intensity suggesting that the two analogs 
could occupy the red cone binding pocket (Fig. 4.15). As in the case of rhodopsin, UV-visible 
spectroscopy was performed in order to monitor purified red cone pigment regeneration after 
photoactivation. The spectra showed a typical absorbance band with a maximum wavelength at 
560 nm indicating red cone chromophore formation. Up to a ~60% of regeneration was observed 
with photoactivated red cone opsin with both retinals (Fig 4.15, insets).  The post-bleaching 
regeneration shows a two phase kinetics which includes a sudden drop in fluorescence suggesting 
the fast entry of retinal into the binding pocket, and a slower decaying component suggesting the 
actual binding of retinal to the active site of the pigment. The fact that the fluorescence signal 
decreases to a level below that of the original pigment baseline may be due to the presence of 
non-regenerated opsin resulting from the immunopurification process. In this case, the retinal can 
also enter this non-regenerated opsin. Alternatively, this large decrease can also be partly due to 
the quenching of other Trp residues in addition to W281 in the retinal binding pocket.  In the case 
of the 9CR, this isomer may be a better quencher because of the position it adopts in the binding 
pocket and its increased interaction with Trp residues.    
 
Figure 4.15. Regeneration of photoactivated red cone opsin with retinal analogs. Analogous to 
rhodopsin regeneration experiments, red cone opsin was illuminated (>495 nm) after a stable dark-state 
spectrum was obtained, followed by 11CR/9CR addition (A, B). UV-visible spectroscopy of red cone 
opsin was also measured as in the rhodopsin case (inset A, B; 1; dark, 2; illuminated, 3; regenerated). 
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In order to understand how retinal regeneration occurs at a molecular level it is important to 
understand the structural changes associated with the transition from the inactive to the active 
states and vice versa. In rhodopsin, K2967.43 and W2656.48 represent important residues of the 
retinal binding pocket. The aldehyde group of retinal covalently binds to K2967.43, whereas 
W2656.48 remains proximal to the -ionone ring of retinal (90). Comparison of the extracellular 
region in the dark-state (11CR-bound) and active rhodopsin structures (159,160) reveals structural 
differences between them.  
Two homology models for the red cone opsin were constructed based on the crystal structures of 
dark-state rhodopsin and opsin soaked with ATR. 11CR and 9CR retinals were docked to the 
opsin forms of rhodopsin and red cone opsin (148). There is no structure of bovine rhodopsin 
available with 9CR. However, squid rhodopsin has been crystallized with both 11CR and 9CR 
revealing only one minor differences between them: a shift in the localization of the C10 and C11 
atoms by ~1 Å. (161,162). Accordingly, it was assumed in that study that the same mimicry should 
apply to rhodopsin and to the red cone opsin. 
Fig. 4.16A-B represent an initial state of 11CR or 9CR rhodopsin and red cone opsin regeneration 
prior covalent binding to K296/3127.43. Similar binding scenarios, for both retinals in both 
rhodopsin and red cone opsin, can be observed. According to the molecular model, a remarkable 
difference between the two photoreceptor proteins is the presence of W1834.56 in red cone opsin 
(corresponding to C1674.56 in rhodopsin), which may contribute to the stabilization of the retinal-
opsin complexes (163). Therefore, W183 can help preserving the native conformation of the opsin 
binding pocket -in the absence of retinal- and facilitate increased accessibility of the retinal to red 
cone opsin binding pocket by favoring retinal-protein interactions. This specific Trp residue may 
prevent the red cone opsin binding pocket from becoming unstructured, and it can also contribute 
to the large drop in fluorescence caused by 9CR addition in the fluorimetric experiments. The 
main difference between the two retinals is that the 9-cis isomer makes more favorable contacts 
with W265/2816.49 and Y268/2846.51 than the 11-cis isomer in the two receptors in the region in 
the vicinity of the C13 methyl group. Thus, it is likely that 9CR benefits from higher stabilization 
energy than 11CR in the two photoreceptors (148). The modeling results show only remarkable 
changes in TMs 3, 6 and 7. In specific, a decrease from 8.5 Å to 6.5 Å in the distance between 
TM5 and TM6 (measured as the distance between the α-carbons of F2085.43 and A2696.52) is 
observed. In turn, TM7 becomes closer to TM6 (from 5.5 Å to 4.9 Å, measured between the α-
carbons of P2676.50 and P2917.51. On the other side, the distance between TM3 increases (from 
10.7 Å to 13.4 Å, measured between E1133.28 and K2967.43). Thus, without the inverse agonist 
11CR, TM6 packs more tightly with TM5. Since TM7 moves closer to TM6, the distance to TM3 
increases. A major consequence of these changes is that the main counter-charge of K2967.43 
changes between the dark and the active forms from E1133.28 to E181C-6. Table 4.1 shows a 
comparison between residues forming the retinal binding sites in rhodopsin and red cone photo- 
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Figure 4.16. Molecular models of rhodopsin and red cone opsin. (A, B) Molecular complexes for 11-cis (pale-yellow) and 9-cis (orange) retinal bound to rod (A) and 
red cone (B) opsins. (C) Comparison between helical arrangements in dark-state rhodopsin (PDB id: 1GZM, shown as white transparent cartoon) (2) and opsin soaked 
with ATR (PDB id: 2X72, shown as colored cartoons) (3). The color-code for opsin helices is TM1: light-gray, TM2: gold, TM3: red, TM4: dark-gray, TM5: green, TM6: 
blue and TM7: pale-red. Dashed lines display the distances between the shown amino acids (see Text; dark-state rhodopsin: white, active opsin: yellow). D, E) The 
entrance site for retinals in the dark (D) and opsin (E) states. Rod opsin residues are shown in colors, whereas residues in red opsin are shown in white.  
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-receptors. Despite the fact that they share the same endogenous ligand, only a third of the residues 
are conserved between rhodopsin and the red cone opsin. Crystal structures reveal also the 
existence of different networks of interactions close to the retinal. This suggests specific 
recognition mechanisms at the molecular level. Retinal has been proposed to enter the opsin 
binding pocket between either TM1 and TM7 (called opening A) or TM5 and TM6 (called 
opening B). This opening B region is flanked by V2045.39, F2085.43, F2125.47, A2696.52, F2736.56 
and F2766.59 (49,53). In the dark state these residues constitute a zipper between the two helices 
that keeps the access to the protein interior closed. A similar zipper is observed in the molecular 
model of the red cone opsin, though stabilized mainly by Met/Cys-Met/Cys interactions instead 
of aromatic-aromatic and aromatic-aliphatic interactions. These sulfur-containing residue 
interactions, which are of the same magnitude an even higher than aromatic-aromatic interactions 
can act as molecular gears in GPCRs (164). In the activated rhodopsin, F2085.43 exhibits a 
conformational change that, together with the translation of TM5, opens a cavity within the zipper 
and allows the retinal into the retinal binding site (Fig 4.16D, E). The molecular model shows 
clearly that this cavity is conserved in red cone opsin, except that the opening of the zipper would 
be controlled by M2145.43 instead of F2085.43 (Fig. 4.16E). In addition, substitution of four Phe 
residues by residues with smaller volume (Met, Cys and Ala) may facilitate the entrance of retinal. 
The molecular models of opsin forms in complex with 11CR and 9CR, without formation of the 
Schiff base with K2967.43, suggest that 9CR benefits from stronger interactions with W2656.49 and 
Y2686.51 than 11CR. In the red cone opsin, in addition to Y2816.49 and W2846.51 positions, W1834.56 
also contributes to maximal higher stabilization energy towards both retinals. The opening of 
TM6 after photoactivation shows that W2656.49 presumably favors binding of 9CR which has 
shorter C9 to β-ionone ring length than 11CR. This would favor the 9-cis isomer to enter the 
retinal binding site. The previous finding that 9-demethyl retinal could inhibit the formation of 
active MetaII conformation of rhodopsin (165), but not of red cone opsin (166), suggests that the 
retinal binding site of red cone opsin is more accessible and more versatile than that of rhodopsin. 
The specific interaction of residues W265 and Y268 may contribute to enhance 9CR quenching 
observed in the fluorescence spectroscopic measurements. This is compatible with the present 
results of retinal regeneration long time after photobleaching. More versatile the ligand binding 
site, less constriction within the retinal entry and exit channels, hence either of retinal analogs, 
added exogenously after photoactivation, may be accommodated into the retinal binding site as 
observed in our fluorimetric measurements. 
  
4.2.3. Accessibility of retinal binding sites of rhodopsin and red cone opsin by retinal analogs 
In order to prove the hypothesis of different accessibility of the two retinal analogs to the binding 
pocket, 11CR or 9CR were added to rhodopsin and red cone pigment, prior to illumination and 
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the fluorescence intensity was monitored (Fig 4.17). No significant change in rhodopsin 
fluorescence in the dark upon addition of 11CR was detected, whereas only a minimal increase 
could be detected after illumination (with light >495 nm) (Fig 4.17A). This increase is much 
smaller than the typical MetaII decay curve (see Fig 4.10A) and may be due to the presence of 
excess amount of 11CR around MetaII that may replenish the activated pigment with ligand as 
previously reported (60). Addition of hydroxylamine resulted in a slight increase in the 
fluorescence signal. However, in the case of 9CR added to rhodopsin in the dark, an appreciable 
decrease in fluorescence intensity could be detected (Fig. 4.10B). Illumination only slightly 
altered the Trp fluorescence, though to a much smaller extent as compared to 11CR. Addition of 
hydroxylamine somehow increased the retinal release from the rhodopsin binding pocket (Fig. 
4.10B). 
 
Figure 4.17. Difference in accessibility of retinal binding sites of rhodopsin and red cone opsin with 
retinal analogs. 11CR and 9CR (2.5 fold than rhodopsin concentration) were added to purified 
rhodopsin, followed by illumination (>495 nm), and 50mM hydroxylamine addition in the same sample 
when the stable spectra was obtained after each treatment (A, B). Same experiment was carried out with 
purified red cone opsin (C, D). 
 
In the case of red cone pigment, the addition of either 11CR or 9CR caused a decrease in the 
fluorescence intensity indicating entry of both retinals into the binding pocket of free opsin. Upon 
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illumination, the fluorescence intensity was not affected, and subsequent treatment with 
hydroxylamine resulted in a saturation curve with t1/2 of ~3 min that would reflect the formation 
of retinaloxime which would be released from the red cone pigment. 
Strikingly, the decrease in fluorescence was observed with either retinal, and subsequent 
illumination did not alter the fluorescence intensity. UV-visible spectra of the dark state purified 
visual pigments indicate that, along with the peak of regenerated pigment in the visible region, 
the characteristic protein peak at 280 nm can also be detected which may account for the presence 
of both regenerated opsin and free opsin. At least a fraction of this opsin can be non-misfolded 
opsin as has already been previously reported (138,167). The A280/A560 ratio of red cone opsin, 
from the UV-visible spectrum, indicates the presence of non-regenerated opsin in the eluted 
purified sample. The decrease in fluorescence observed in both red cone opsin and rhodopsin, in 
the dark before photoactivation, could be due to the presence of free opsin that can accept the 
exogenously added free retinal during the fluorimetric experiments. The lack of a classical photo-
response upon illumination (Fig. 4.17) can be explained by the presence of excess free retinal in 
the sample. Interestingly, a saturation curve is obtained upon hydroxylamine addition which may 
reflect additional retinal release from the binding pocket. The t1/2 of this process is ~3 min and 
this parameter can be used to assess the regeneration properties of red cone opsin mutants 
(associated with visual disorders). The observation of similar features in the case of rhodopsin 
with the addition of 9CR -except the fact of faster formation of retinaloxime-, and the lack of 
effect with 11CR conclusively supports the hypothesis that the binding pocket of free opsin from 
rhodopsin can be accessible by 9CR but not by 11CR under our experimental conditions. A recent 
study on the thermal properties of rhodopsin reports that exogenous addition of 11CR 10 min 
after photoactivation shows a decrease in Trp fluorescence intensity which is 20% of the total 
fluorescence increase observed after photobleaching. However, the conditions used in this study 
are different from those in the present study, namely that they used a 1:1 retinal:opsin ratio, a 
temperature of 55°C and a shorter post-bleaching time (142).  
 
4.2.4. Improvement of rhodopsin regeneration with 9CR using low salt buffer 
In order to determine the possible effect of buffer conditions on rhodopsin regeneration, 
recombinant rhodopsin was purified in sodium phosphate (NaPi) buffer (see Methods) and 
photoactivated in the spectrofluorimetric cuvette. The fluorescence increase was measured until 
it reached a plateau indicating complete MetaII decay and after addition of 2.5 fold concentration 
of 9CR (over rhodopsin). An immediate decrease in fluorescence intensity was detected after the 
addition of 9CR, suggesting a faster regeneration of photoactivated rhodopsin (Fig. 4.18). A 
parallel sample monitored by UV-visible spectrophotometry showed a regeneration which was 
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quantitatively larger (~70%) than the case of the experiment performed with rhodopsin purified 
with PBS elution buffer (Figure 4.18A, inset; compare to inset in Figure 4.10A).  
The results indicate that photoactivated rhodopsin in NaPi buffer shows improved post-bleaching 
regeneration with 9CR. An interesting aspect was to find out whether oligomerization could alter 
retinal binding to the receptors. To this aim the receptors were purified using two different buffers, 
PBS or NaPi buffers, which may affect the regeneration abilities of the receptors. Blue native 
polyacrylamide gel electrophoresis (BN-PAGE) was carried out with equal concentration of 
rhodopsin expressed in HEK-293S-GnTi- cells. Rhodopsin purified using NaPi buffer clearly 
show the predominant presence of oligomeric forms (dimer and less intense trimer bands; Fig. 
4.18B).  
 
Figure 4.18. Phosphate buffer (low salt conditions) improves 9CR regeneration of photoactivated 
rhodopsin. (A)Purified recombinant rhodopsin in 2 mM NaPi buffer (containing 0.05% DM) was 
illuminated (>495 nm) after the dark state spectra had stabilized. Then 2.5 fold of 9CR to the 
concentration of rhodopsin was added and mixed thoroughly. The experiment was also followed by 
UV-visible spectroscopy (inset A; 1; dark, 2; illuminated, 3; regenerated). (B, C) Blue Native PAGE 
and SDS-PAGE was performed with rhodopsin purified PBS and in NaPi which was expressed in 
HEK293S-GnTi- cells. (D) The Western blot was carried out with rhodopsin, expressed in COS-1 cells 
and purified in PBS, in NaPi. 
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In contrast, rhodopsin purified using PBS buffer shows the presence of a strong monomeric band 
and a much less intense dimer band (Fig. 4.18B). SDS-PAGE was also carried out with rhodopsin 
expressed in HEK-293S-GnTi- cells and purified using PBS or NaPi. The results show that 
rhodopsin appears as a single monomeric band in both cases with no indication of oligomeric 
behavior due to the denaturing conditions of the gel (Figure 4.18C). The red cone pigment failed 
to show regeneration in NaPi, and this lack of regeneration, in the low ionic strength buffer, could 
be related to the requirement of chloride ions which are known to have a specific binding site in 
cone opsins (168). The Western blot of rhodopsin in both buffers, subsequent to a denaturing 
SDS-PAGE gel, resulted in a similar smeary pattern probably due to the glycosylation behavior 
of COS-1 cells (Fig. 4.18D).  
In order to understand the nature of the improved regeneration of photoactivated rhodopsin in 
NaPi buffer, BN-PAGE was performed to identify the presence of rhodopsin oligomers in 
different buffers (169). High molecular weight bands, corresponding to oligomeric forms of 
rhodopsin, appear to be more intense in NaPi buffer (Fig. 4.18B). These oligomeric forms of 
rhodopsin may provide a better environment for post-bleaching regeneration of rhodopsin due to 
increased stability provided by dimeric opsin units. The differences in oligomerization may 
account for the different kinetics observed for rhodopsin regeneration in PBS and NaPi buffers. 
Recent studies have highlighted the influence of rhodopsin dimers on its capacity for regeneration 
with either 11CR or 9CR (83) and on the asymmetry of the rhodopsin dimer complex with 
transducin (84). Attempts to purify red cone opsin using NaPi buffer resulted in destabilized 
protein and no regeneration could be obtained. Thus, regenerated red cone opsin could only be 
obtained in PBS buffer consistent with the fact that a chloride ion in its binding site is crucial for 
the optimal conformation of cone pigments (168).   
Overall, the observed different regeneration ability of rhodopsin and red cone opsin, with 9CR 
and 11CR, may be due to a combination of both stability and accessibility effects. These two 
effects may act in concert and may help explain the differences observed for the two visual 
pigments. In the case of samples in PBS buffer, the opsin protein would show lower stability -
being predominantly monomeric- and this would alter the conformation of the retinal binding 
pocket thus affecting the accessibility of retinal to the pocket. In contrast, in NaPi buffer the 
presence of dimers would help stabilize opsin and this would better preserve the correct retinal 
binding conformation allowing a faster and better accessibility of retinal to the interior of the 
protein. Therefore, increased stability of the opsin retinal binding pocket structure would result 
in a better accessibility of the retinal and would facilitate its entrance to the pocket and chemical 
binding to the pigment. 
An analogous experiment was performed with 11CR and the chromophore regeneration could be 
detected in NaPi buffer (Fig 4.19). This finding stresses the importance of the buffer (and the 
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corresponding monomeric or dimeric status of the pigment) on the chromophore regeneration of 
the pigment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19.  Photoactivated rhodopsin purified in NaPi shows regeneration with 11CR. Purified 
recombinant rhodopsin in 2 mM NaPi buffer (containing 0.05% DM) was illuminated (>495 nm) after 
the dark state signal had  stabilized. Then, 2.5 fold of 11CR to the concentration of rhodopsin was added 
and mixed thoroughly. The experiment was also followed by UV-visible spectroscopy (inset:  1; dark, 
2; illuminated, 3; regenerated).  
 
4.2.5. Transducin activation of 9CR-regenerated rhodopsin and red cone opsin 
To study the ability of regenerated pigments to activate transducin, purified visual pigments were 
tested in the dark, upon illumination, and after addition of 9CR under experimental conditions 
similar to those of the fluorimetric experiment (Fig. 4.20). To do this, different sample aliquots 
were taken from the cuvette during the fluorimeter measurements, added to the transducin mix 
immediately and the activation was measured by means of a radioactive GTPS35 binding assay. 
In the case of rhodopsin, an increase in transducin activation immediately after photoactivation 
was observed, which decreases over time. However, the fact that upon subsequent addition of 
9CR the functional activity of rhodopsin decreased may indicate regeneration of photoactivated 
rhodopsin with the added 9CR and formation of a dark-state pigment. Further illumination with 
white light of this regenerated pigment resulted in functional activation suggesting the formation 
of a small amount of functionally active regenerated rhodopsin from the whole sample (Fig. 
4.20A, C). Importantly, the results show that photoactivated rhodopsin regenerated with 9CR is 
functionally active.  
On the other side, transducin activation of red cone opsin samples taken along the fluorescence 
experiment was determined as mentioned above for rhodopsin. Unlike rhodopsin, red cone opsin 
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exhibited gradual transducin activation over time after illumination and a slower ability to activate 
transducin upon addition of 9CR (Fig. 4.20B, C). 
On the functional side, rhodopsin appears to activate rod transducin more effectively than red 
cone opsin. This result is in line with a recent study where transducin activation by cone pigment 
is slowed immediately after photoactivation in contrast to the rhodopsin behavior (149). We also 
found that the photobleached regenerated rhodopsin retains more Gt activating capacity than red 
cone opsin.  
 
Figure 4.20. Transducin activation of 9CR regenerated visual pigments. Rhodopsin (A) and red cone 
opsin (B) were monitored by means of fluorescence spectroscopy, and samples were treated by 
illumination (λ>495 nm), 9CR addition and a second illumination using white light. Rhodopsin and red 
cone opsin samples, taken at different time points from the experiments reported in panels A and B, 
and denoted as S1 – S6 (with the corresponding time in min)  were analyzed for transducin activation 
(C). 
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4.3. Beyond spectral tuning: functionally-relevant molecular 
differences between cone opsins 
 
 
 
 
 
(The contents of this chapter have been published as 
Srinivasan S, Cordomí A, Ramon E, Garriga P. Beyond spectral tuning: human cone 
visual pigments adopt different transient conformations for chromophore regeneration. 
Cellular and Molecular Life Sciences (2015) (accepted) 
 
Srinivasan S, Ramon E, Garriga P.  The photoactivated conformational change in blue 
cone opsin modulates the specificity of secondary retinal uptake. (to be submitted)
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Specific amino acids at the retinal binding site, as well as their interactions with the retinal 
chromophore and surrounding water molecules, modulate spectral tuning of visual opsins 
(48,170,171). Cone opsin pigments have been much less characterized than the rod photoreceptor 
rhodopsin due to their lower availability and their higher conformational instability. With only 
4% variance between red and green cone opsin sequences, these are believed to have analogous 
structure-function relationships, other than the well-established wavelength absorption 
modulation in the visible region of the spectrum. In this section, the regeneration behavior and 
kinetics of photoactivated green cone opsin and red cone opsin have been compared. Blue cone 
opsin has been studied separately because the typical regenerated absorbance is blue shifted to a 
position close to the free retinal absorbance.  
4.3.1. Comparison of red and green cone opsin regeneration mechanism  
4.3.1.1. Photoactivated green cone opsin regenerates with an unprotonated SB linkage with 
11CR.  
The dark state UV-vis spectrum of purified green cone opsin showed two typical characteristic 
absorbance bands with absorption maxima at 530 nm and 280 nm respectively (Figure 4.21A, 
continuous line). The amplitude of the band at 530 nm corresponds to the bound 11CR 
chromophore and reflects the amount of regenerated green cone pigment present, and the band at 
280 nm corresponds to total opsin pigment. The regeneration experiment was done in the 
spectrophotometer cuvette by adding, in the dark, an aliquot of a concentrated stock sample of 
11CR that corresponds to a 2.5- fold molar concentration with regard to opsin. This resulted in a 
spectrum which showed, in addition to the two dark absorbance bands in the visible and in the 
UV regions, another band at 380 nm corresponding to the added free 11CR (Fig. 4.21A, dashed 
line). Illumination of the sample was carried out by using a cut-off filter (λ>495 nm) which only 
bleaches the green cone opsin but not the added retinal, and the spectrum measured after 30 min 
showed an increase at 380 nm corresponding to photobleached opsin (Fig. 4.21A, dashed line). 
Illuminated sample, containing exogenously added 11CR, did not show any absorbance increase 
at 530 nm (Fig. 4.21A, dashed line) which suggests that the modified conformation of green cone 
opsin, immediately after photobleaching, is not the same as dark adapted green cone opsin and 
impairs 11CR binding. Conversely, a parallel experiment performed with 9CR, showed a visible 
region regenerated band around 495 nm with 85% maximal regeneration (Fig. 4.21B). 
Photoactivated red cone opsin regenerates via a PSB with both 9CR / 11CR. An analogous 
regeneration experiment was carried out with purified red cone opsin, monitored using UV-vis 
spectrophotometry and extending the measuring range to 700 nm due to the fact that the typical 
absorption maximum of red cone opsin is 560 nm. In both experiments, 9CR and 11CR can bind 
opsin after illumination and regenerate the visible chromophore with PSB linkage indicated by 
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the presence of absorbance increase in the visible region above 440 nm. In particular, complete 
regeneration with 11CR was achieved as indicated by the re-appearance of the typical absorption 
maximum at 560 nm (Fig 4.21C) whereas ~70% regeneration with 9CR was recovered with an 
absorption maximum at ~520 nm (Fig 4.21D). The shifted absorption maximum of the protein is 
due to its different interaction with 9CR. 
 
 
Figure 4.21. Regeneration of photoactivated green and red cone pigments with 11CR and 9CR. 
(A, B) Immunopurified human recombinant green cone opsin was analyzed by UV-visible 
spectrophotometry in the dark (1, solid line) and after addition of exogenous ligand, i.e. 2.5-fold 
of either 11CR (A) or 9CR (B) over opsin (2, dotted line). The pigment was then illuminated for 
30 s (>495 nm) and a spectrum was recorded after 30 min (3, dashed line). (C, D) Red cone opsin 
was spectroscopically measured in an analogous way to green cone opsin and spectra were 
measured in the dark (1, solid line), after 11CR (C) or 9CR (D) addition (2, dotted line), and 30 
min after illumination (3, dashed line). 
 
11CR regenerates with photoactivated green cone opsin with an unprotonated SB linkage. The 
lack of absorbance increase in the visible region suggested lack of 11CR binding and prompted 
the question whether green cone opsin could be regenerating with 11CR by means of an 
unprotonated SB linkage. To test this hypothesis, the photobleached sample was acidified which 
resulted in a shift of the band to 440 nm characteristic of a PSB. This shift indicates that 11CR 
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was covalently bound to the protein but via an unprotonated SB (Fig 4.22A). In order to confirm 
this result, two parallel UV-vis spectroscopic experiments were carried out with the same green 
opsin sample that was illuminated and split into two aliquots. One of the aliquots was acidified 
immediately after photobleaching whereas the other was acidified 30 min after illumination. The 
difference spectrum between the two aliquots clearly showed a difference band at about ~450 nm 
(Fig 4.22B) which clearly indicated that the photoactivated green cone opsin formed an 
unprotonated SB linkage with 11CR. 
 
Figure 4.22. Photoactivated green cone opsin regenerates with 11CR by means of an unprotonated 
Schiff base linkage. (A) The UV-vis spectrum of purified green cone opsin was measured in the dark 
(1, solid line). After addition of 2.5 fold 11CR, it was illuminated for 30s (λ>495 nm) (2, dotted line). 
Then, the sample was split into two aliquots in which one was acidified with 2N H2SO4 immediately 
(3, dashed line) and the other 30 min (4, dot-dashed line) later. (B) A difference spectrum was obtained 
by subtracting the spectrum of the sample acidified after 30 min and the sample acidified immediately 
after photoactivation. (C) Green cone opsin, in a fluorimetric micro-cuvette was illuminated for 30s (λ 
>495 nm) after a stable baseline was obtained. Then, 2.5 fold of 11CR to the concentration of green 
cone opsin was added immediately after photoactivation and mixed thoroughly.   
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The photobleaching process was also measured by means of fluorescence spectroscopy by 
monitoring the Trp fluorescence increase upon green cone opsin illumination. In the dark state, 
the fluorescence from a specific Trp residue at the retinal binding pocket is quenched by the -
ionone ring of the retinal, and upon photoactivation and retinal release the Trp fluorescence is no 
longer quenched and an increase in fluorescence can be measured. Purified green cone opsin 
sample in the fluorescence cuvette was illuminated (λ> 495 nm) after a stable dark baseline was 
obtained. The sudden increase in fluorescence, upon illumination of the green cone opsin sample, 
indicated a faster MetaII decay. Subsequent addition of exogenous 11CR  (2.5 fold 11CR over 
protein) to the illuminated sample resulted in a decrease in the fluorescence signal confirming 
entry of 11CR into retinal binding site of activated green cone opsin (Fig 4.22C).   
The conformation of opsin and the photochemistry of the chromophore determine the spectral 
properties of cone visual pigments and in turn the observed spectral behavior could provide hints 
about the structural details of the receptor proteins (172). When green cone opsin is regenerated 
with 9CR, the molecular coefficient of the pigment varies with regard to that of the protein 
regenerated with 11CR. Hence, the same opsin regenerated with different retinal analogs results 
in shifts in the wavelength of the visible absorption maximum and also differences in the 
maximum absorbance amplitude. The measured maximal chromophore regeneration of red and 
green cone opsin with 9CR was 85% and 70% respectively of the original dark spectra before 
illumination (Fig 4.21). Thus, it emphasizes that the different and specific behavior observed for 
11CR and 9CR and the importance to take this into account in vision research. 
It is striking that green cone opsin regenerates through an unprotonated SB intermediate 
conformation that eventually has to become protonated in vivo to regenerate the 530-nm absorbing 
chromophore. This novel intermediate conformation may have a decreased pKa of the SB 
nitrogen, in the case of green cone opsin, that could imply electrostatic changes at the SB linkage 
vicinity including changes in the SB-counterion distance. Green cone cells are less abundant in 
the human retina (the ratio of red cone cells to green cone cells in the human retina mosaic is 
estimated to be 1.5 to 1) and their response is believed to be analogous to that of red cone cells(28). 
Green and red cone opsins differ in only 14 residues, with most changes located in the central 
portion of TM5 and TM6. The similarity is remarkable in the retinal binding pocket (Fig 4.23), 
except the position 3097.40 in TM7 (Tyr and Phe in red and green opsins, respectively). Assuming 
a similar movement of this residue with activation as observed in the crystal structures of 
rhodopsin, in the dark-state red opsin F3097.40 would form a hydrogen bond with T201 in ECL2. 
This interaction, which is not possible in green opsin, could underlie the observed differences in 
spectral and retinal regeneration properties. 
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Figure 4.23. Molecular model of retinal binding site around SB region. Molecular model of 
inactive red opsin showing the proposed interaction between F3097.40 (in TM7) and T201 (in ECL2). 
The cartoon of TM7 and the conformation of F3097.40 in the active state are shown with a transparent 
representation, and the arrow indicates the movement. 
 
To validate the modeling observation, F309Y mutation was introduced into green cone opsin and 
the 11CR regeneration experiment was carried out with the purified mutant pigment which 
showed a regenerated peak at 530 nm (Fig. 4.24A). The difference between the acidified and the 
regenerated spectra showed a clear band at 530 nm representing the PSB in 309Tyr mutant of 
green cone opsin, and the difference band at 440 nm corresponds to the amount of net SB from 
the regenerated pigment (Fig. 4.24B). The fact that the amplitude of the 530 nm band is lower 
than that of WT pigment regenerated with 11CR, suggests that other residues, like A285 (Thr in 
red cone opsin) and F279 (Tyr in red cone opsin) which are also in the vicinity of the retinal 
binding pocket, can also play a role in the formation of the PSB linkage for green cone opsin. 
However, the role of Y309 in modulating the process of protonation of photoactivated green cone 
pigment during 11CR regeneration has been substantiated.  
A clear difference is found in the intermediate conformation after photoactivation of red and green 
cone opsins that may be related to differences arisen in the molecular evolution of these two 
genetically closely related visual pigments. Such transient intermediate conformations of the 
ligand free opsin during the process of the regeneration have also identified for rhodopsin (173). 
The unprotonated SB conformation detected could be involved in the dark adaptation process of 
the photoactivated receptor, in an excess of retinal environment, and consequently play a role in 
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the molecular basis of color vision by differentially modulating the chromophore regeneration 
and functionality of green and red cone photoreceptor cells. 
 
Figure 4.24. Phe309 regulates Schiff base protonation during 11CR regeneration of 
photoactivated green cone opsin. (A) DNA sequencing result showing the introduction of F309Y 
into green cone opsin by site directed mutagenesis using the primers (the forward primer - 
5’GCCCTGCCGGCCTACTTTGCCAAAAGTGCC3’; and the reverse primer - 
5’GGCACTTTTGGCAAAGTAGGCCGGCAGGGC3’) (B) 11CR regeneration experiment was 
carried out with purified F309Y green cone opsin mutant. After measuring a dark state spectra (1), 
11CR was added prior to illumination (2) and the regenerated spectrum was recorded after 30 min 
(3) showing a band at 530 nm and the sample was acidified (4). (B, inset) A closer look at the visible 
region of dark (1) and (2) regenerated spectra. (C) The difference spectrum, obtained by subtracting 
the acidified spectrum and the regenerated spectrum, shows a clear difference band at 530 nm. 
 
However, these results suggest that there is a clear difference in the conformation after 
photoactivation of red and green cone opsins that may be related to differences arisen in the 
molecular evolution of these two genetically closely related visual pigments. The unprotonated 
SB conformation detected could be involved in the dark adaptation process of the photoactivated 
receptor, in an excess of retinal environment, and consequently play a role in the molecular basis 
of color vision by differentially modulating the chromophore regeneration and functionality of 
green and red cone photoreceptor cells. Furthermore, the proposal of unprotonated SB binding of 
11CR to green cone opsin reflects a novel unreported conformational difference between 
photoactivated green and red cone opsins as discussed above.  
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4.3.1.2. Red and green cone opsins chromophore regeneration kinetics 
The conformation of opsin and the photochemistry of the chromophore determine the spectral 
properties of cone visual pigments and, in turn, the observed spectral behavior could provide hints 
about the structural details of the receptor proteins (172). Illumination causes a decrease in 
absorbance of the regenerated pigment band in the visible region which would be apparently 
parallel to an absorbance decrease at 380 nm. The 380 nm absorbance decrease, upon 
chromophore regeneration, could reflect either 11CR binding to, or ATR release from, the opsin 
receptor. Each data point corresponding to the absorption maximum in the visible region and the 
retinal region of each regenerated spectra was plotted versus time. The data could be fit to the 
curves reflecting a fast regeneration process that rapidly reached a plateau.   
Regeneration kinetics of green and red cone opsin with 9CR. In red and green cone opsins, the 
kinetics of the 9CR regeneration process gave t1/2 of 1.0-1.5 min (Fig. 4.25A). The decrease in 
absorbance at 380 nm parallels the visible increase and represents entry of retinal into 
photoactivated opsin during the regeneration process (Fig. 4.25B) as expected. Parallel 
experiments were carried out with purified rhodopsin, in which the regeneration with 11CR and 
9CR followed single saturation patterns which are significantly slower than those observed for 
cone opsins, and can be correlated with absorbance changes at 380 nm (Fig. 4.26). 
 
Figure 4.25. Regeneration and retinal release kinetics of green and red cone opsin with 9CR. (A) 
The absorbance increase at the λmax in the visible region of each regenerated red/green pigment was 
plotted and fit with a saturation curve. Chromophore regeneration with 9CR was measured for red 
and green cone opsins for 30 min. The dark-state spectral values of red and green cone opsin were 
normalized to have equivalent dark absorbance and the regenerated absorbances were also 
normalized by the same factor. (B) Absorbance changes at 380 nm for the regenerated samples were 
plotted and fit to a single exponential decay curve. 
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Figure 4.26. Regeneration kinetics process of rhodopsin with 11CR and 9CR. Regeneration 
experiments of rhodopsin with 11CR and 9CR were carried out by means of UV-visible 
spectrophotometry, in which retinal was added prior to illumination (λ>495 nm), and the regeneration 
was followed for 30 min. The dark-state spectra of rhodopsin were normalized to have equal dark 
state absorbance at λmax and the regenerated spectra were normalized by the same factor. (A) The 
visible λmax of each normalized regenerated spectrum was plotted and fit with a saturation curve 
and (B) the A380 nm change was also plotted and fit with an exponential decay curve. 
 
4.3.1.3. Secondary retinal uptake kinetics by cone visual pigments after regeneration.  
Analogous regeneration experiments were carried out with 11CR but only for red cone opsin as 
green cone opsin showed no absorbance increase in the visible region upon regeneration. A 
similar pattern to that observed for 9CR was obtained in the case of red cone opsin regenerating 
with 11CR with a t1/2 less than 1.0 min, and the regeneration with 11CR was found to be even 
faster than with 9CR (Fig 4.27A). This behavior is in agreement with the complete fast 
regeneration observed for red cone opsin with 11CR (Fig. 4.21C). 
Cone opsin regeneration is usually quantified by measuring the absorbance increase at the 
characteristic visible band, but in our case this was not possible for green cone opsin chromophore 
regeneration with 11CR. In order to estimate the regeneration kinetics, we measured the decrease 
in absorbance at 380 nm with time. This would reflect retinal entry into the binding site of cone 
opsins and was expected to parallel the regeneration process. In this regard, the change in 
absorbance at 380 nm after illumination was plotted and the data could be unexpectedly fit to a 
sigmoidal curve (Fig. 4.27B) which suggested entry of 11CR into visual pigments at a slower 
rate, with t1/2 of 10.6 min for red cone and 13.7 min for green cone respectively. This behavior is 
in contrast to the faster binding kinetics of cone opsins regenerated with 11CR (Fig. 4.27A). This 
fast regeneration which is complete in about 1.0 min suggests that the slower process observed 
(Fig. 4.27B) cannot be due to retinal binding to the 11CR canonical pocket but suggested 
Time (min)
0 10 20 30
A
b
s
o
rb
a
n
c
e
3
8
0
n
m
0.025
0.030
0.035
0.040
Time (min)
0 10 20 30
A
b
s
o
rb
a
n
c
e
0.000
0.005
0.010
11CR
9CR
11CR
9CR
Rho
Rho
BA
 84 
 
additional uptake of 11CR into a secondary binding site facilitated by the presence of 11CR excess 
in the protein milieu.  
 
Figure 4.27. Regeneration and secondary retinal uptake kinetics of red and green cone opsins with 
11CR. (A) 2.5 fold of 11CR to the concentration of red cone opsin was added in the dark and 
illuminated for 30s (λ>495 nm). UV-Visible spectra of the sample were obtained every min for 30 
min. The λmax at the visible region of each regenerated spectrum was plotted and fit with a saturation 
curve. (B) In the regeneration experiments with 11CR, the regeneration was followed at 380 nm and 
the absorbance change at this wavelength was monitored for 30 min and the data fit to a sigmoidal 
curve.  
 
In the search for a possible secondary binding pocket for 11CR, we computed interaction potential 
maps for a hydrophobic probe in both inactive and active models of red and green opsins (see 
Methods). The maps revealed a cavity between TMs 1 and 7 in the active models of both red and 
green opsins with sufficient size to accommodate a second retinal molecule (Fig. 4.28). Because 
TM7 moves with activation, increasing the size of the cavity, only the active structures seem to 
allow binding of a second retinal in this region. This cavity is compatible with the proposed 
entry/exit channels for retinal (53) and with the presence of hydrophobic molecules observed in 
the crystal structures of rhodopsin, as we previously noted (147).  
We interpret this phenomenon as a slower binding of a second 11CR molecule to the regenerated 
pigment to a site with lower affinity than that at the canonical ligand binding pocket. This 
secondary 11CR uptake might be potentially coupled with a delay in ATR release from the 
protein. We propose that this slower secondary retinal uptake is a distinct phenomenon to that of 
the fast regeneration of red and green cone opsins observed in a ~1 min time frame with 11CR. 
Such a behavior was not observed when photoactivated red and green cone opsins were 
regenerated with 9CR (Fig. 4.25B) suggesting that it is specific in the case of the native 11CR 
chromophore.  
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Figure 4.28. Model of red cone opsin with secondary retinal. Molecular model of the active red 
opsin showing the potential coexistence of two retinal molecules (yellow and red for the primary and 
secondary sites, respectively). The side-chains of neighboring hydrophobic residues are shown with 
sticks. 
 
We believe that our spectral changes are not reflecting potential retinal binding to other regions 
on the surface, or external side of the protein, for several reasons. First, the secondary binding 
observed is not covalent, so binding to external Lys residues is excluded. It should also be pointed 
out that retinal binding to the protein surface is unlikely to cause the spectral change at 380 nm 
observed.  Furthermore,   such non-specific retinal-protein surface interactions would not be 
isomer specific but, in our case, only 11CR can induce the spectral behavior observed. Thus, the 
secondary binding site proposed shows specificity towards 11CR, but not 9CR, and such ligand 
specific accessibility would be difficult to explain if the secondary retinal binding would happen 
at the surface of the protein. All these arguments reinforce our proposal of secondary retinal 
binding at the proposed site by our molecular modeling analysis. 
These  findings are in agreement and support the results of previous studies proposing that more 
than one retinoid can interact with visual opsins (174) which strongly suggests the presence of  
functionally-relevant secondary binding sites of retinoids in opsin (175). Furthermore, previous 
experimental evidence showed an important role for non-covalent 11CR binding to opsin prior to 
regeneration (176) and in its ability to bind to a selective conformation of the protein among 
various conformational modes of visual pigments prior and after photoactivation (173).  
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In addition to the secondary 11CR binding event, changes at 380 nm could also be reflecting 
changes in ATR release that could alter the rate of retinoid recycling thus regulating dark state 
adaptation after photoactivation for cone opsins. Retinoid binding protein, ABCA4, is an ATP 
dependent transporter of ATR from the luminal side to the cytoplasmic side of photoreceptor 
cells. At the cytoplasmic side, ATR is converted to all-trans-retinol by RDH8 which is then 
released to Müller cells or retinal pigment epithelium (for the retinoid cycle) and further converted 
to 11CR which in turn diffuses into photoreceptor cell and results in dark adaptation of visual 
pigments (177-179). Stargardt disease is an autosomal recessive disorder characterized by 
mutations at ABCA4, in which vision loss is associated with accumulation of ATR and its 
derivatives that can be toxic by causing oxidative stress that can result in damage of the retinal 
cells (180,181).  It is also known that transportation of ATR by ABCA4 is a multi-step process 
and that the substrate for ABCR4 is N-retinylidene-phosphotidyl ethanolamine (NRPE) formed 
from the interaction of ATR with phosphotidyl ethanolamine. NRPE is a reversible product, and 
the conversion process of RDH8 from ATR to all-trans-retinol is slow (177,182). Hence, the 
controlled release of ATR after photoactivation, coupled to 11CR binding to a secondary binding 
site other than the canonical retinal binding pocket, would help regulating the effective transport 
of ATR,  from cone opsins. This may suggest a temporary entrapment of ATR to the same or 
other secondary binding site, and this may be connected to a slower movement of the hydrophobic 
retinal molecule along the ligand channel proposed between openings A and B which would be 
perpendicular to the helices axis. A secondary retinal binding site in cone visual pigments can 
accommodate a retinal molecule in addition to the one bound to the classical retinal binding 
pocket (174). We propose that this second binding site which would be specific for 11CR, and 
not for 9CR, may function as a retinal buffer, in cone opsins, rather than playing an allosteric role 
for retinal binding to its primary site. The different behavior for 11CR and 9CR is also evident 
from the faster initial velocity for the chromophore regeneration observed with 11CR than 9CR 
(Figs. 4.25 and 4.27). This secondary binding site may allow retinal pre-binding and subsequent 
fast transfer of this retinal molecule to the primary retinal binding pocket for covalent binding and 
dark-adapted pigment regeneration ready for another light stimulus.    
 
4.3.2. Blue cone opsin regeneration mechanism 
4.3.2.1. Regeneration of photoactivated blue cone opsin with 11CR 
The dark-state UV-Vis spectrum of purified blue cone opsin in DM shows its characteristic 
regenerated protein band at 420 nm and the total opsin protein band at 280 nm. Upon illumination 
using white light, the release of isomerized 11CR shifts the peak from 420 nm to 380 nm. The 
regeneration experiments in blue cone opsin were carried out only after illumination, unlike 
red/green cone opsin where the retinal was added prior to illumination, as the absorption 
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maximum of blue cone opsin is closer to the λmax of retinal. First, the 11CR regeneration 
experiment was carried out with photoactivated blue cone opsin immediately after illumination. 
In order to do that, after measuring the dark-state spectrum of blue cone opsin in the 250-650 nm 
range, 11CR was added immediately after the sample was illuminated using white light, and the 
regeneration was followed for 60 min. The regeneration of photoactivated blue cone opsin cannot 
be observed because the band corresponding to the exogenously added retinal completely masks 
the overall regenerated band of blue cone opsin (Fig. 4.29A). Hence, the sample was acidified 
with H2SO4 and a shift in the max and an increase in absorbance at 440 nm could be detected 
which would account for the presence of Schiff-base linked material from the regenerated sample. 
For the better observation of the acidified spectrum of the regenerated sample, a difference 
spectrum was obtained by subtracting the acidified spectrum with the regenerated spectrum and 
this difference spectrum  
 
Figure 4.29. Photoactivated blue cone opsin regenerates with 11CR immediately after illumination. 
(A) The UV-vis spectrum was measured in the dark (1, solid line). Immediately after illumination (2, 
dotted line) 2.5 fold 11CR was added (3, short dashed line), and followed for 60 min (4, dotted-dashed 
line) and acidified 30min later (5, long dashed line). (B)  Difference spectra between dark and 
illuminated, and between acidified and regenerated. (C) Absorbance change at 380 nm was monitored 
for 60 min and the data fit to a sigmoidal curve.   
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was compared with the difference spectrum between dark and illuminated sample of the same 
blue cone opsin (Fig. 4.29B). This experiment distinctly shows the regeneration of photoactivated 
blue cone opsin with 11CR immediately after illumination. Unlike red/green cone opsin 
estimating the regeneration kinetics is not possible in the case of blue cone opsin as the added 
free retinal overlaps with the protein regeneration region of the spectrum. In any event, the 
changes at 380 nm were measured by plotting the absorbance change at this wavelength from 0 
min to 60 min. This process showed a sigmoidal pattern similar to that observed in the case of red 
and green cone opsins (Fig. 4.29C). The estimated t1/2 of the process is 26.6 min which is longer 
than that for the other cone opsins. It was reasonable to assume that blue cone opsin would show 
a fast regeneration process similar to green and red cone opsins, which is also supported by the 
high reactivity to hydroxylamine (Fig. 4.6) suggesting a more “open” retinal binding pocket than 
red/green cone opsins. 
Considering the observation of slower fluorescence decrease in blue cone opsin after 
photoactivation (Fig. 4.4C), regeneration of blue cone opsin, after a stable post-photoactivated 
phase could be obtained, could be compared with the behavior of the protein immediately after 
dark adaptation. From this comparison, the structural changes associated with the regeneration 
mechanism can be elucidated.   
In order to do that, regeneration of blue cone opsin with 11CR was carried out 15 min after 
illumination. All the experimental conditions were the same as those in the previous experiments, 
and the results showed that, upon acidification at the end of the regeneration experiment, the 
appearance of a shoulder in the 440 nm-520 nm region (Fig. 4.30A) which was similar to that 
obtained in the regeneration experiment carried out immediately after illumination. The difference 
spectrum between acidified and regenerated samples suggested a similar regeneration behavior 
(Fig. 4.30B) to that previously obtained. In contrast, there was no change in absorbance at 380 
nm (Fig. 4.30C) suggesting no secondary retinal uptake when the regeneration is carried out 15 
min after illumination. Furthermore, the regeneration at the primary binding site appeared to be 
unaltered.  
The fluorescence decrease, observed after illumination of blue cone opsin, could be interpreted 
as reflecting a conformational change taking place with a slower kinetics that impairs secondary 
retinal uptake by the photoactivated receptor. These results would also be compatible with the 
assumption of a fast regeneration kinetics with 11CR (with maximal obtained regeneration) and 
the lack of absorbance changes at 380 nm.   
The 11CR regeneration experiments with blue cone opsin, immediately and 15 min after 
illumination, were also carried out by means of fluorescence spectroscopy. In these experiments, 
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the samples of purified blue cone opsin were illuminated with white light after a stable baseline 
was obtained and the same amount of 11CR as that used for the UV-Vis regeneration experiment   
 
Figure 4.30. Photoactivated blue cone opsin regenerates with 11CR 15 min after illumination. (A) 
The UV-vis spectrum was measured in the dark (1, solid line). 15min after illumination (2, dotted 
line) 2.5 fold 11CR was added (3, short dashed line), and followed for 60 min (4, dotted-dashed line) 
and acidified 30min later (5, long dashed line). (B)  Difference spectra were plotted dark against 
illuminated and acidified against regenerated. (C) Absorbance change around 380 nm was monitored 
for 60 min and the data fit to a linear pattern.   
 
was added immediately, and 15 min, after illumination. In both cases a decrease in fluorescence 
was observed suggesting blue cone opsin regeneration (Fig. 4.31). Particularly, the net 
fluorescence change observed in both cases was different but the fluorescent decrease seen during 
the regeneration of 11CR after 15 min of photoactivation would reflect a conformational change 
and the subsequent regeneration of the dark-adapted state. In contrast, the regeneration of the 
protein immediately after illumination would reflect only the occupancy of retinal binding site by 
the exogenous retinal and no additional imposed conformational change (observed only 15 min 
after photoactivation of the receptor).  These result may suggest that the conformational change 
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exhibited by the blue cone opsin leads to the formation of a specific conformation that would 
prevent binding of 11CR to the postulated secondary site (Fig. 4.30C).  
Overall, this behavior might lead the understanding that the fluorescence decrease observed after 
illumination may be due to a major conformational change happening in the blue cone opsin in a 
slower fashion which disables the secondary retinal uptake by the photoactivated blue cone opsin. 
This is also consistent with the recent study that analyzes the real time conformational dynamics 
of rhodopsin which identified a major conformational change with photoactivated rhodopsin with 
an extended larger movements of H5 and H6 about 80% larger than any helical movements 
observed earlier (183).  
  
Figure 4.31. Fluorescent changes during the regeneration of blue cone opsin with 11CR. Purified 
blue cone opsin in DM added to the micro-cuvette was illuminated for 30 s after the stable baseline 
was obtained. 2.5 fold of 11CR to the concentration of blue cone opsin sample was added, either 
immediately (A) or 15 min after illumination (B).  
 
4.3.2.2. Regeneration of photoactivated blue cone opsin with 9CR 
In an analogous experiment to that of regeneration with 11CR, photoactivated blue cone opsin 
was regenerated with 9CR immediately and 15 min after illumination. Blue cone opsin was 
photobleached and acidified in a similar manner. The result showed that blue cone opsin can 
regenerate with 9CR immediately after illumination in a similar fashion as what was observed in 
the case of regeneration with 11CR (Fig. 4.32A, B). However, in this case, the changes observed 
at 380 nm, which follow a sigmoidal pattern (Fig. 4.32C), suggest a secondary retinal uptake 
unlike other cone opsins (Fig. 4.25B) which do not show secondary retinal uptake with 9CR. This 
behavior highlights the specificity of the retinal binding site of blue cone opsin when compared 
to those of red and green cone opsins. The measured half-time of the kinetics of this secondary 
9CR uptake is 34.7 min which is significantly longer than that for 11CR suggesting that, 
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immediately after illumination, the secondary retinal binding site has more affinity for binding 
11CR than 9CR. 
Blue cone opsin shares merely 43% homology when compared to the higher homology of red-
green pigments, and with that of the red cone pigment and rhodopsin which is 41% (184). It 
evolved from a different pathway than red/green cone opsins exhibiting a differential molecular 
basis of spectral tuning (185,186) with significant differences in key amino acids at the retinal 
binding pocket. Particularly relevant appears to be Y262, which is W281 in the case of red/green 
cone opsins (23), in the proposed secondary 9CR uptake during blue cone opsin regeneration 
immediately after illumination. 
 
Figure 4.32. Regeneration of blue cone opsin with 9CR immediately after illumination. (A) The UV-
vis spectrum was measured in the dark (1, solid line). Immediately after illumination (2, dotted line), 
2.5 fold 9CR was added (3, short-dashed line), and spectra recorded up to 60 min (4, dotted-dashed 
line), and subsequently acidified 30 min later (5, long-dashed line). (B)  Difference spectra were 
obtained from the dark minus illuminated spectra and acidified minus regenerated spectra respectively. 
(C) Absorbance change at 380 nm was monitored for 60 min and the data was fit to a sigmoidal curve.   
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The regeneration behavior of blue cone opsin was also analyzed with 9CR at the post-illuminated 
phase, i.e. 15 min after illumination. The results showed that 9CR can still regenerate 
chromophore with photoactivated blue cone opsin in a similar fashion that 11CR. Surprisingly, 
what we attribute to a secondary retinal uptake was observed with t1/2 28.8 min (Fig. 4.33C) which 
is faster than the kinetics of 9CR binding immediately after illumination. This behavior is also 
different in the case of 11CR which does not appear to have secondary retinal entry into the 
binding pocket of the 15 min post-illuminated conformation of blue cone opsin. 
 
Figure 4.33. Regeneration of blue cone opsin with 9CR 15 min after illumination. (A) The UV-vis 
spectrum was measured in the dark (1, solid line), and 15 min after illumination (2, dotted line), 2.5 
fold 9CR was added (3, short-dashed line), and spectra were recorded up to 60 min (4, dotted-dashed 
line), and subsequently acidified 30min later (5, long-dashed line). (B)  Difference spectra were 
obtained from the dark minus illuminated spectra and acidified minus regenerated spectra respectively. 
(C) Absorbance change at 380 nm was monitored for 60 min and the data was fit to a sigmoidal curve 
with a t1/2 of 28.8 min.   
 
Overall, the regeneration experiments of photoactivated blue opsin, with retinal analogs, at 
different time points after illumination, suggest a conformational change (other than the canonical 
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photoactivated conformation obtained after retinal photoisomerization) that would be coupled 
with a sophisticated fine-tuning mechanism that involves a secondary retinal binding site which 
does not withhold 11CR, 15 min after photoactivation, but only 9CR and with a faster kinetics. 
This previously unreported phenomenon may show mechanistic similarities to the rearrangement 
events observed in the primary binding site of rhodopsin (chapter 2 of this thesis) (148). Thereby, 
differences in intragenic epistatic interactions among these structurally similar red, green and blue 
cone opsins may justify the different functionally-relevant conformations observed (187,188).    
An intriguing correlation can be made between the estimated secondary retinal uptake t1/2 for the 
binding kinetics with 11CR, immediately after illumination, versus the typical absorption 
maximum of cone opsins.  Interestingly, the data perfectly match a linear pattern that suggests a 
relationship between the energetics of the pigments (the differences in energy for the electronic 
levels associated with the maximal wavelength absorption) and the kinetics of the secondary 
binding event (Fig. 4.34). Though the interpretation of this correlation is yet unclear, coupling of 
thermodynamic properties of the cone pigments (and the isomerized retinal leaving the protein), 
and the kinetics of the entry of a secondary retinal molecule at a specific site of the protein might 
help explain the perfect correlation observed and the connection to the wavelength maximum 
detected. A shorter wavelength may be correlated with a higher energy level and suggest a less 
stable pigment and this could be linked to a longer time needed for retinal binding to the proposed 
putative secondary binding site. An interesting possibility arises to further analyze additional 
opsins with different wavelength maxima and check if they could adjust to the obtained line. 
 
 
 
 
 
 
 
 
 
 
Figure 4.34. Correlation between secondary retinal uptake kinetics and absorption maximum of cone 
opsins. The estimated t1/2 for secondary 11CR uptake kinetics for red (10.6 min), green (13.7 min) and 
blue (26.6 min) cone opsins, immediately after illumination, were plotted against their characteristic 
max at the visible region. 
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4.4. Molecular investigation of cone opsin mutants associated 
with retinal disorders 
 
 
 
 
 
 
 
 
 
 
 
(The contents of this chapter are in preparation for a publication as 
 Srinivasan S, Ramon E, Garriga P. Molecular mechanism of green cone opsin mutants 
associated with color blindness (in preparation))
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Natural selection depends on adaptive evolution from the genetic variability within species. Point 
mutations give rise to variability in genes which can be either neutral (synonymous mutations 
which do not alter the amino acid sequence of the protein), favorable (optimizing the functionality 
of the protein), or deleterious (non-synonymous mutations which are amino acid-altering and can 
potentially disrupt the protein structure) (189-191). Adaptive evolution of the visual system serves 
to accumulate constructive mutations yielding enhanced spectral tuning capabilities thus 
stabilizing the well-functioning trichromatic color vision system. However, from time-to-time 
various missense mutations have been identified in humans which lead to abnormalities in the 
visual system ranging from minor polymorphisms with modified spectral tuning  to severe retinal 
degenerative cone dystrophies (44,192).   
 
4.4.1. Blue cone opsin mutants  
The major intention in studying tritanopic mutants, causing inherited blue color vision deficiency 
is to reveal the conformational changes in the protein that could justify the malfunction of the 
pigment. Site directed mutagenesis was employed to introduce the point mutations, associated 
with retinal disorders, into the WT of blue cone pigment. Such mutations were G79R, T190I, and 
S214P. The mutated plasmids were sequenced in order to confirm the successful introduction of 
the mutations (Fig 4.35).   
 
 
Figure 4.35. Mutagenesis of blue cone mutants. Mutagenic primers used contained the mutations for 
the G79R mutant (A), 5’GGTCAACGTGTCCTTCAGAGGCTTCCTCCTCTGC3’, 5’GCAGAGGAG 
GAAGCCTCTGAAGGACACGTTGACC3’; for the T190I mutant (B), 5’GCCCTGACTGGTACAT 
CGTGGGCACCAAATACC3’, 5’GGTATTTGGTGCCCACGATGTACCAGTCAGGGC3’; and for 
the S214P mutant (C) 5’GCTTCATTGTGCCTCTCCCCCTCATCTGCTTCTCC3’, 5’GGAGAAGC 
AGATGAGGGGGAGAGGCACAATGAAGC 3’. The mutations were constructed by a thermocyclic 
PCR method. The resulting mutants were subject to DNA sequencing and the mutated codons are shown 
boxed. 
A B
C
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WT and mutants of blue pigments were expressed and immunopurified, and the UV-visible 
spectra were measured. The UV-visible spectrum of WT blue cone pigment showed a 
characteristic absorption maximum at 420 nm (Fig. 4.36). On the other hand, the clinically 
identified mutants G79R, T190I and S214P did not show this characteristic retinal band, meaning 
that there was no regeneration with the chromophore, and aggregation of the protein was also 
presumably observed, determined by the shift from 280 nm to 260 nm at the opsin protein band. 
This result confirms that the structural alterations caused by the replaced amino acid destabilize 
the protein preventing retinal binding to the protein. 
 
 
 
 
 
 
 
 
 
Figure 4.36. Expression of blue cone opsin mutants. The UV-Vis Spectra of purified blue cone 
pigment WT and their mutants, G79R, T190I, S214P  in the dark, which were expressed in COS-1 cells 
and regenerated with 10M 11CR.  
 
The protein band of all the purified mutants of blue cone opsins has shifted to ~260 nm suggesting 
protein aggregation as a consequence of protein misfolding.  It is assumed that the replacement 
of the bulkier, positively charged Arg against the non-polar and smaller Gly, in the G79R mutant, 
would affect folding and compromise the stability of blue cone opsin. The corresponding position 
in rhodopsin is A822.49, located at TM2, which is a small and non-polar residue not reported as 
being important for protein folding or stability. This position is next to the highly conserved 
D832.50 which is however a Gly in the blue cone opsin. S214P mutation is also believed to disrupt 
the optimal functional conformation of blue cone opsin by afftecting protein folding and stability 
of the protein (110). 
T190 is present at the EII and it has been reported to have a significantly different behavior than 
other deutan or protan mutants during light- and dark-adapted conditions, in the sense that this S-
cone mutant results in mild to moderate S-cone dysfunction and loses its sensitivity at low light 
levels (113). T193 of rhodopsin is the homologous position in rhodopsin and the mutation T193M 
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has been identified to cause RP in humans (193). T193M was classified as a Class II rhodopsin 
mutant that showed poor chromophore regeneration with 11CR, and inefficient transport to the 
plasma membrane (194,195). 
 
4.4.2. Red cone opsin mutants 
Mutations in red cone opsin genes lead to dichromatic clinical condition, in which the spectral 
sensitivity of affected individuals lies within the green region of the visual spectrum. The 
clinically identified mutants that cause protanopia include, S180A, R247Ter, and G338E which 
are the point mutations in the red cone opsin gene. In the case of R247Ter, the nucleotide position, 
CGA 739 is mutated to TGA, a stop codon. Hence the protein will be truncated at the position of 
247 and it could not be immunopurified because it would lack the epitope for 1D4 antibody which 
is at the C-terminal end of the protein. Mutations S180A and G338E were introduced into the WT 
red cone opsin and the corresponding mutated plasmids were sequenced in order to verify the 
correct introduction of the mutations (Fig 4.37).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.37. Mutagenesis of red cone mutants. Mutagenic primers used contained the mutations for 
the S180A mutant (A), 5’ GCCTTCTCCTGGATCTGGGCTGCAGTGTGGACAGCC   3’, 
5’GGCTGTCCACACTGCAGCCCAGATCCAGGAGAAGGC3’; and for the G338E mutant (B), 
5’GCAGCTTTTCGAGAAGAAGGTTGACGATGGC3’, 5’GCCATCGTCAACCTTCTTCTCGAA 
AAGCTGC3’; were constructed by a thermocyclic PCR method. The resulting mutants were subject 
to DNA sequencing and the mutated codons are shown boxed. 
 
WT and S180A were regenerated and no aggregation problems were observed (Fig. 4.4.4). This 
result is expected because S180A is a polymorphism, being Ser present in 62% of Caucasian 
males, and causing only little variations in normal color vision (about 4-5 nm blue-shift in the 
A
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absortion maximum). S180 is one of the residues involved in spectral tuning of the pigment 
(44,196).  
In the case of G338E, the introduction of a negatively charge at the C-terminal end of the protein 
appears to dramatically affect protein regeneration ability and probably induces some aggregation 
as observed by the shift from the typical protein opsin band at 280 nm to 260 nm. 
 
 
 
 
 
 
 
 
 
Figure 4.38. Expression of red cone opsin mutants. The UV-Vis Spectra of purified red cone WT 
pigment and its mutants, S180A and G338E, in the dark, which were expressed in COS-1 cells and 
regenerated with 10M 11CR.  
 
4.4.3. Green cone opsin mutants 
Though red and green cone opsin genes are located in an array at chromosome X sharing a high 
degree of homology, the frequency and prevalence of deuteranopia is slightly higher than 
protanopia (197).  Red/green cones are allelic variants from a single gene, hence some of the 
mutations associated with red/green cone genes can be combined. These mutations can lead to 
different conditions, ranging from dichromacy to cone monochromacy in which the affected 
individuals possess only functional blue cone opsin (198,199).  
Green cone mutants N94K, W177R, C203R, and R330Q were introduced into the WT plasmid of 
green cone pigments by site directed mutatgenesis using mutagenic primers carrying the required 
mutations. The sequencing results of the mutant products confirm that green cone mutant opsin 
plasmids were generated for subsequent characterization studies (Fig 4.39). Expression of these 
mutants was carried out in COS-1 cells. The transfected cells were harvested and regenerated with 
11CR and immunopurified using 1D4 antibody. The UV-Spectra of W177R and C203R showed 
that there was no regeneration in the visible region of the spectra (Fig 4.40A) suggesting that the 
Wavelength (nm)
300 400 500 600
A
b
s
o
rb
a
n
c
e
0.00
0.07
0.14
WT 
S180A 
G338E
 99 
 
mutated conformations of W177R and C203R are altered preventing entry and/or covalent 
binding of 11CR by means of a Schiff base to K312. 
 
 
Figure 4.39. Mutagenesis of green cone mutants. The primers used containing the mutations for the 
N94K mutant (A), 5’GGATCCTGGTGAAGCTGGCGGTCGC3’, 5’GCGACCGCCAGCTTCACCA 
GGATCC 3’; for the W177R mutant (B), 5’GCATTGCCTTCTCCAGGATCTGGGCTGC3’, 5’GCA 
GCCCAGATCCTGGAGAAGGCAATGC3’; for the C203R mutant (C), 5’CCACGGCCTGAAGAC 
TTCAAGGGGCCCAGACG3’, 5’CGTCTGGGCCCCTTGAAGTCTTCAGGCCGTGG3’; and for 
the R330Q mutant (D) 5’CCGGCAGTTTCAAAACTGCATCTTGC3’, 5’GCAAGATGCAGTTTTG 
AAACTGCCGG3’. The mutations were constructed by a thermocyclic PCR method. The resulting 
mutants were subject to DNA sequencing and the mutated codons are shown boxed. 
 
 
The UV-Vis spectrum of R330Q shows a band at 530 nm indicating the ability of the mutant to 
regenerate with 11CR. Even though N94K does not show regeneration in the vision region, a 
peculiar peak at 360 nm was observed (Fig 4.4.6B).  
Green cone proteins behaved differently depending on the localization of the mutation. WT and 
R330Q showed the characteristic green pigment visible peak, at 530 nm, as reported elsewhere 
(89,200,201). On the other hand, W177R and C203R, showed no protein regeneration, as 
previously described (59). Green W177R is associated with X-linked cone dystrophy and the 
behavior of W177R was expected because of the dramatic replacement of an aromatic and 
hydrophobic residue to a positively charged at a highly conserved position (202).  
The C203R mutation would interfere with the formation of the Cys-Cys conserved disulfide 
bridge present in all G protein coupled receptors superfamily and important for their stability and 
integrity (202). C203R has been observed in some individuals identified as dichromats 
(deuteranopia) with a single mutation at the active green cone opsin in the gene array at 
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chromosome X, whereas it was also identified to cause blue cone monochromancy in which the 
mutation was identified in red/green cone hybrids (115,203,204). C203R is also associated with 
disruption of the cone mosaic and lower pigment density in the retina than normal (205).  Mutation 
C187Y, at the homologous site in rhodopsin has been found to disrupt the protein folding and 
decrease its stability resulting in a severe and early onset form of RP (206). 
 
Figure 4.40. Expression of green cone opsin mutants. UV-Vis spectra of purified WT green cone 
pigment and its mutants, in the dark. The mutants were expressed in COS-1 cells, regenerated with 
10M 11CR. (A) Spectra of the mutants W177R and C203R with WT; and (B) spectra of the mutants 
N94K and R330Q with WT. 
 
In the deutan mutant R247Ter, cytidine1233 at exon 4 of the green cone opsin gene is converted to 
thymidine, which turns the amino acid position at 247 to a stop codon and hence the translated 
protein gets truncated after TM5 of the WT protein (119). 
The observation of a clear band at 360 nm, led to think about the possibility of formation of an 
unprotonated Schiff base linkage with the protein by N94K.  The protein band observed below 
280 nm would suggest some potential aggregation of the mutant protein. R330Q, which shows 
regeneration at the visible region, and N94K have with its atypical absorbance band at 360 nm, 
were chosen in order to further analyze the structure-function differences exhibited by these 
mutants and to shed some light into the associated retinal dysfunction. In the case of the R330Q 
mutant, located at the C-terminal domain of the protein, it does not appear to alter protein 
expression, regeneration and purification. 
Green N94K and green R330Q were identified as causing deutanopia and first studies showed 
that R330Q can regenerate with retinal and that N94K does not show any regeneration with the 
natural chromophore (114) but no detailed molecular characterization was performed. Now, it 
was aimed to carry out a detailed characterization of the spectral properties of these mutants.   
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Figure 4.41. Localization of green cone mutants. Images from immunofluorescence of COS-cells 
transfected with green WT (A), green N94K (B), and green R330Q (C). The transfected cells were 
subject to mouse rho-1D4 antibody as the primeray antibody (1:5,000) followed by goat anti-mouse 
tagged with FITC (1:200).   
 
Fig. 4.41 shows pictures taken of WT, N94K and R330Q green cone pigment and their trafficking 
in COS-1 cells. The fluorescent images confirm the WT-like behavior of R330Q which is located 
to the plasma membrane, whereas opsin is being spread in the cell cytosol, and inclusion bodies 
can be detected for the N94K mutant. 
4.4.3.1. Green N94K mutant 
In order to examine the nature of the band at 360 nm of the purified N94K mutant of green cone 
pigment, by means of UV-vis spectrophotometer, a purified sample was measured in the dark and 
after acidification of the sample (Fig 4.42A). It shows a shift in the peak from 360 nm to 440 nm 
suggesting the presence of an unprotonated Schiff base linkage between retinal and the green 
opsin mutant. This was confirmed by plotting the difference spectra of the two spectra in Fig. 
4.42A. The difference spectrum (Fig. 4.42B) shows a positive band at ~440 nm and a negative 
band around 360 nm which indicates that the pigment is clearly red shifted with acidification. 
In spite of this Schiff base presence it is important to note that the opsin band suggests potential 
aggregation that would result from partial misfolding of the protein.  The detailed study of the 
stability and regeneration ability of this mutant is presented in the next chapter this thesis.  
4.4.3.2. Green R330Q mutant 
Among all the mutants of cone pigments causing retinal disorders constructed and expessed, only 
green R330Q shows regeneration in the visible region. Therefore, it is of interest to further 
characterize this mutant because it can reveal the possible structure-function differences with the 
wild type green cone pigment resulting in receptor malfunction which could be linked to the 
molecular basis of the clinical condition. 
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Figure 4.42. Characterization of green N94K. (A)The UV-Vis Spectra of purified Green N94K dark, 
which were expressed in COS-1 cells, regenerated with 10M 11R, and acidified using 2N H2SO4 
(insest,A) closer look at the visible region of the spectra distinctively showing the dark-state (1) and 
acidified state (2) of the mutant.  A difference spectra was plotted by subtracting the time course 
absorbance of Green N94K acidified with Green N94K dark (B). 
 
Figure 4.43. Characterization of green R330Q. (A) The UV-Vis Spectra of purified green R330Q in 
the dark, which were expressed in COS-1 cells, regenerated with 10M 11R, and illuminated (>495 
nm). (inset, A) A closer look at the visible region showing the dark-state and illuminated state of the 
spectra. (B) A difference spectrum was obtained by subtracting the dark spectrum minus the illuminated 
spectrum of R330Q. 
 
Expression and purification of green R330Q.  Green R330Q mutant was expressed in COS-1 
cellsand immunopurified in PBS buffer containing 0.05% DM. The dark state spectrum shows a 
band at 530 nm indicating that the mutant can regenerate with 11CR in the visible region unlike 
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other cone mutants tested. Illumination of the sample shifts the band to 380 nm (Fig 4.43A).  A 
difference spectrum was obtained by subtracting the absorbance between illuminated and dark 
which clearly indicates the band at 530 nm (Fig 4.43B). 
Meta II decay. The process of Meta II decay can be well studied by means of fluorescence 
spectroscopy. Similar to WT cone pigment, a Trp residue at the retinal binding site quenches the 
fluorescence of the retinal chromophore. Upon photoactivation, and as a result of retinal release, 
there will be an increase in the Trp fluorescence which can be recorded. The kinetics of this 
fluorescence increase reflects the Meta II decay process and subsequent retinal release. The 
purified green R330Q sample was illuminated after a stable baseline was obtained and the 
fluorescent changes were recorded. It showed a sudden increase in the fluorescence immediately 
after illumination similar to WT green cone pigment (Fig 4.44) suggesting a fast decay of the 
Meta II photointermediate. 
 
 
 
 
 
 
 
 
Figure 4.44. MetaII decay of green WT and green R330Q. Trp fluorescence was measured for green 
WT and green R330Q in the dark and after illumination (λ>495 nm).  
 
Thermal stability. By measuring the behavior of the regenerated visual pigment at a given 
temperature, the stability of the protein can be determined which is on the correct folding and the 
thermodynamic properties of the visual pigments. Measuring the time taken for the complete 
decay of the chromophoric visible band and comparing it with the WT pigment would provide 
information on the effect of the introduced mutation on protein conformational stability. Green 
R330Q mutant thermal stability was measured by UV-Vis spectrophotometry at and compared 
with WT green cone opsin. The measured t1/2 for R330Q thermal decay was 7.91± 0.32 min (Fig. 
4.45A) which is similar to that of the WT green cone pigment (7.17± 0.98 min). This result 
confirms that the R330Q has the same thermal stability than WT and rules out important structural 
defects for the protein. 
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Chemical stability.  The chemical reagent hydroxylamine, added in the dark, decreases the visible 
maximal absorbance. This is due to the more open retinal conformation in the binding pocket of 
cone opsins, when compared to rhodopsin, which leads to a more exposed SB linkage that can be 
broken and the retinal sequestered from the binding pocket. The half time obtained for this process 
was 38.65 ± 4.03 for green WT and 30.0 ± 1.72 from green R330Q mutant (Fig. 4.45B). This 
result suggests that the binding pocket of the R330Q mutant is more susceptible to hydroxylamine 
than green WT. 
 
Figure 4.45. Thermal and chemical decay of green WT and green R330Q. Thermal stability assay 
was carried out at 37ºC with green WT and R330Q purified in DM. The plot showing the decrease of 
absorbance at the λmax in the visible region over time (A). Green WT and R330Q were treated with 50 
mM hydroxylamine pH 7.0 at 20ºC for the chemical stability assay. (B) Chemical reagent stability was 
determined by monitoring the decrease at λmax over time.  
 
Transducin activation.   The functionality of the pigments was studied by testing their ability to 
activate rod transducin. To do this, a sample of green R330Q and WT were mixed with transducin 
and the activation was measured by means of a radioactive GTPS35 assay before and after 
illumination.  Upon illumination, there is a binding of transducin with R330Q pigment which is 
reduced when compared to WT green cone opsin (Fig 4.46). Thus the C-terminal mutant R330Q 
of green cone pigment presents impaired transducin binding which may cause deficiencies in 
green cone functionality and can help explain the resulting color blindness. 
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Figure 4.46. Transducin activation of green WT and green R330Q. Functionality of green WT and 
R330Q mutant were determined by measuring bound GTPS35 to an opsin-transducin complex in a 
radionuecleotide filter-bound assay. This was carried out with 300 nM green WT and R330Q in the 
dark and after illumination. The SD of the experiments is shown by error bars. 
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4.5. Strategies for stabilizing the deuteranopic N94K mutant 
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From the previous results section, it was identified that green N94K (which causes deuteranopia 
in humans), was shown to bind retinal by means of an unprotonated Schiff base linkage but the 
low protein yield, and a UV absorbance band for opsin shifted to 260 nm suggested an unstable 
conformation of the protein and possible aggregation. Therefore, providing a stable environment 
for the protein in solution would possibly keep the protein in an optimally folded state that could 
be used for further studies. Changes in buffers, the chemical nature of the chromophoric isomer 
of retinal, and introducing positive changes into the structure of the proteins are the key aspects 
to be considered in this section. 
4.5.1. Purification of green N94K mutant using 9CR 
Green cone opsin was expressed in COS-1 cells and the transfected cells were regenerated 
overnight with 50M 9CR. The cell membrane was solubilized using DM and the protein was 
immunopurified using 1D4 antibody. The obtained sample was analyzed by UV-vis 
spectrophotometry. The resulting spectrum (Fig. 4.47) did not show any regenerated band in the 
visible region suggesting that there is no regeneration of green N94K with 9CR in the visible 
region, but it showed a smaller band around 380 nm which is similar to Green N94K purified with 
11CR.   
 
 
 
 
 
 
 
 
Figure 4.47. Green N94K purified with 9CR. The UV-Vis Spectrum of purified Green N94K mutant 
in the dark, which was expressed in COS-1 cells and regenerated overnight with 50M 9CR. 
 
4.5.2. Effects of lipids on green N94K 
The effective molecular characterization of membrane proteins can be achieved by studying them 
in a detergent-solubilized form, but this state compromises the stability of the proteins. The 
detergents used to solubilize biological membranes, form a micelle around protein thereby 
preserving the main structural and functional features of the membrane proteins. Membrane 
proteins are quite unstable in the micelles of detergent and denature during the course of time, 
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especially the mutants of integral membrane proteins which possess an altered conformation 
compared to the wild type.  Moreover, the membrane-mimic support provided by the detergent 
micelles may expose certain surfaces of the protein which were previously buried into the lipid 
bilayer membrane, potentially leading  to protein aggregation (207). Hence, it is known that 
membrane proteins can be successfully stabilized when reconstitute into lipid systems. We 
thought that this approach would increase the stability of the green N94K mutant and would help 
in its chromophore regeneration for subsequent characterization.  
 
Figure 4.48. Schematic lipid environments in membrane proteins. (A) The membrane protein was 
integrated into a micelle of DM. (B) Mixed micelles were formed by DDHA-PC and DM which would 
cover the hydrophobic transmemebrane helices of the receptor. (C) The protein was embedded into a 
bilayer of DMPC and capped by DHPC at the rim region, which is known as DMPC/DHPC bicelle. 
 
Purification of green N94K regenerated with 11CR and 9CR in DDHA-PC / DM mixed 
micelles.  
In general, the visual pigments are purified and stored in a buffer containing the mild neutral 
detergent DM. DM is a non-ionic detergent, which forms a micelle (Fig 4.48A.) around the protein 
(208,209). It is known that the retina is rich in docosahexaenoic acid (DHA), a specific lipid which 
has been proposed to interact directly with opsin visual pigments (210). In a previous study, 1, 2-
didocosahexaenoyl-sn-glycero-3-phosphocholine (DDHA-PC) was reported to stabilize 
rhodopsin (157), and therefore the same strategy could be employed along with DM to form a 
mixed micelles which would provide an improved support for the membrane protein.  
DDHA-PC was dissolved in chloroform (CHCl3): methanol (CH3OH) in 1:1 ratio, mixed well and 
the organic solved completely evaporated with nitrogen gas. To that 1 ml of PBS with 0.05% DM 
was added and sonicated for 1 min at 30% in order to break the DDHA-PC liposomes and enabling 
the formation of mixed micelles of DDHA-PC and DM (Fig 4.48B.).  
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COS-1 cells expressing the green N94K mutant were harvested and regenerated overnight with 
11CR. The visual pigment was purified using 1D4-antibody. The protein bound Sepharose beads 
were washed using PBS containing mixed micelles and eluted into the same buffer containing the 
C’-terminal nonapeptide. The same protocol was carried out by regenerating the sample with 
9CR. The purified sample was analyzed by UV-Vis spectrophotometry (Fig 4.49A) which shows 
that green N94K mutant fails to regenerate in the visible region with either retinal analog. A faint 
peak at 360 nm region was observed with the sample regenerated with 11CR, which is similar to 
the mutant purified in DM alone. Hence, the mixed micelles cannot promote chromophore 
regeneration for the mutant. 
Purification of green WT and N94K in DMPC / DHPC bicelles  
Bicelles are disc-like bilayer-mimic structures that are composed of a long tailed phospholipid 
such as 1,2-dihexanoyl-sn-glycero-3-phospho choline (DMPC) which assemble as bilayer 
surrounding the membrane protein and a short tailed phospholipids like, 1,2-dimhexanoyl-sn-
glycero-3-phospho choline (DHPC) which orient as a rim to DMPC bilayer (Fig. 4.48C.). Because 
of their bilayer morphology, solubility in water, and likely to stabilize the protein in their optimal 
folding (207), bicelles have been employed in various studies from functional analysis like the 
one suggesting rhodopsin incorporated with bicelles show inproved functional efficiency with 
transducin (211) to crystallizing the membrane proteins (212). 
 
Figure 4.49. Effects of lipds on green N94K. (A) The UV-Vis spectra of purified green N94K mutant 
in the dark, which was expressed in COS-1 cells, regenerated overnight with 10M 11R / 50M of 
9CR, and eluted in PBS containing DDHA-PC/DM mixed micelles. (B) Green WT and Green N94K 
were purified using DMPC:DHPC bicelles.  
 
Green WT and N94K mutant were expressed in COS-1 cells and immunopurified using 
Sepharose-1D4 beads. The protein bound beads were washed using buffer A) added with 0.05% 
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DM and the purified pigments were eluted in 1:1; DMPC:DHPC bicelle mixture also containing 
100M nonapeptide (see Methods section). The measured UV-Vis Spectra of the purified 
pigments in bicelles show that the conformation of green N94K is not able regenerate with 11CR 
and thus bicelles are not able to improve the stability of the mutant per se the regeneration (Fig 
4.49B). This finding suggests that the Lys introduced in the membrane imposes, without any 
counterion, a high energetic cost impairing optimal protein folding and visible chromophoric 
regeneration. 
4.5.3. Co-transfection of green N94K with a rhodopsin triple mutant 
Co-expression of a mutant together with WT would result in alterations in the folding, trafficking 
and behavior of each one (213,214). Rhodopsin is more stable than cone opsins in solution, so it 
is possible that formation of rhodopsin and cone opsin dimers (215) could improve the stability 
and regeneration of cone opsins. If both the receptors of opsin-dimer regenerate with 11CR, the 
regenerated peaks at UV-Vis would overlap which would question the significance of the 
experiment and hence it was decided to mutate the Lys of rhodopsin which binds the retinal 
molecule, i.e. K296. It is known that mutating the K296 of rhodopsin would affect the stability of 
the receptor. Therefore, the stable rhodopsin mutant N2C/N282C was used which is more stable 
even in the ligand free form (216). N2C/N282C/K296G mutations were introduced into rhodopsin 
which turns WT opsin into a very stable opsin structure which cannot covalently bind the retinal 
molecule. 
 
 
 
 
 
 
 
 
Figure 4.50 Green N94K co-transfected with a triple mutant of rhodopsin. The UV-Vis Spectrum of 
purified Green N94K co-transfected with rhodopsin N2C/N282C/K296G in the dark, which was 
expressed in COS-1 cells and regenerated with 11CR. The inset shows the same spectrum at the 
wavelength from 350 nm-550 nm which was magnified. 
 
This rhodopsin triple mutant was co-transfected with green N94K into COS-1 cells and the 
transfected cells were harvested after 48 h. The cells were regenerated with 10M 11CR and the 
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pigments were immunopurified using Sepharose-1D4 beads in PBS with 0.05% DM. UV-Vis 
spectrum of the purified sample was measured (Fig 4.50) which shows that a distinct band around 
360 nm which has been already noticed with the previous purification methods and also a less 
intense band in the 500 nm region (Fig 4.50 inset).  
In order to identify the band at 500 nm, the rhodopsin triple mutant alone was expressed in COS-
1 cells, harvested, and regenerated with 11CR and immunopurified. The purified sample was 
analyzed in a Spectrophotometer in dark and followed by the sample was illuminated. 
Interestingly, there was a shift in the absorbance from ~490 nm to ~374 nm upon illumination Fig 
4.51A.) which can be clearly visualized from the difference spectrum between dark and 
illuminated states (Fig 4.51B). This result suggests that in a stable ligand free rhodopsin K296G 
mutant, still the retinal molecule can occupy the binding pocket which support the idea of covalent 
bond between the protein and retinal is not necessary for the activation of the visual pigment (217) 
and translocation of active-site Lys (218).    
 
Figure 4.51. Rhodopsin triple mutant N2C/N282C/K296G. (A) The UV-Vis Spectra of purified 
rhodopsin triple mutant in dark (solid line), and after illumination (λ> 495 nm) (dashed line). (B) 
Difference spectrum between the dark and illuminated rhodopsin triple mutant.  
 
4.5.4. Expression of N94K introduced into a double Cys green mutant 
One of the problems of cone pigments that complicates our understanding of cone opsins 
structure-function relationships, is their low stability in their purified form. Such intrinsic 
instability may affect structure-function relationship determinations for purified pigments during 
the course of time. Introducing Cys residues in membrane proteins at positions which are 
structurally closer enough to form disulfide linkages is an established approach for rhodopsin 
(216). This approach can be a good strategy to stabilize these membrane receptors and also to 
acquire further insights into their structure-function relationships. This system can facilitate the 
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study of the conformational alterations and molecular properties of opsin mutants associated with 
retinal dysfunctions.  
Construction of a stable green cone pigment by introducing two Cys mutations 
Using the theoretical model for green cone opsin, 1KPW (50) in PyMol molecular visualization 
system, the residues close to each other but distant in sequence were analyzed and the potential 
amino acids which can form disulfide linkage, when mutated to Cys, were identified. One of such 
pairs is W90 at TM2 and A169 at TM4 from the cytoplasmic domain of the receptor (green SS) 
(Figure 4.52).  
 
Figure 4.52. Green W90C/A169C model. Using PyMol, 1KPW, green cone pigment (A) was 
magnified at the C-terminal side around TM2 and TM4 showing W90 and A169 residues (B) which 
were mutated to Cys thus could form a disulfide linkage between W90C and A169C (C). 
 
Expression of green SS 
The green cone opsin double mutant (green SS) containing W90C and A169C was constructed 
by site directed mutagenesis of the green WT gene cloned into the pMT4 plasmid. The double 
mutant was sequenced in order to confirm the successful introduction of the mutations. The 
obtained sequence was aligned and the introduced mutations were validated (Fig 4.53A). Green 
SS was expressed and immunopurified as usual and the UV-vis spectrum measured. The UV-vis 
spectrum of the purified sample, in the dark, indicates that the double Cys mutant could 
successfully regenerate with 11CR showing the typical absorbance band at 530 nm. In addition 
some absorbance at 380 nm could be detected suggesting the presence of some amount of 
unprotonated Schiff base species. Acidification shifted the absorbance to 440 nm confirming the 
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presence of protonated Schiff Base species and reflecting a covalent linkage between the double 
Cys mutant opsin and 11CR (Figure 4.53B). 
 
 
Figure 4.53. Mutagenesis of green cone opsin to introduce the double cysteines and expression (A) 
The sequence alignment of WT and SS confirming the introduction of Cys mutations. Using the primers 
containing the mutations for the W90C mutation, 5’CCCGCTGAACTGCATCCTGGTGAA3’, 
5’TTCACCAGGATGCAGTTCAGCGGG 3’; and for the A169C mutation, 5’GCCAAGCTGCATCG 
TGGGCATT3’, 5’AATGCCCACGATGCAGCTTGG C3’, green SS was constructed by a 
thermocyclic PCR method. The mutants were sequenced, the sequences aligned and the mutated codons 
were shown boxed. (B) Expression of green SS. Green SS gene was expressed in COS-1 cells, 
regenerated with 11CR and purified using Sepharose-1D4 beads. UV-Vis spectra of the protein were 
measured in the dark (solid line) and after acidification using 2N H2SO4 (dotted line). 
 
Estimation of sulfhydryl groups 
The actual presence of the disulfide bond could be confirmed by quantifying the free sulfhydryl 
groups that could be labeled in the protein  (136). 5,5’-dithio-bis-(2-nitrobenzoic acid) or DTNB 
or Ellman’s reagent reacts with free sulfhydrals at the periphery of the protein and produces a 
mixed disulfide with protein and a yellow colored TNB2- (see methods) which can be measured 
at 412 nm (137). 
Measuring the free sulfhydryl groups of green SS and comparing this number with that for green 
WT would confirm that the introduced Cys amino acids are involved in forming a disulfide bond. 
Equal concentrations of green WT and green SS were taken in duplicates and mixed separately 
with Ellman’s reagent and incubated for 15 min. Absorbance at 412 nm was measured and the 
average was calculated. Using the following formula, the amount of free Cys amino acids present 
in green SS was calculated and compared with green WT.  
Wavelength (nm)
300 400 500 600
A
b
s
o
rb
a
n
c
e
0.00
0.02
0.04
0.06
dark
acidified
A B
 114 
 
c = 
𝐴
𝑏𝐸
 
c - concentration of free sulfhydryls 
A - Average of absorbance at 412 nm (green WT: 0.0135; green SS: 0.01705) 
b - pathlength of the cuvette (1 cm) 
E – Molar extinction coefficient of DTNB (14,150 M-1cm-1) 
Free sulfhydryl groups in green WT: 
c = 
0.0135
(1 )(14,150)
 
= 9.54 x 10-7 M 
25 l of green WT was added to total volume of 280 l reaction mixture 
Therefore,  
280
25
  x 9.54 x 10-7 M  
= 10.6848 M 
The concentration of free sulfhydryl groups in 25 l of green WT is 10.6848 M which accounts 
from two Cys residues present at the cytoplasmic side of the protein which are the ones that can 
be labeled only with the Ellman’s reagent. The other Cys in opsin are not accessible to the reagent. 
Free sulfhydryl groups in green SS: 
c = 
0.01705
(1 )(14,150)
 
= 1.2 x 10-6 M 
25 l of Green SS was added to total volume of 280 l reaction mixture 
Therefore,  
280
25
  x 1.2 x 10-6 M  
= 13.44 M 
The concentration of free sulfhydral groups in 25 l of green SS is 13.44 M. 
If the presence of two Cys residues in green WT accounts for 10.6848 M free sulfhydryls, 
addition of two more Cys residues into the protein would result in double the concentration of 
sulfhydryls in green SS if this were not forming a disulfide bond. The concentration calculated, 
13.44 M, is merely 1.25 fold that of WT free sulfhydryl groups when it should be double. This 
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proves that W90C and A169C are forming a disulfide linkage between TM2 and TM4 of green 
cone opsin. 
Thermal and chemical stability of green SS 
The decay kinetics of green SS at 37ºC was measured and compared with that for green WT. This 
comparison can provide information about the stability of the helical structures favoring the 
optimal functionality of the protein. In order to do that, after measuring the dark spectra, green 
WT and green SS spectra were recorded at 37ºC continually every min until the complete decay 
of the sample was attained. The absorbance maximum at the visible region of each spectra was 
plotted and fit to an expontential decay curve (Fig. 4.54A.). Green WT follows a decay kinetics 
with a t1/2 of 7.17±0.98 min whereas green SS shows a t1/2 of 12.05±3.4 min. This suggests only 
a slight stabilization in the case of the double cysteine mutant.   
 
Figure 4.54. Thermal and chemical stability of green SS. (A) Thermal stability assay was carried out 
at 37ºC with green WT and green SS in DM. Plot showing the decrease of absorbance at the λmax in 
the visible region over time. (B) Green WT and Green SS were treated with 50 mM hydroxylamine pH 
7.0 at 20ºC for the chemical stability assay. Chemical reagent stability was determined by monitoring 
the decrease of λmax over time.  
 
The binding pocket of cone opsins is more “open” or “flexible” than that of rhodopsin (148,200) 
allowing hydroxylamine to get into the binding pocket and react with retinal forming  
retinaloxime and shifting the absorbance to ~360 nm. After measuring the dark state spectra of 
green WT and green SS at room temperature, 50 M hydroxylamine was added, mixed well and 
the spectra were recorded every min until the complete decay of the visible band could be attained. 
The kinetics of the chemical decay process was measured by plotting the absorbance maximum 
versus time (Fig. 4.54B). Interestingly, the t1/2 of the hydroxylamine decay kinetics for green WT 
is 34.65± 4.03, and for green SS is 44.7±3.25. This shows that the disulfide bond introduced can 
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slightly increase the chemical stability of the chromophore.  Therefore, green SS may be a good 
candidate to study the molecular properties of cone pigments as, biochemical and biophysical 
properties are similar, or even better, to those of green WT. 
 
Green SS-N94K 
After establishing that green SS binding pocket is stable, it would be interesting to introduce the 
N94K mutation into green SS and compare the results with green SS and green WT. Site directed 
mutagenesis was carried out using green SS as a template with N94K mutagenic primer. The 
resulting product was sequenced and the corresponding mutation was validated. Green SS-N94K 
gene was expressed in COS-1 cells. The transfected cells were harvested and regenerated with 
11CR and immunopurified using 1D4-Sepharose beads. The purified sample was analyzed by 
means of UV-Vis spectrophotometry. The dark spectrum showed a similar behavior to that 
previously seen, with a band around 360 nm and a non-aggregated protein peak at 280 nm (Fig. 
4.55). It suggests that N94K mutation at the TM2 of green cone opsin has an altered conformation 
which is very hard to revert.  
 
 
 
 
 
 
 
 
 
Figure 4.55. Expression of green SS-N94K. The UV-Vis Spectrum of purified Green SS-N94K in the 
dark, which was expressed in COS-1 cells and regenerated with 11CR. 
 
4.5.5. Comparison of green cone N94K mutant with a sectoral Retinitis Pigmentosa (RP) 
mutant of rhodopsin  
Retinitis Pigmentosa (RP) is a group of inherited heterogenous retinal degenerative diseases 
clinically characterized by progressive night blindness, visual field restriction, tunnel vision, and 
eventually complete blindness and they are prevalence in 1 in 4000 worldwide (219). Sectoral RP 
is an atypical form of RP, characterized by pigmented retinopathy and initially restricted to the 
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inferior quadrant of the retina and further progressive over time (147,220). Though several point 
mutations are known to cause such sectoral RP, N78I mutant of rhodopsin (Rho N78I) has been 
identified to cause sectoral RP and this mutation is located at the corresponding analogous 
position to that of N94K in the case of green cone opsin, N2.45 of TM2 (221). Considering the 
structural instability of green N94K, comparing the molecular properties of rhodopsin N78I with 
green N94K may shed some light into the structural defects underlying the disease phenotype.  
 
Rhodopsin N78I 
Site directed mutagenesis was employed to introduce the N78I mutation into the pMT4 plasmid 
containing the rhodopsin gene. After validating the sequence of the N78I mutated gene, it was 
expressed into COS- cells using PEI transfection and incubated for 36-48 hrs. The transfected 
cells were harvested, regenerated with 11CR, solubilized with DM and immunopurified using 
rho-1D4-Sepharose beads. The purified sample was spectrally analyzed in the dark, and after 
illumination and acidification. The results showed that N78I can regenerate with 11CR at 500 nm 
similar to WT rhodopsin. The illuminated and acidified samples of rho N78I also behave as WT 
rhodopsin (Fig 4.56). 
 
 
 
 
 
 
 
 
Figure 4.56. Characterization of rhodopsin N78I. The UV-Vis Spectrum of purified rhodopsin N78I 
in dark, which was expressed in COS-1 cells and regenerated with 11CR. The sample was illuminated 
(>495 nm) followed by acidification using 2N H2SO4. 
 
Rhodopsin N78K 
To the aim of comparing N2.45 of rhodopsin and green cone opsin, and obtain further information 
it was decided to construct the mutant of rho N78K.   
Using site directed mutagenesis, rho N78K was constructed and the sequence was validated. The 
mutant was transfected into COS-1 cells and regenerated with 11CR. The expressed rho N78K 
was immunopurified and the sample was spectrally analyzed. The dark state spectrum of the 
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sample consists of a peak at 360 nm which is similar to Green N94K and upon acidification the 
peak is shifted to 440 nm suggesting binding or 11CR to opsin by means of an unprotonated Schiff 
base linkage (Fig 4.57). 
 
Figure 4.57. Characterization of Rhodopsin N78K. (A) The UV-Vis Spectra of purified rhodopsin 
mutant in dark (solid line), and acidified by 2N H2SO4 (dashed line). (B) Difference spectrum between 
the acidified - dark N78K rhodopsin.  
 
It is worth noting that the Lys residue introduced may alter specific amino acid interactions 
disrupting the functional conformation of visual pigments around the region of N2.45. In the case 
of a similar mutation in rhodopsin, N55K, also causing sectoral RP and located at TM1, the 
introduced Lys impairs the retinal release from the binding pocket of rhodopsin (147).  
Overall, from the different experimental approaches undertaken in order to analyze the structural 
alterations behind the lack of chromophore regeneration for the N94K green mutant, it can be 
concluded that the lysine in green N94K encompasses a structural instability by the introduced 
Lys mutation which cannot be successfully compensated by any of these strategies. Further 
studies should be carried out in order to obtain more insights that can provide meaningful 
information that can be of therapeutic interest for cone opsin mutations associated with vision 
disorders. 
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5. GENERAL DISCUSSION 
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Rhodopsin is the most thoroughly studied GPCR and the first GPCR whose crystal structure was 
elucidated (48) which confirmed the basic structural features of the receptor shared by the diverse 
GPCR superfamily. Later, in the past eight years, various active and inactive conformations of 
GPCRS were determined by successive crystallizations and this lead to an important advance in 
our understanding of the mechanism of GPCR function, and the specific roles of individual amino 
acids (49,81,222). Among the ~700 identified members of the rhodopsin-like family of GPCRs, 
>20 of them have been crystalized and their structures have been solved at atomic resolution. 
These structures have been used as templates to study the behavior of other members of the 
GPCRs, from which, most of them could be of therapeutic interest (223-225). As the crystal 
structure of the cone pigments is yet to be resolved, identifying the key structural and functional 
features of these pigments (which are different from those of rhodopsin) should provide useful 
clues on the color vision process and would help in finding novel therapeutic strategies for 
congenital retinal disorders associated with cone dysfunction. In that aspect, the present study has 
determined novel molecular properties of these cone pigments by means of biochemical and 
biophysical methods. The current study also highlights key differences in the structural 
determinants of cone opsin function and regeneration which has been traditionally believed to be 
similar to that of rhodopsin.  
Concerning the stability of opsins, it is commonly accepted that the ligand-free opsin species are 
highly unstable in solution, and the chromophore accessibility is questionable in the later phase 
of photoactivation. The fate of purified opsin after photoactivation was examined in a previous 
study (158)  where the regeneration ability of photoactivated rhodopsin gets abolished with time 
and this effect was correlated with the stability of ligand-free opsin in detergent solution. The 
results of the present study are in agreement with the previous finding in a way because we find 
that 11CR is not able to regenerate with rhodopsin 90 min after photoactivation, but interestingly 
we observed that it can regenerate with 9CR under the same experimental conditions (Fig. 4.10). 
More interestingly, cone opsins which are believed to have a less stable opsin conformation than 
rhodopsin (chapter 1, results and discussion) can regenerate better than rhodopsin with both 
retinal analogs (Fig. 4.15). These findings lead to a reevaluation of the criteria on the stability of 
ligand-free opsin, particularly for cone opsins.  
The structure-function relationships of the photoreceptor proteins from cone cells have been 
classically compared to those of rhodopsin, and only differences in spectral tuning have been 
proposed. Thus, the structure of rhodopsin served, until now, as a template for understanding the 
molecular mechanisms of cone opsins (50). Similarly, from part of the thesis, the regeneration 
process of photoactivated red cone opsin was compared to that of rhodopsin at a later phase after 
illumination, where the flexible red cone opsin regenerates with 11CR and 9CR, but rhodopsin 
appears to restrict the entry of 11CR. Red cone opsin was also compared with green cone opsin 
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for the regeneration process immediately after illumination. Intriguingly, different regeneration 
behavior was observed which has led to the proposal of different regeneration modes for the two 
highly homologous red and green cone opsins regenerating with both the analogs as mentioned 
above. These findings are schematically represented in Fig. 5.1 with a red cone opsin central 
model and attributing a more versatile conformational nature of red (and green) cone opsin 
conformation in the regeneration process when compared to rhodopsin.    
 
Figure 5.1. Schematic representation of regeneration of visual pigments with retinal analogs. The 
regeneration experiments with retinal analogs were carried out with rhodopsin and red cone opsin at 
a later phase of photoactivation suggesting the versatile nature of red cone opsin binding pocket. The 
same was compared between red and green cone opsins but immediately after illumination, reveal 
different retinal binding modes but the behavior of red cone opsin unaltered. 
 
Leber’s congenital amaurosis (LCA) is a group of retinal degenerative disorders, in which vision 
loss is associated with abolished 11CR synthesis but featuring relatively preserved retinal cells 
(226,227). QLT, an undisclosed 9-cis-retinoid analog, has been tested as a potential therapeutic 
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molecule for the clinical abnormalities associated with LCA (228). In the present study, it was 
also found that 9CR has better regeneration properties in various time-points after photoactivation 
as well as with all the visual pigments examined. These results are coherent with the view that 
9CR, or chemically modified analogs of 9CR, could eventually be employed for the treatment of 
various visual disorders in which mutations impair chromophore regeneration of visual opsins.  
A recent study has identified a proposed mechanism for conformational selection of retinal 
isomers by opsins (173). This study can be correlated with the present study in which the 
regeneration experiments performed with cone pigments and rhodopsin at immediately and later 
phase after photoactivation using 11CR and 9CR. We postulate that the fine-tuning mechanism 
mediated by the activated transient conformations (which are able to regenerate differently with 
different specific retinal analog) would depend on the complementary combination of 
accessibility and specificity of the chromophore towards a specific transient intermediate opsin 
conformation. This would provide a mechanistic, a possible functional, difference between the 
cone opsins and rhodopsin. 
 
Figure 5.2. Molecular mechanism of chromophore regeneration in photoactivated cone opsins. 
The cone pigments heterologously expressed in mammalian cells are regenerated with 11CR and 
immunopurified (I). Exogenous 11CR is added in the dark, to the immunopurified regenerated 
sample, and the sample is subsequently illuminated. This causes the isomerization of opsin-bound 
11CR to ATR resulting in a protein conformational change. This facilitates fast pre-binding of free 
11CR to a secondary, lower affinity, retinal binding site followed by chomophore regeneration (II). 
Fast chromophore regeneration would be achieved by translocation and covalent binding of this pre-
bound 11CR to the chromophoric binding pocket by displacing ATR which in turn would move out 
from the protein. Further, a secondary uptake of 11CR by the visual pigment, with a slower kinetics, 
may be associated with the conformational change of the regenerated protein coupled with the 
reduced availability of bulk 11CR that would synergistically decelerate 11CR binding to the 
secondary site (III). Under the experimental conditions of the present study this would lead, at this 
stage, to 11CR-regenerated visual pigment harboring an additional 11CR bound to the postulated 
secondary binding site (IV). 
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The molecular mechanism behind the transient conformation regenerating with 11CR is 
represented in the model depicted in Fig. 5.2. This secondary retinal uptake regeneration 
mechanism is not observed with 9CR in red/green cone pigments, but can be clearly identified in 
the case of blue cone opsin. This suggests that the secondary retinal uptake, by the photoactivated 
visual pigments, is not only modulated by the accessibility of the free retinal occupying the 
secondary site, but also to the specificity towards the functional groups of specific amino acids 
involved in ligand binding for the different opsins.  
 
Figure 5.3. Interhelical interactions from green cone pigment. The interactions between S176, 
W177 and N94 was visualized using PyMOL showing a polar clamp hydrogen bonded network 
between TM2 and TM4. The hydrogen bonds are shown in dashed lines. 
 
Molecular modeling of the native green cone pigment (Fig. 5.3) identified a polar clamp hydrogen 
bonded network between TM2 and TM4, formed by the residues W1774.50, S1764.49 and N942.45  
where the OH of S176 hydrogen bonded with NH2 of  N94 and the C=O of N94 establishes a 
polar interaction with nitrogen from the indole ring of W177, similar to rhodopsin (229,230). 
W4.50 is a highly conversed residue, among GPCRs, and the cytoplasmic ends of TM2 and TM4 
diverge and TM3 penetrates towards TM5 enabling the counterion E3.28 to position to the closer 
vicinity of the Schiff base by 3.5 Å for protonation (48,222). Disrupting the interhelical hydrogen 
bonding network which stabilizes the TM2 and TM4, may result in an unstable conformation.  
The role of W1774.50 in the functional folding of green cone pigment has also been identified 
earlier (59). W177R mutation, in human green cone, causes protein misfolding and retention in 
endoplasmic reticulum, and purified mutant does not show any regeneration (Fig.4.40). This 
could be the underlying cause of degenerative cone dystrophy. The N94K may possibly disrupt 
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the polar interaction with W177 which may not as drastic as W177R (177 position is further away 
from the retinal binding site). Hence the Lys mutation destabilizing the optimal conformation of 
the green cone opsin with a structural alterations, either by steric hindrance exhibited by the 
bulkier functional group or by charged amino group polar contacting with neighboring residues. 
This may result in a shift of E1293.28 counterion away from the Schiff base which could lead to 
an unprotonated Schiff base linkage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
6. CONCLUSIONS  
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The molecular investigation of human recombinant cone opsins, using various biochemical and 
biophysical approaches, unraveled novel molecular mechanisms underlying chromophore 
regeneration of these pigments. Clinically identified cone opsin mutants, associated with visual 
disorders have been characterized at the molecular level. 
The main findings of the present study are: 
General properties of human cone opsins  
 
 The biophysical properties of human cone opsins, i.e. photoactivation, MetaII decay, 
thermal stability and hydroxylamine reactivity, have been compared with those of 
rhodopsin and confirm that cone opsins are less stable in solution and their retinal binding 
site is more accessible than that of rhodopsin. 
 
 With regard to functional activity, cone opsins appear to activate rod transducin less 
efficiently, which would be consistent with the known physiological response for cone 
pigments. 
 
Regeneration of red cone opsin compared with rhodopsin 
 
 The constricted retinal binding site of rhodopsin (together with an inherently less-stable 
retinal binding pocket in the opsin conformation) restricts the entry of 11CR but permits 
the entry of 9CR into the retinal binding site a long time after photoactivation. In contrast, 
the flexible (and more stable in the opsin state) retinal binding site of red cone opsin is 
open to the entry of either retinal isomer.  
 
 In red cone opsin, both retinals benefit from the interaction with W1834.56 (lacking in 
rhodopsin), which favors the entry of 11CR and 9CR into the retinal binding site. 
However, 9CR interacts more favorably than 11CR with Y268/2846.51 and W265/2816.48. 
This would be justified by the stronger interaction energy acquired by the C-13 methyl 
group of 9CR from Y268 and W265, favoring the entry into the rhodopsin retinal binding 
site, which is lower in the case of the 11CR ligand.  
 
 NaPi buffer improves the regeneration of rhodopsin by presumably favoring the 
oligomerization status of rhodopsin in detergent solution. This buffer lacks chloride 
(which is present in PBS buffer), and as chloride binding to opsin is important for the 
stability of cone opsins, these fail to regenerate with retinal when using NaPi buffer. 
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Mechanism of chromophore regeneration in red, green and blue cone opsins  
 
 The photoactivated green cone opsin regenerates with 11CR via an unprotonated Schiff 
base linkage whereas red cone opsin forms a typical protonated Schiff base with its 
natural chromophore. It is possible that these two pigments regenerate with 9CR via a 
protonated Schiff base linkage. 
 
 The lack of F309 hydrogen bonding with T201 in green cone opsin, and the fact that the 
Y309F mutant of green cone opsin can partially regenerate via a protonated Schiff base 
with 11CR, proves that these two highly homologous visual pigments adopt different 
transient intermediate conformations prior to dark adaptation. 
 
 The retinal binding kinetics of red/green cone opsins is faster when compared to that of 
rhodopsin with both retinal analogs. Considering retinal entry into the protein, 11CR 
follows (unlike 9CR) a slow sigmoidal pattern which is in contrast to the faster retinal 
binding kinetics, suggesting a secondary retinal entry into photoactivated red/green cone 
opsins. 
 
 In the case of blue cone opsin, the proposed secondary retinal uptake has been observed 
with both retinal analogs and 15 min after photoactivation. After this period of time, blue 
cone opsin loses the ability to bind 11CR to the secondary site but this is not the case with 
9CR. This behavior would be due to the binding of 11CR to the canonical binding site of 
rhodopsin at a later phase after photoactivation. 
 
Characterization of cone opsin mutants associated with visual dysfunction  
 
  Most of the mutants of cone pigments which are associated with congenital visual 
disorders used in the present study fail to regenerate with retinal due to protein 
misfolding, defective trafficking and also aggregation of the corresponding apoproteins 
in solution. 
 
 R330Q mutant of green cone opsin, causing deuteranopia in humans, is able to regenerate 
with 11CR. The characterization studies showed that the biochemical and biophysical 
properties of this mutant are similar to WT pigment except for an altered transducin 
activation ability. 
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 Another deuteranopic mutant, N94K shows a band at 360 nm which shifts to 440 nm 
upon acidification, suggesting the presence of unprotonated Schiff base binding of 11CR 
to the apoprotein with a compromised stability. 
 
 Various stabilizing attempts performed with the N94K mutant include incorporating the 
mutant into micelles and bicelle environments, regenerating with retinal analogs, co-
transfecting with a thermostable rhodopsin mutant, and introducing potentially stabilizing 
disulfide bonds. None of these attempts has been successful in stabilizing the opsin 
conformation so as to allow chromophore regeneration of the N94K mutant. 
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